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Ongoing advances in tissue engineering with the goal to address the clinical 
shortage of donor organs have encouraged the design and development of biomaterials to 
be used in tissue-engineered scaffolds.  Furthermore, biomaterials have been used as 
delivery vehicles for vaccines that aim to enhance the protective immunity against 
pathogenic agents.  These tissue-engineered constructs or vaccines are usually 
combination products that combine biomaterial and biological (e.g. cells, proteins, and/or 
DNA) components.  Upon introduction into the body, the host response towards these 
products will be a combination of both a non-specific inflammatory response towards the 
biomaterial and an antigen-specific immune response towards the biological 
component(s) [1].  Recently, the biomaterial component was shown to influence the 
immune response towards a co-delivered antigen.  Specifically, poly(lactic-co-glycolic 
acid) (PLGA), but not agarose, scaffolds or microparticles (MPs) enhanced the humoral 
response to a model antigen, ovalbumin [2-4].  This in vivo result echoed with the in vitro 
study that PLGA, but not agarose, supported a mature phenotype of dendritic cells (DCs), 
the most potent antigen-presenting cells.  Therefore, it is hypothesized that the effect of 
biomaterials on DC phenotype may influence the adaptive immunity against a co-
delivered antigen.  Understanding how biomaterials affect DC response will facilitate the 
selection and design of biomaterials that direct a desired immune response for tissue 
engineering or vaccine delivery applications.  
The objectives of this research were to elucidate the correlations between material 
properties and DC phenotype, develop predictive models for DC response based on 
material properties, and uncover the molecular basis for DC response to biomaterials.  
Well-defined biomaterial systems, including clinical titanium (Ti) substrates and two 
polymer libraries, were chosen to study induced DC phenotype.  
xix 
 
Due to the time-consuming nature of conventional methods for assessing DC 
phenotype, a high-throughput (HTP) method was first developed to screen for DC 
maturation based on surface marker expression (CHAPTER 4).  A 96-well filter plate-
based HTP methodology was developed and validated for the assessment of DC response 
to biomaterials.  A “maturation factor”, defined as CD86/DC-SIGN and measured by 
immunostaining, was found to be a cell number-independent metric for DC maturation 
and could be adapted to screen for DC maturation in a microplate format. This 
methodology was shown to reproducibly yield similar results of DC maturation in 
response to biomaterial treatment as compared to the conventional flow cytometric 
method upon DC treatment in 6-well plates.  In addition, the supernatants from each 
treatment could easily be collected for cytotoxicity assessment using glucose-6-phosphate 
dehydrogenase (G6PD)-based assay and cytokine profiling using multiplex technology.  
In other words, the 96-well filter plate-based methodology can generate three outcomes 
from one single cell culture: 1) maturation marker expression, 2) cytotoxicity, and 3) 
cytokine profile.   
To examine which material properties were critical in determining DC phenotype, 
a set of three clinical titanium (Ti) substrates with well-defined surfaces was used to treat 
DCs (CHAPTER 5).  These Ti substrates included pretreatment (PT), sand-blasted and 
acid-etched (SLA), and modified SLA (modSLA), with different roughness and surface 
energy.  DCs responded differentially to these substrates.  Specifically, PT and SLA 
induced a mature DC (mDC) phenotype, while modSLA-treated DCs remained immature 
based on surface marker expression, cytokine production profiles and cell morphology.  
Both PT and SLA induced higher CD86 expression as compared to iDC control, while 
modSLA maintained CD86 expression at a level similar to iDC.  PT- or SLA-treated DCs 
exhibited dendritic processes associated with a mDC phenotype, while modSLA-treated 
DCs were rounded, a morphology associated with an iDC phenotype.  Furthermore, PT 
induced increased secretion of MCP-1 by DCs compared to iDCs, indicating that PT 
xx 
 
promoted a pro-inflammatory environment.  SLA induced higher IL-16 production, 
which is a pleiotropic cytokine, by DCs, most likely as a pro-inflammatory response due 
to the enhanced maturation of DCs induced by SLA.  In contrast, modSLA did not 
induced enhanced production of any cytokines examined.  Principal component analysis 
(PCA) were used to reduce the multi-dimensional data space and confirmed these 
experimental results, and it also indicated that the non-stimulating property of modSLA 
co-varied with certain surface properties, such as high surface hydrophilicity, % oxygen 
and % titanium of the substrates.  In contrast, high surface % carbon and % nitrogen were 
more associated with a mDC phenotype.  Furthermore, PCA also suggested that surface 
line roughness (Ra) did not contribute to the expression of CD86, an important maturation 
marker, suggesting that roughness had little impact on DC response (CHAPTER 5).  
DC response-material property relationships were also derived using more 
complex materials from a combinatorial library of polymethacrylates (pMAs) 
(CHAPTER 6).  Twelve pMAs were selected and were found to induce differential DC 
response using the HTP method described in CHAPTER 4.  These pMAs resulted in a 
trend of increasing DC maturation represented by the metric CD86/DC-SIGN, which was 
consistent with the trends of the production of pro-inflammatory cytokine, TNF-α, and 
chemokine, IL-8.  Interestingly, this set of pMAs induced an opposite trend of IL-16 
production, which is most likely released as an anti-inflammatory cytokine in this 
situation. These polymers were characterized extensively for a number of material 
properties, including surface chemical composition, glass transition temperature (Tg), air-
water contact angle, line roughness (Ra), surface roughness (Sa), and surface area.  
Similar to the results from the Ti study, PCA determined that surface carbon correlated 
with enhanced DC maturation, while surface oxygen was associated with an iDC 
phenotype.  In addition, Tg, Ra, and surface area were unimportant in determining DC 
response.  Partial square linear regression (PLSR), a multivariate modeling approach, was 
implemented using the pMAs as the training set and a separate polymer library, which 
xxi 
 
contained methacrylate- and acrylate-based terpolymers, as the prediction set.  This 
model successfully predicted DC phenotype in terms of surface marker expression with 
R
2
prediction = 0.76.  Furthermore, prediction of DC phenotype was effective based on only 
theoretical chemical composition of the bulk polymers with R
2
prediction = 0.80 (CHAPTER 
6).  Nonetheless, one should note that a predictive model can be only as good as what it is 
trained on and cannot be used to predict the DC response induced by a type of materials 
different from the training set.  Also, this model might not contain all the important 
material properties such as polymer swelling and cannot predict specific types of immune 
responses.  However, these results demonstrated that a generalized immune cell response 
can be predicted from biomaterial properties, and computational models will expedite 
future biomaterial design and selection (CHAPTER 6). 
From the pMA library, pMAs that induced the two extremes of DC phenotype 
(mature or immature) were identified for elucidating the mechanistic basis of biomaterial-
induced DC responses (CHAPTER 7). Two pMAs, polyhydroxyethylmethacrylate 
(pHEMA) and poly(isobutyl-co-benzyl-co-terahydrofurfuryl)methacrylate (pIBTMA), 
were selected because they induced the least and the most mature DC phenotype, 
respectively.  These pMAs were used to elucidate the activation profiles of transcription 
factors in DCs after biomaterial treatment and were compared to the iDC and mDC 
controls.  In addition, a combined treatment of pHEMA and LPS was also included to 
determine if pHEMA could maintain an iDC phenotype in the presence of LPS.  
Interestingly, pIBTMA induced DC maturation primarily through the activation of NF-
κB, while pHEMA mediated suppression of DC maturation through multiple TFs, 
including the activation of ISRE, E2F-1, GR-PR, NFAT, and HSF.  GR-PR and E2F-1 
have been shown to be associated with the suppression of DC maturation; ISRE, E2F-1, 
and NFAT are linked to apoptosis induction; HSF regulates the production of heat shock 
proteins (HSPs) that induce DC maturation and inhibit apoptosis.  The activation of HSF 
by pHEMA was most likely a natural defensive mechanism against the other apoptotic 
xxii 
 
signals.  Therefore, pHEMA suppressed DC maturation through the induction of 
apoptosis.  Surprisingly, in the presence of pHEMA, the effect of LPS was completely 
eliminated, suggesting that biomaterials can override the effect of soluble factors.  The 
morphology and surface marker expression of DCs treated with these different 
biomaterials or controls were consistent with TF activation profiles (CHAPTER 7). 
Overall, this research illustrates that biomaterial properties, within the chosen 
biomaterial space, can be correlated to DC phenotype and more importantly, can be used 
as predictors for relative levels of DC phenotype.  Furthermore, the differential responses 
induced by different biomaterials were mediated through the distinct activation profiles 
of transcription factors.  Together, these findings are expected to facilitate the design and 










CHAPTER 1: INTRODUCTION 
 
Biomaterials are widely used as scaffolds for tissue-engineered constructs and as 
delivery vehicles for vaccines, both of which often combine biological and biomaterial 
components.  The success of such engineered products relies on their ability to minimize 
or maximize host immune response, respectively.  In addition to the non-specific 
inflammatory response against the biomaterial component, the biologics can induce 
antigen-specific immune response from the host.  However, the potential of biomaterials 
to modulate the specific immune response towards the antigens associated with the 
biological component, through an adjuvant effect, has only been recently explored [3,4]. 
Biomaterials commonly used in combination products were previously shown to 
differentially affect DC phenotype in vitro. Specifically, PLGA and chitosan films 
promote DC maturation, agarose films maintain an iDC phenotype, and hyaluronic acid 
films promoted an even more immature phenotype [5,6].  In addition, PLGA, but not 
agarose, enhanced the humoral immune response towards a co-delivered antigen in vivo 
in a murine model through a biomaterial adjuvant effect [3,4].  These studies suggested 
that biomaterials can be employed to modulate DC phenotype, thereby controlling the 
associated in vivo host immune response towards the biologic components in 
combination products.  However, the biomaterial systems used previously were not 
sufficient in determining which material properties directed the distinct DC response.  
Therefore, well-characterized material systems and combinatorial libraries of polymers 
are expected to allow for the elucidation of correlations between DC phenotype and 
material properties, which will provide guidelines for immuno-modulatory biomaterial 
design for both tissue engineering and vaccine delivery applications.  
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However, the assessment of DC maturation by flow cytometry is a time-
consuming process that is suitable to evaluate only a limited number of biomaterials.  As 
a result, a high-throughput (HTP) methodology to study DC phenotype is desired to 
facilitate the derivation of biomaterial property-DC phenotype relationships as well as the 
development of computational models for predicting DC response from material 
properties.  Furthermore, although toll-like receptors (TLRs) and integrins have been 
recently shown to play a role in mediating DC response, the exact mechanisms by which 
DCs recognize and respond to biomaterials remain to be elucidated.   
The objectives of this thesis research were to derive DC phenotype-
biomaterial property relationships and to correlate DC response to biomaterials 
with activation profiles of transcription factors.  The central hypothesis was that using 
well-defined biomaterial systems with controlled variations in material properties, 
correlations can be drawn between material properties and DC response.  More 
specifically, DCs respond to the biomaterials differentially due to the different material 
properties, which result in differential presentation of proteins on the surfaces as shown 
previously [7].  It was hypothesized that different biomaterials trigger differential DCs 
respond through signaling pathways leading to distinct activation profiles of transcription 
factors.  
The overall objectives were accomplished by testing our central hypothesis in the 
following specific aims: 
 
Specific Aim 1:  Validate a 96-well filter-plate-based, high-throughput 
screening methodology to assess the effects of biomaterials on dendritic cells.  The 
working hypothesis was that DC treated with biomaterials in a 96-well format would 
respond similarly as the DCs treated in the conventional 6-well format with the results 
obtained by the fluorescent plate reader for CD86 expression (DC maturation) being 
equivalent to the flow cytometry analysis, in this way validating the HTP analysis.  
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Different cell fixation schemes were examined to choose the best fixation method for 
DCs in the filter plate method.  Cell normalization methods by DC-specific markers, 
including CD1c and DC-SIGN, were investigated.  The assessment of DC maturation by 
the filter-plate methodology was compared to the conventional flow cytometric analysis.  
Finally, biomaterials with known effects on DC maturation were used to validate the HTP 
methodology by comparing the results to conventional flow cytometric analysis. 
 
Specific Aim 2: Correlate DC phenotype upon treatment with biomaterial 
surfaces of controlled changes in material properties using the high-throughput 
screening methodology.  The working hypothesis was that correlations between DC 
maturation and material properties could be derived using controlled biomaterial systems. 
Through collaboration with Drs. Barbara Boyan and Zvi Schwartz at Georgia 
Institute of Technology, titanium (Ti) disks of distinct surface roughnesses, 
hydrophilicity, and chemistry were used to study DC phenotype.  DC response was 
assessed by maturation marker expression using flow cytometry, cell morphology using 
scanning electron microscopy, and cytokine profiles by multiplex bead-based cytokine 
assay based on the Luminex xMAP technology.   Principal component analysis was used 
to confirm the differential responses induced by the different Ti surface and derive 
material property-DC response relationships.  
Through collaboration with Dr. Joachim Kohn at Rutgers University, two 
combinatorial libraries of polymers, namely, a pMA library and a methacrylate- and 
acrylate-based terpolymer (simplified as “terpolymer”) array were used to further study 
the correlations between DC phenotype and biomaterial properties.  Twelve polymers 
from each of the libraries were selected.  Material properties characterized included a) 
surface roughness (Ra and/or Sa), b) contact angle, c) Tg, and d) surface chemical 
composition for both libraries.  For the terpolymer library, additional characterization 
was carried out, including water modulus and time of flight secondary ion mass 
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spectroscopy (ToF-SIMS).  DC phenotype was characterized using the HTP method 
developed in Specific Aim 1, which provided surface maturation marker information as 
well as cytokine profile data.  PCA was then performed on the DC phenotype data 
derived from the pMA library to discover covariations between material properties and 
DC phenotype.  Furthermore, several partial linear squares regression (PLSR) models 
were developed using the pMA library as the training set and the terpolymer library as 
the prediction set.  PLSR models aimed to optimize the correlations between X and Y 
data matrices, where X included the material property information and Y contained DC 
phenotype data.   
 
Specific Aim 3: Correlate biomaterial-induced DC response with activation 
profiles of transcription factors.   The working hypothesis was that using the pMA 
library and the HTP method, pMAs that induced the two extremes of DC phenotype 
(mature or immature) could be identified, and the differences in DC behavior to material 
properties could be mediated by distinct activation profiles of transcription factors. Two 
pMAs, polyhydroxyethylmethacrylate (pHEMA) and poly(isobutyl-co-benzyl-co-
terahydrofurfuryl)methacrylate (pIBTMA), were chosen from Specific Aim 2 because 
they induced the least and most mature DC phenotype, respectively.  The activation 
profiles of eight transcription factors, including NF-κB, ISRE, AP-1, E2F-1, CREB, 
GR/PR, NFAT, and HSF, induced by these two pMAs were analyzed and compared to 
the TCPS-treated immature DC (iDC) or LPS-treated mature DC (mDC) control.  
Specifically, nuclear extracts were prepared from differentially treated DCs and were 
quantified for the binding of target transcription factors to specific DNA probes.  The 
morphology and surface marker expression of differentially treated DCs were also 
assessed to further confirm the effects of the two pMAs on DCs.   
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CHAPTER 2: RESEARCH SIGNIFICANCE 
 
 As of 2005, in the United States, there were nearly 90,000 patients registered to 
receive 95,000 organ transplants.  However, the total number of available organs for 
transplantation was approximately 27,000 (Transplant Statistics: The Organ Procurement 
and Transplantation Network / The Scientific Registry of Transplant Recipients).   
Furthermore, the current national healthcare costs are in excess of $1.5 trillion annually, 
or 13% of Gross Domestic Product (GDP).  With the ageing population, it is estimated 
that 25% of the U.S. GDP would be contributed to health care by 2040 (U.S. Department 
of Health and Human Services).   As a result, health care economics are now driving 
industry to produce cures and vaccines rather than simply therapies, and tissue 
engineering and preventative medicine have emerged to be prospective alternatives to 
organ transplantation and a means to prevent diseases, respectively[1,8,9].    
 Biomaterials are widely used as the carriers of biologics in combination products 
for tissue regeneration [10,11] or vaccine delivery [12].  In order for tissue engineered 
devices to reach their full therapeutic potential, they must be accepted by the host to 
integrate in a fully functional manner.   In contrast, vaccine delivery seeks to enhance or 
maximize a protective immunity.    These devices may evoke both an adaptive immune 
response against the biologics and a non-specific inflammatory response against the 
biomaterial component.  The success of such products relies on their ability to minimize 
or maximize host immune response, respectively.   
 Biomaterials commonly used in tissue engineering or vaccine delivery were 
previously shown to differentially influence DC phenotype in vitro [5,6], which were 
translated into corresponding in vivo humoral response against a co-delivered antigen 
[3,4].  Understanding how biomaterials elicit such distinct DC responses will facilitate 
the design and selection of future biomaterials for tissue engineering or vaccine delivery, 
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where distinct and optimal immune responses are desired.  However, the material systems 
used in previous studies were not sufficiently controlled to determine which material 
properties contributed to such differential effects.  
 The objectives of this research were two-fold.  First, it aimed to derive 
correlations between material properties and DC phenotype as well as to develop 
computational model for predicting DC phenotype based on material properties.  Second, 
this research sought to correlate DC’s response to biomaterials with the profiles of 
transcription factor activation.  With the understanding of DC phenotype-material 
property relationships, the computational models developed could predict DC response 
based on the chemical composition of the polymers, which is expected to expedite future 
biomaterial design for immunomodulatory effects on DCs.  Such predictive models will 
reduce research costs overall because they allow for rational selection of biomaterial 
formulations before any synthesis, characterization, and biological experiments are 
performed.  Furthermore, the understanding of the transcription factor activation profiles 
upon biomaterial treatment will facilitate the design of biomaterials that can trigger the 
activation of certain TFs.  Specifically, for tissue-engineered devices or modulation of 
transplant rejection, biomaterials that trigger the activation of immunosuppressive TFs 
should be selected.  In contrast, for vaccine delivery or cancer therapy, biomaterials that 
can trigger strong activation of immunostimulatory TFs should be selected for maximal 





CHAPTER 3: LITERATURE REVIEW* 
 
3.1. Innate and adaptive immunity  
Vertebrates are protected by two systems of immunity: innate and adaptive.  
Innate immunity serves as the first line of defense against foreign entities that is achieved 
by conserved effector functions such as complement activation to mark foreign entities 
with activation fragments [13] that can be recognized by phagocytes [14,15] for clearance 
and destruction of the invader.  It is a rapid and non-specific response by the host to clear 
the foreign pathogens or materials, to repair tissue damage and to remove apoptotic cells 
[16-18].  The complement system is composed of a set of plasma proteins that can bind to 
the pathogen surfaces leading to proteolytic cleavage, whose fragments mediate an 
inflammatory response, pathogen recognition by phagocytes and ultimately resulting in 
cell lysis through the membrane attack complex [19,20].  The recognition of pathogens 
by these phagocytes results in the release of cytokines and chemokines that attract 
monocytes and neutrophils to infiltrate into the infected tissues from circulation and 
initiate the inflammatory response [21].    
Host organisms can also detect the presence of pathogens by recognizing a limited 
number of conserved structures, called pathogen-associated molecular patterns (PAMPs), 
associated only with micro-organisms [22,23].  Professional APCs including DCs and 
MΦs bind to PAMPs via pattern recognition receptors (PRRs) [24].  The ligation of PRRs 
often results in activation of the APCs for their enhanced abilities to stimulate T cells, 
which then causes the direct lysis of the infected cells by cytotoxic T cells, or activation 
of B cells to differentiate into plasma cells and synthesize antigen-specific antibodies 
[25,26].  An important family of PRRs is the toll-like receptors (TLRs) family, which, for 
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mammals, has 13 members in different cellular locations (both intra- and extracellularly) 
and has specificity to a broad array of microbial epitopes [25,27-31].  Other PRRs on 
DCs include C-type lectin receptors (CLRs), which bind to carbohydrates [32,33] and 
scavenger receptors, which has broad specificity to a variety of polyanionic ligands [27].  
In addition to these receptors, DCs can also recognize intracellular pathogens or 
pathogenic components with nucleotide-binding oligmerization domain (NOD) 
proteins[34], retinoic acid-inducible gene I (RIG-I)-like receptors such as melanoma-
differentiation-associated gene 5 (MDA5, also known as Ifih1 or helicard) [35] and RIG-I 
and DNA-dependent activator of interferon-regulatory factors (DAI) [36].  
 
3.2. Dendritic cells  
 Since the initial discovery of DCs by Steinman and Cohn [37], DCs have been 
demonstrated to play a pivotal role in the host responses to a variety of foreign entities 
[38].   Dendritic cells are sparsely but widely distributed APCs of hematopoietic origin 
that are specialized in the uptake, transport, processing and presentation of antigens to T 
cells [39-41].   Among APCs, which also include MΦs and B cells, only DCs are 
believed to be capable of stimulating naïve T cells [42].  Approximately 10 years ago, 
monocytes, initially thought to be the precursors of MΦs in vivo, were also found to 
migrate to injured sites and differentiate into DCs [43] in response to granulocyte-MΦ 
colony-stimulating factor (GM-CSF) and IL-4 [44,45].  Interestingly, in the presence of 
fibroblasts, which generate IL-6, monocytes differentiated into MΦs despite the presence 
of GM-CSF and IL-4 [46].  Thus, IL-6 may play a role in regulating the development of 
monocytic DCs and MΦs.  Analogous to MΦ’s M1 and M2 phenotypes, DCs can be 





Figure 3-1: Different subsets of monocyte-derived DCs, their inducers, phenotype, and functions.  
Immature DCs (iDCs) can be derived from monocytes in the presence of IL-4 and GM-CSF.  IL-6 
may maintain the differentiation of monocytes into MΦ despite the presence of IL-4 and GM-CSF.  
DCs can acquire different phenotypes in response to stimuli.  Danger signals and PAMPs can 
activate iDCs into classical mDCs that express higher levels of costimulatory molecules (CD80/86 and 
CD40), MHC class II molecules, release pro-inflammatory cytokines, migrate to the lymph nodes and 
stimulate naïve or memory T cells.  During the steady state, tolerogenic DCs are naturally actively 
induced in response to apoptotic cells and self-antigens.  These tolerogenic DCs release anti-
inflammatory cytokines such as IL-10 and induce T-cell anergy, T-cell apoptosis and/or Treg 
expansion.  DCs can also be alternatively activated by anti-inflammatory molecules such as 
dexamethosone and IL-10.  These aaDCs have been shown to release anti-inflammatory cytokines, 
induce Treg expansion and promote angiogenesis. 
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3.2.1. Inflammatory DCs (of myeloid origin) 
In the immature state, DCs act as sentinels in peripheral tissues, constantly 
sampling their microenvironment for potentially dangerous or foreign antigens and 
self/non-self proteins [41,48].  Immature DCs take up antigens through actin-dependent 
process of phagocytosis for particulate antigens and macropinocytosis or receptor-
mediated endocytsis for soluble antigens [48,49].  The receptors involved in endocytosis 
of pathogens include Fc receptors for antigen-antibody complexes, CLRs for glycans and 
complement receptors for complement fragment-coated pathogens.  Interestingly, CLRs 
and TLRs undergo cross-talk; that is, the binding of a ligand to one receptor can modulate 
or fine-tune the immunological outcome that arises from the binding of another ligand to 
the other [50].  Fc and complement receptors (CRs) are expressed on DCs and their 
expression alters upon DC activation.  For instance, during DC maturation, the 
percentage of CR3 positive cells decreased.  CR3 (CD11b/CD18) and CR4 
(CD11c/CD18) recognizes iC3b, the ligation of which facilitates antigen uptake.  In 
addition, DCs express FcγRs, FcαRs and FcεRs.  Binding of these FcRs to immobilized 
immunoglobulins leads to different DC responses [51].  For example, the ligation of 
CD32a (FcγRIIa), but not CD32b (FcγRIIb), with immobilized IgG induces DC 
maturation [52].  Furthermore, immature and mature DCs themselves can produce 
complement components C1q, C7, C8 and C4b binding protein [53,54].  The presence of 
complement component, C3, is also important in supporting functional DC differentiation 
and maturation in response to LPS in vitro [55].  Understanding the functions and 
interplay of these receptors and complement components during innate immune 
responses will provide insights into how DCs regulate immunity and tolerance.  
In addition to mediating the endocytosis of antigens, the recognition of pathogens 
by PRRs initiates signaling cascades (e.g., activation of NFκB, AP-1, MAPK and others) 
that leads to the maturation of DCs, which results in the change of morphology, the up-
regulation of co-stimulatory molecules (notably CD80 [B7.1] and CD86 [B7.2] in the B7 
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family) and MHC class I and II molecules and the release of pro-inflammatory cytokines 
[49,56].  Activated DCs transiently enhance antigen uptake but down-regulate their 
endocytic capacity after several hours [57,58] through the inactivation of a required 
rhoGTPase called Cdc42 [59].  Furthermore, DCs express different chemokine receptors 
at different stages of maturation.  Immature DCs express “inflammatory” chemokine 
receptors such as CCR2, CCR5, CCR6, CXCR1 and CXCR2 that allow them to respond 
to the chemokines released at the sites of inflammation.  Upon encountering maturation 
stimuli, DCs down-regulate the “inflammatory” chemokine receptors, up-regulate CCR7 
and migrate towards draining lymph nodes where they prime naïve T helper (Th) cells.  
CCR7, which regulates chemotaxis and migratory speed, binds to the chemokine, 
CCL21, expressed on the endothelial cells lining the lymphatic vessels and to CCL19 
expressed on the T cell area of the lymph node [60,61].  Matrix metalloproteinase-9 
(MMP-9) was demonstrated to be involved in DC migration through epithelial tight 
junction [62].   
Besides PRR ligands, extracellular matrix (ECM) proteins have also been found 
to affect DC phenotype.  For example, type I collagen, but not fibronectin or laminin, 
induced a fully matured DC phenotype, including the up-regulation of co-stimulatory 
molecules and enhanced allostimulatory capacity [63,64].  Furthermore, DCs possess 
many adhesion molecules such as the β1-integrin (CD29/CD49) [65] and β2-integrin 
family (CD11/CD18) [65,66].  These integrins mediate interactions between DCs and the 
ECM and may modulate DC phenotype.  Recently, the β2-integrin, CD18, was suggested 
to play a role in regulating DC behavior [67].  The maturation of DCs is a continuous 
process initiated in the periphery upon the encounter of antigens and the balance of pro- 
and anti-inflammatory cytokines and completed during the DC-T cell interaction in the 
secondary lymphoid organs [49,68].   
In the secondary lymphoid organs, mature DCs provide three signals to T cells to 
trigger their clonal expansion: “Signal 1” is the binding of antigen-loaded MHC molecule 
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with the T-cell receptor (TCR); “Signal 2” derives from the costimulatory molecules 
from mature DCs; “Signal 3” generates from cytokines that the cells secrete [58].  These 
signals also function to instruct the polarization of T cells and tune the immune response 
by modulating the amplitude or the type of the response depending on the type of 
pathogen [69].  In a 3D collagen matrix model, DC/T cell interactions were shown to be 
dynamic and short lived, and these repetitive short-term contacts trigger signaling for 
effective antigen presentation [70].  Furthermore, priming of T cells was inhibited in 
mindin deficient mice, suggesting that efficient T cell priming depends on the ECM 
protein mindin [71].   
The selection of effector immune functions is controlled by antigen-specific Th 
cells, which include Th1-, Th2-, Treg- and the recently discovered Th17-type cells at 
different ratios [58,72-74].  The most potent Th1 response inducer is thought to be IL-12, 
whose source seems to be restricted to the populations of APCs.  IL-12 directs the 
development of Th1 cells that express the T-box transcription factor T-bet and produce 
high amounts of IFN-γ.  In contrast, IL-4 directs Th2 response, causing the Th2 cells to 
express the zinc-finger transcription factor GATA3 and secret IL-4 [75].  More recently, 
pro-inflammatory cytokine IL-23 was shown to take a prominent role in the expansion of 
IL-17 secreting T cells and hence the name Th17 response [74].  These Th cells are 
differentially regulated and have distinct functions in immunity.  The antigen-specific Th2 
cells that are activated by DCs can secret a copious amount of IL-4, which supports B-
cell production of antibodies [58].  In contrast, the Th1 cells can be activated by DCs to 
generate cytotoxic T cells [76].  Th17 cells are important in fighting bacterial and fungal 
infections [74].  Treg cells keep immune response in check and prevent autoimmunity 
[77].  Hence, DCs not only play a crucial role in bridging innate and adaptive immunity, 
but they also possess the capability to direct a particular pathway of immune response.  




3.2.2. Tolerogenic dendritic cells 
When DCs capture immunogenic antigens, it is likely that they also process and 
present self-derived and harmless environmental antigens to T-cells.  If the presentation 
of such self or environmental antigens induces adaptive immune response, autoimmunity 
or chronic inflammation against harmless agents may be developed.  As a result, intrinsic 
or extrinsic mechanisms have evolved to induce different types of peripheral tolerance.  
Dendritic cells induce deletion or anergy of T-cells in the thymus in the intrinsic 
mechanism, or regulatory T cells (Treg) in the extrinsic mechanism, respectively [77,78].  
DCs pulsed with low doses of blood-borne circulating C5 protein were able to delete C5 
reactive transgenic thymocytes in culture, and they were also evidenced to induce 
deletional tolerance in vivo, which delineates the role of DCs in central tolerance [79,80].  
In peripheral tolerance, Tregs express high affinity IL-2 receptor (CD25) and transcription 
factor, forkhead box P3 (Foxp3), secrete copious amount of IL-10 and have a suppressive 
role in host responses [73,81,82].   DCs that express low levels of CD80/CD86 are able to 
induce Foxp3
+
 Treg from Foxp3
-
 precursors and induce abundant IL-2 from the T-cells in 
the presence of TGF-β, whereas other APCs failed to stimulate IL-2 secretion and Treg 
expansion [83,84].  Low doses of soluble antigens targeted to DCs at steady state can 
induce peripheral tolerance through the deletion of naïve peripheral T cells [77].  
Apoptotic cells, rather than necrotic cells, can also trigger the apoptosis of cytotoxic cells 
as well as the induction of Treg and Th2 cells, resulting in tolerance [85].  It has been 
shown in an in vivo model that the induction of peripheral CD8
+
 T cell tolerance depends 
on PD-1 and CTLA-4 [86].  Therefore, DCs are specialized APCs that can actively 
induce the formation of Tregs in the periphery and play a central role in immunological 
self-tolerance.  These DCs that develop naturally to prevent autoimmunity are tolerogenic 
DCs.  In order to generate DCs with tolerogenic phenotype for therapeutic applications, 
various strategies have been developed to induce regulatory DCs, or often called 
alternatively activated DCs.  
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3.2.3. Alternatively activated DCs (aaDCs) 
In contrast to the DC maturation-inducing PAMPs, many agents were found to 
suppress DC maturation, inducing a tolerogenic phenotype, in both human and mice.  
These “alternatively activated” DCs, or “regulatory DCs”, are generally characterized by 
low allogeneic T cell stimulation and low expression of maturation markers and co-
stimulatory molecules [77].  For instance, glucocorticoids such as dexamethasone, 
methylprednisolone and prednisone severely impeded the differentiation and antigen-
presentation capability of DCs [87].  Another well-known example is IL-10, which 
induced immature DCs into tolerogenic APCs in vitro and inhibited ovalbumin-specific T 
cell proliferation in an in-vivo mouse model [88].  Murine bone marrow-derived DCs 
treated with IL-10 and TGF-β secreted IL-10, induced Foxp3
+
 Treg expansion, induced 
alloantigen-specific hypo-responsive T cell proliferation and prolonged the survival when 
delivered in a donor-strain heart graft by co-stimulatory blockade with CTLA4-Ig [89].  
Interestingly, human DCs that matured in the presence of calcitriol, PGE2, or IL-10 
produced higher level of the pro-angiogenic cytokine VEGF as compared conventionally 
activated DCs that were only treated with LPS [90], suggesting that aaDCs may 
participate in wound healing by promoting angiogenesis – an interesting link between 
immunity and regeneration. 
In addition, a new subset of regulatory DCs, termed diffDCs, was discovered by 
co-culturing mature DCs with splenic stroma.  The diffDCs were found to maintain 
immune homeostasis by activating NK cells, which in turn kill surrounding diffDCs 
[91,92].  Human monocyte-derived DCs treated with anti-inflammatory molecules such 
as dexamethasone, 1α,25-dihydroxyvitamin D3 (the active form of vitamin D3), in the 
presence of LPS acquired a semi-mature phenotype and anti-inflammatory cytokine 





 T cell responses; however, these aaDCs were not able to induce Foxp3
+
 Treg 
expansion [93].  A semi-mature state of DCs may also be induced by the ligation of 
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signal-regulatory protein-α (SIRP-α) to CD47 on DCs.  After the treatment, DCs first 
appeared to become mature and migratory, but at later time points, DCs reverted back to 
their immature-like state.  Such a semi-mature stage may represent a checkpoint for the 
regulation of DC maturation [94].  The identification and development of non-
pharmacological biomaterial-based means of obtaining DCs with distinct functional 
phenotypes is a powerful strategy to control immune and wound healing responses.  
 
3.2.4. Modulation of dendritic cell phenotype by innate immune cell types 
The cells from innate immunity have been demonstrated to modulate DC 
maturation.  Co-culture of activated platelets with DCs induced the up-regulation of 
CD80, CD86 and ICAM-1 by DCs to a level similar to LPS-stimulated maturation.  
Activated platelets also enhanced the production of IL-12 and IL-6 by DCs [95].  Such 
activated platelet-induced DC maturation might have been mediated through CD154 and 
may suggest a link of blood coagulation to adaptive immunity by the maturation of DC.  
Interestingly, platelets had a neutralizing effect by binding Gp96, a heat shock protein 
released from cells after tissue damage, thereby modulating Gp96-induced DC 
maturation.  This may represent a control mechanism by which HSP-induced DC 
activation is limited locally during wound healing processes [96].  In addition, activated 
neutrophils were shown to induce DC maturation and enabled these DCs to trigger strong 
T cell proliferation and Th1 polarization by the interaction of the C-type lectin, DC-SIGN 
on DCs and Mac-1 (CD11b/CD18) on neutrophils [97].  Furthermore, antigens from live 
and from apoptotic neutrophils could be acquired by DCs, which then elicited antigen-
specific T cell responses [98].  These insights suggest that cross-talk between innate 






3.3. Dendritic cell response to biomaterials  
Unlike macrophage (MΦ) response to biomaterials, which has been investigated 
for decades, DC response to biomaterials has only recently been studied, beginning in the 
context of adjuvant effects of biomaterials in combination products on associated 
immune responses.  An increasing number of combination products that incorporate both 
biomaterial and biological components have been designed for tissue-engineering and 
vaccine delivery applications [1,99-102].  While the biomaterial component elicits a non-
specific inflammatory response that is mediated through a number of components such as 
platelets, polymorphonuclear cells and MΦs, the immunogenic biological component 
may induce an antigen-specific immune response [1].  Because DCs are the most potent 
antigen-presenting cells (APCs) that can activate naïve T-cells, and because the primary 
mechanism by which adjuvants enhance an adaptive immune response is the maturation 
of APCs, primarily DCs, the effect of biomaterials on DCs has been investigated. 
Conversely, because DCs are central in inducing Tregs, their ability to induce tolerance is 
emerging as a significant area for research for tissue engineering/transplantation 
applications in which biomaterials are used.   
 
3.3.1. Biomaterials in combination products 
Since the advent of “tissue engineering” in 1987, it has demonstrated a potential 
of revolutionizing treatment and therapies for patients [103].  Tissue-engineered devices 
are typically composed of biomaterial and biologic components [1,99].  Polymers are 
increasingly favored to be the biomaterial component because of their high processibility 
and controllable degradability [104].  For example, polymeric biomaterials have been 
used as a scaffold to bridge peripheral nerve gaps [105], to encourage  vascularized tissue 
growth[106], and to repair bone defects [107].  In addition to tissue-engineered 
constructs, polymers have also been widely used as carriers for biologic drugs, nucleic 
acids, and vaccines [100-102].  However, the process of implantation and delivery of the 
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biomaterial results in an injury to host tissues, which perturbs the homeostatic 
mechanisms and leads to wound healing, a classical outcome of an innate immune 
response [108].  The biologics, such as cells and proteins, if immunogenic, may be a 
source of antigens from the biomaterial carriers and initiate a specific adaptive immune 
response [1].  Elucidating how the presence of biomaterials alters the host immune 
response to co-delivered biologics will provide insight into improved modulation of host 
response against combination products.  
 
3.3.2. Biomaterial adjuvant effect on DCs 
Biomaterials were previously shown to have an adjuvant effect that enhances the 
immunogenicity of a model antigen, ovalbumin (OVA).  OVA adsorbed on non-
biodegradable polystyrene microparticles (MPs), or OVA co-delivered in biodegradable 
75:25 Poly(lactic-co-glycolic acid) (PLGA) MPs or scaffolds (SCs) were found to 
support a moderate humoral immune response that was maintained for the 18-week 
duration of the experiment, and the response was primarily Th2 response as indicated by 
the predominant IgG1 isotype [2].  The OVA co-delivered PLGA SCs induced a higher 
and longer lasting humoral response, while the MP counterpart induced a more transient 
response [3].  Such enhanced immune response is presumably due to the implantation-
associated tissue injury that released “danger signals”, which act as endogenous adjuvants 
[3].  Upon tissue injury, HMGB1, a potent danger signal, is released by necrotic cells 
[109] and is found at higher concentration in exudates from subcutaneously implanted 
PLGA SCs in comparison to naïve control [110].  This result suggested the possible role 
of danger signal biomaterial-induced adjuvant effect. 
 
3.3.3. Biomaterials affect DC phenotype 
Treatment of human monocyte-derived DCs with PLGA MPs or films induced 
enhanced expression levels of costimulatory molecules (CD40, CD80, and CD86), MHC 
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class II molecules (HLA-DQ and HLA-DR) and DC maturation marker (CD83) as 
compared to the untreated immature DC (iDC) control, but to a lesser extent as compared 
to the LPS-treated positive mature DC (mDC) control [111].  PLGA-treated DCs possess 
dendritic processes resembling those on mDCs and enhanced allostimulatory capability to 
stimulate T-cell proliferation in a mixed lymphocyte reaction (MLR) [111].  A study 
investigating the different effects of PLGA and agarose on mouse bone-marrow derived 
DCs showed similar DC maturation in response to PLGA, but DC maturation of agarose-
treated DCs was not significantly different from iDCs [112].  In addition, cytokine 
analysis showed that DCs treated with PLGA secreted higher amounts of TNF-α, IL-8, 
IL-6 and IL-10 than those secreted by agarose-treated DCs.  Interestingly, DCs treated 
with PLGA MPs released increasing amount of these cytokines in a MP-dose dependent 
manner, but they produced low amounts of IL-1β and IL12-p70.  Such biomaterial-
induced DC maturation was found to require cell-biomaterial contact in a transwell assay 
[111].   
Furthermore, a differential effect of DC maturation was induced by different 
biomaterials.  More specifically, PLGA or chitosan films induced DC maturation while 
alginate and agarose did not and hyaluronic acid film exhibited suppressed DC 
maturation [113].  Mixed lymphocyte reaction showed that DCs treated with PLGA and 
chitosan films supported higher levels of T-cell proliferation as compared to iDCs, DC 
treated with hyaluronic acid films induced lower levels of T-cell proliferation, and DCs 
treated with agarose and alginate films did not differ from iDCs in allostimulatory 
capacity [114].  Surprisingly, both PLGA and agarose induced higher NFκB activation 
than iDCs, and the activation level is much higher in the DCs treated with agarose 
[6,112].   
Importantly, biomaterial-specific in vitro induced DC phenotype could be 
translated into in vivo host responses by the studies that demonstrated that PLGA, but not 
agarose, enhanced the humoral immunity against a co-delivered model antigen in vivo 
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[3,4].  Clearly, biomaterials can affect DC phenotype and can be manipulated to modulate 
immune responses.  However, the biomaterials used in these studies have very different 
properties and it is impossible to deduce which material properties are the most important 
in affecting DC phenotype.   
In order to understand the correlation between biomaterial properties and DC 
maturation, materials with better defined surface chemistries were used to study the 
biomaterial effects on DCs.  DCs were treated with self assembled monolayer (SAM) 
surfaces of alkanethiols with defined and distinct terminal groups (-CH3, -OH, -COOH 
and -NH2).  Based on cell morphology, allostimulatory capacity or expression of 
maturation markers, all four SAMs elicited modest DC maturation in comparison with 
iDCs, while -CH3 SAMs were found to be the least activating.  However, these DCs 
secreted the highest levels of pro-inflammatory cytokines TNF-α and IL-6, which 
contradicts the least mature phenotype.  The investigation into DC viability revealed that 
CH3 SAMs supported fewer live human monocyte-derived DCs.  The number of early 
apoptotic, late apoptotic and necrotic and nonviable cells was significantly higher on CH3 
SAMs than any other surface or controls.  Surprisingly, CH3 treated DCs induced higher 
expression of CTLA-4 on T-cells, which is a negative signal for T cell proliferation 
[115].  These results are opposite to those previously observed using MΦs wherein the 
CH3 functional group induced more leukocyte adhesion and more fibrosis [116].   
In addition to the treatment of DCs with biomaterial films, studies have also been 
carried out to investigate the interactions of DCs with porous scaffolds.  The phenotype 
of DCs upon seeding the cells on PLGA or agarose scaffolds was examined.  It was 
found that, similar to treatment of DCs with the film versions of these polymers, DCs 
treated with PLGA scaffolds displayed moderately mature phenotype with dendritic 
processes, elevated expression of maturation markers and increased secretion of pro-
inflammatory cytokines to the level similar to cells treated with PLGA films, while 
agarose scaffold did not induce DC maturation [117].  It was also found that biomaterial 
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scaffolds engineered with proper lymphoid microenvironment allow DC migration and 
interaction with T-cells, which represents a promising strategy to create ectopic lymphoid 
tissue [118].  
 
3.3.4. Mechanisms by which DCs respond to biomaterials 
The exact mechanisms by which DCs recognize biomaterials remains to be 
elucidated.  It is possible that complement, plasma proteins (with associated carbohydrate 
modifications) and other “danger signals” adsorb to the biomaterials, which are then 
recognized by the PRRs, primarily CRs, CLRs and TLRs, on DCs (Figure 3-2) [119].  
Recent research using MyD88 and TLR knocked out mice demonstrated that DCs use 
TLR2, TLR4 and TLR6 for the responses to a group of chemically and physically diverse 
biomaterials [120].  Mice lacking any of these TLRs or MyD88 had impaired expression 
of activation markers and reduced production of pro-inflammatory cytokines relative to 
the wild type controls [120].  Recently, β integrins were shown to play a role in 
mediating DC adhesion and response to biomaterials [121].  The other receptors such as 
FcR and CR as well as their cross-talk with PRRs may also play a role in biomaterial-
induced DC phenotype (Figure 3-2).  ECM proteins adsorbed on tissue-culture 
polystyrene plates have been shown to affect DC morphology, cytokine production and 
allostimulatory capacity.  For example, DCs cultured on collagen or vitronectin substrates 
released higher levels of IL-12p40, while DCs treated on albumin or serum-coated 
substrates generated higher amounts of IL-10 compared to other substrates.  Higher levels 
of IL-12p40 release correlated with enhanced CD4
+
 T cell priming and Th1 response 
[122].  Therefore, intelligently engineered biomaterials may guide the presentation, 
orientation or conformation, of adsorbed proteins in such a way that these “biomaterial-
associated molecular patterns (BAMPs)” either induce DC activation or tolerance against 
co-delivered antigens.  Biomaterials represent an exciting non-pharmacological tool, by 
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which DC phenotype may be modulated to achieve a desired host immune response to 
combination products.  
 
Figure 3-2: Possible mechanisms by which biomaterials influence DC responses.  Complement and 
plasma proteins differentially adsorbed to the biomaterials are likely to be recognized by the PRRs, 
primarily TLRs and CLRs, on DCs.  Other receptors such as FcR, CR, and integrins and their cross-
talk with TLRs and CLRs may also play a role in biomaterial-induced DC phenotype. 
 
 
3.4. Vaccines and adjuvants 
Biomaterials have also been used to enhance immunogenicity of vaccines as 
alternatives to the only FDA-approved aluminum-based adjuvants.  In addition to 
enhancing immunogenicity, adjuvants may also skew the response toward a particular 
type, such as humoral or cell-mediated immunity.  This is of paramount importance 
because the immunity to different pathogens may require distinct types of immune 
22 
 
protection [69].  Many adjuvants have been developed to enhance the efficacy of 
vaccines, but their mechanisms have not been fully understood.  Mineral salts (e.g. alum), 
liposomes and biodegradable polymer microspheres are believed to enhance 
immunogenicity by causing a depot effect at the site of injection [12,123], while others 
such as complete Freund’s adjuvant (CFA) and incomplete Freund’s adjuvant (IFA) act 
as immunostimulators [12,124,125].  Although CFA is a potent adjuvant, it is too toxic 
for human use [124].  To date, only alum, MF59 (oil-based emulsion) and 
monophosphoryl lipid A (MPL) are licensed for human applications [123].  Better and 
more effective adjuvants that can direct controlled Th1 or Th2 responses are desired and 
of great research interest.    
 
3.4.1. DCs and biomaterial adjuvants 
Because of DCs, as nature’s responders to adjuvants, possess potent capability of 
activating naïve T-cells and initiating adaptive immunity, they have become the major 
target of vaccine design and development.  Certain polymers, especially in particulate 
forms, have shown to act as adjuvants due to their ability to induce DC maturation 
[6,101,111,113].  Furthermore, block copolymers with both hydrophilic and hydrophobic 
domains were found to have increased adjuvant activity with higher percentage of 
hydrophobic monomers.  It is possible that hydrophobic polymers activate DCs in a way 
that mimics the hydrophobic domains of PAMPs [119].  As proposed by Seong and 
Matzinger in the “hyppo hypothesis”, although TLR ligands are different in structure, all 
of them have hydrophobic domains, which may function as “damage-associated 
molecular pattern” (DAMP) that trigger PRR activation [16]. 
Biomaterial MPs and nanoparticles (NPs) have been widely used in vaccine 
delivery.  Particulate adjuvants cause pro-inflammatory cytokine IL-1β secretion from 
DCs when associated with LPS.  Interestingly, processing of pro-IL-1β requires 
inflammasomes, complex intracellular proteins consisting of NALP3, ASC, CARD and 
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Casp1 and the uptake of particulate adjuvants by DCs activates NALP3 inflammasomes 
[126].  Furthermore, biomaterials may also be manipulated to modulate trafficking of the 
co-delivered immunogen, thereby controlling the efficiency of cross-presentation by 
DCs.  Cross-presentation of immunogens is important in mediating cytotoxic CD8
+
 T cell 
response against intracellular pathogens.  PLGA MPs encapsulated with OVA were able 
to induce CD8 response towards an exogenous antigen at antigen concentration of 1000-
fold lower than soluble antigen and 10-fold lower than antigen-coated latex beads [127].  
MPs, instead of NPs, were able to induce higher cross-presentation in vitro, possibly due 
to the fact that larger particles take longer to be degraded in the endosomal pathway and 
hence protect the antigen, to allow it to be available intracellularly for loading to MHC 
class I molecules [128].  However, in an in vivo study, NPs were shown to be more 
efficient in accessing DC population in the lymph nodes due to their readily being taken 
up into lymphatics after interstitial injection [129].  Therefore, a balance between uptake 
and cross presentation efficiency needs to be optimized for cytotoxic T cell response.  In 
addition, pH-sensitive “smart” polymer has also been developed to protect the antigen 
from being degraded intracellularly [100].  Another strategy to shift the immune response 
to CD8 T cell response is to deliver silencing RNA (siRNA) against IL-10 to DCs.  Co-
delivery of siRNA and DNA antigens to DCs by MPs was shown to induce strong DC 
activation and T cell proliferation, switching the response to cytotoxic CD8 response 
[130].  Subsequently, a model DNA vaccine delivery system was developed using in-situ 
crosslinking hydrogels that only gel in vivo for the delivery of chemokines and MPs 
encapsulating siRNA against IL-10 and DNA antigen.  Such system was shown to 
enhance DC recruitment to the MPs and effective IL-10 silencing [131].   
A high-throughput MP microarray platform was recently developed to facilitate 
the optimization of particle-based vaccines for DCs.  PLGA microparticles were printed 
on adhesive islands on a glass coverslip, and DCs cultured atop were found to co-localize 
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with the MPs.  This platform may allow the assessment of the effects of a large array of 
MP formulations on DC function [132].  
 
3.4.2. DC anti-tumor activity and DNA vaccines 
Furthermore, DCs have been found to play a critical role in anti-tumor immunity.  
PLGA NPs co-delivering the poorly immunogenic melanoma antigen, tyrosinase-related 
protein 2 (TRP2) and TLR 4 ligand, 7-acyl lipid A, into mice with melanoma B16 tumors 
led to induction of TRP2-specific CD8 T cell response.  Cytokine analysis revealed that 
these CD8 T cells were able to secret IFN-γ in lymph nodes and spleens.  The tumor size 
in the immunized mice with co-delivered TRP2 and 7-acyl lipid A was also the smallest 
[133].  MΦ and DC uptake of biodegradable, pH-sensitive poly-β amino ester MPs was 
shown to be more efficient than PLGA MPs, suggesting that this polymer can cause 
higher transfection efficiency of the APCs and be a more effective non-viral genetic 
vaccine delivery vehicle.  Mice bearing tumor vaccinated with DNA vaccine delivered by 
poly-β amino ester MPs had significantly smaller tumor size than control or PLGA DNA 
vaccine [134].  Self-gelling alginate matrix encapsulating activated DCs, CCL21, or SIY 
peptide was designed for its potential application in immunotherapy.  Alginate gels 
containing activated DCs attracted both host DCs and T cells to matrix in vivo.  In an 
adoptive transfer model, gels containing SIY peptide loaded DCs primed T cell response 
and recruited activated antigen-specific specific T cells to the matrix.  In addition, these 
alginate gels facilitated cellular infiltration and possibly provided a milieu for efficient 
DC-T cell interactions.  Such strategy may be an effective way to engineer “vaccination 
nodes” at tumor site to direct strong immune response [135,136].   
The most recent research endeavor also started to consider the balance among 
different DC subsets for anti-tumor vaccine development.  Macroporous polylactide-co-
glycolide (PLG) matrices were fabricated and loaded with GM-CSF, CpG-rich 
oligodeoxynucleotide (CpG-ODN) and tumor lysate.  These matrices were implanted into 
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subcutaneous pockets on the back of mice and were found to recruit higher ratios of 
CD8
+
 cDCs and pDCs, which are DC subsets that collaborate to enhance cross 
presentation of tumor antigens in CD8
+
 DCs to Th1 cells and CTLs.  The enhanced 
populations of CD8
+
 cDCs and pDCs are correlated with increased IL-12 and IFN 
production, attenuation of FoxP3
+
 Tregs and immunosuppressive cytokines TGF-β and IL-
10 and, most importantly, the decreased tumor growth and improved survival in mice 
bearing melanoma tumors [137].  This work shows that the balance of DC subsets is 
critical in the proper activation of effective immunity, and that biomaterials can be used 
as delivery vehicles for biologics that induce the preferential recruitment of target cell 
populations.  However, it is still unclear if biomaterials themselves can be manipulated to 
recruit different DC subsets.  Elucidating the effects of biomaterials on the recruitment of 
desirable DC populations will allow the use of the intrinsic properties of the materials 
alone without the incorporation of danger signals such as CpG-ODN.   
Biomaterials have also been manipulated to induce mucosal immune responses 
using DNA vaccines.  By control release of DNA using poly(ethylene-co-vinyl acetate), 
local mucus IgA production was induced for a prolonged period of time (8 weeks) in 
murine vaginal tract [138].  Other recent advances in the applications of biomaterials in 
vaccine design have been summarized in an excellent review [139].     
Taken together, biomaterials represent a great tool for vaccine development 
because of their flexibility and multifunctionality.  Biomaterials can be designed to be 
loaded with biomolecules, such as TLR agonists, chemokines, siRNAs and/or antigens, 
during preparation for controlled release of biomolecules; the biodegradability can be 
adjusted to reduce long-term fibrosis around implants; the porosity of a biomaterial 
scaffold can be manipulated to facilitate cell migration into the scaffold for antigen 
uptake or response to co-delivered biomolecules; and biomaterials that have intrinsic 
adjuvant effects (e.g. PLGA or chitosan) on DCs can be used to control DC phenotype 
and its associated immunological outcome.  The biomaterial properties and their adjuvant 
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effects may be correlated to provide rational design of vaccines to induce a desired 
strength and type of effective immunity.  
 
3.5. Biomaterial systems used to study cell response 
The traditional mode of biomaterials design begins with the synthesis of a new 
material, followed by its characterization, and completed by the culturing of certain cells 
on it.  However, this process for the discovery of a suitable biomaterial is slow; hence, 
the adoption of combinatorial and computational approaches to biomaterials design is 
desirable [140,141].   First, Anderson et al. developed an impressive nanoliter-scale 
synthesis of biomaterial combinatorial array of different compositions and observed 
distinct differentiation of human embryonic stem cells on those materials [142,143].  
Second, microcontact printing and chemisorption chemistry were used to fabricate 
structures with controlled topography and hydrophobilicity/hydrophilicity to study cell 
behavior [144].  Although these are discrete biomaterial array systems, no defined wells 
were created to separate cells.  As a result, the major drawback of these systems is their 
applicability to only strongly adherent cells.  By contrast, continual biomaterial libraries 
have also been developed.  For example, Meredith et al. created a system with continual 
changes of topography on glass slide with graded changes in chemical composition using 
blends of poly(D,L-lactide) (PDLA) and poly(ε-caprolactone) (PCL) by exploiting their 
lower critical solution temperature phase behavior, which generated a linear, 
homogeneous crystallinity (nanoscale roughness) gradient.  They identified preferred 
microstructural feature sizes for UMR-106 (rat osteoblastic cell line) and MC3T3-E1 
(mouse osteoblastic cell line) cells [145,146].  Similar systems were developed with 
poly(L-lactic acid) (PLLA) [147] or PLLA and PDLA [148].  In addition to these 
continual biomaterial systems, others have produced surfaces with well-defined 
biocompatible polymer brush nanostructures by using varying graft density of poly(2-
hydroxyethyl methacrylate) (PHEMA) [149,150].  However, the continual nature of 
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material property variations on a single surface renders these systems unsuitable for 
loosely adherent cells such as dendritic cells.   
Discrete combinatorial libraries in micro-liter plate formats have also been 
developed using sebacic acid and 1,6-bis(p-carboxyphenoxy)hexane (CPH) [151], 
tyrosine-containing polyarylates [152], polymethacrylates [153-155], or tyrosine-derived 
polycarbonates [156], the later three systems developed by Dr. Joachim Kohn at Rutgers 
University.  Such systems utilize micro-liter plate to create isolation between 
biomaterials, and therefore are suitable for the study of non-adherent or loosely adherent 
cells such as DCs that cannot be studied using standard cell-based ELISA techniques.  
The libraries of tyrosine-containing polyarylates, polymethacrylates, and polycarbonates 
are of particular interest because of the extensive characterization performed on those 
polymer surfaces and the graded variations in material properties with little changes in 
chemistry [152-158].  More recently, Topochip, fabricated with polyethylene 
oxide/polybutyl terephthalate (PEO/PBT) or polylactic acid (PLLA) and each composed 
of 10,000 distinct topographies, has been developed [159].  This TopoChip system allows 
for the screening of cell response to nanotopographies in a high-throughput manner.  Ti 
substrates represent another valuable biomaterial system for studying induced DC 
phenotype due to their well-defined microtopography and surface energy and have been 
shown to induce distinct responses of human osteoblast-like MG63 cells as well as 




CHAPTER 4: A HIGH-THROUGHPUT METHODOLOGY 





Biomaterials are widely used as the carriers of biologics, such as cells, nucleic 
acids, and/or proteins, in combination products for tissue regeneration or vaccine 
delivery.   These products may evoke both a non-specific inflammatory response against 
the biomaterial component and an adaptive immune response against the immunogenic 
biologics.  Furthermore, the biomaterials also play a role in modulating the host 
responses due to their adjuvant or immunosuppressive effect.  Obviously, the goal of 
tissue engineering is to minimize the host response to allow the proper functioning of the 
device and its integration to the host tissue.  In contrast, vaccine delivery aims to enhance 
or maximize a protective immune response to the delivered antigen. 
 DCs have been hypothesized to be important in mediating the host response 
towards immunogenic antigens co-delivered with biomaterials. DCs are the most APCs 
that are specialized in the uptake, transport, processing, and presentation of antigens to T 
cells [41,163,164].  Using PRRs expressed on DCs, the ligation of pathogens or “danger 
signals” leads to the maturation of DCs [165,166].  Activated DCs transiently enhance 
antigen uptake but down-regulate their endocytic capacity after several hours [57,58], 
accompanied by a decreased expression of C-type lectin, DC-SIGN (DC-specific 
intercellular adhesion molecule-grabbing nonintegrin), which is primarily expressed in 
certain subsets of DCs, including monocyte-derived DCs [167].  
 The primary mechanism by which adjuvants enhance an adaptive immune 
response is the maturation of DCs, which results in their efficient antigen presentation 
                                                 
†
 Adapted and modified from Kou PM and Babensee JE. Validation of a high-throughput methodology to 
assess the effects of biomaterials on dendritic cell phenotype. Acta Biomaterialia. 6:2621-2630 (2010). 
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and T cell stimulation that generate an adaptive immune response to associated antigens.  
Although previous studies indicate that biomaterials commonly used in tissue engineering 
and vaccine delivery can modulate DC phenotype [6,113] via biomaterial adjuvant effect, 
it was unclear which biomaterial properties caused such differential effects.  In order to 
translate a differential biomaterial effect on DC phenotype into design rules for 
biomaterials with distinct immunomodulatory effects, it is necessary to draw correlations 
between biomaterial physiochemical properties and effects on resultant DC phenotype 
using biomaterials with controlled graded variations in their properties in a combinatorial 
array.  Such correlations will serve as criteria for the biomaterial design of combination 
products to modulate the host responses. 
 The assessment of DC maturation in response to biomaterials typically involves 
the treatment of immature DCs (iDCs) with biomaterials pre-placed in wells of a 6-well 
plate to allow for a sufficient number of cells for the assessment of DC phenotype using 
immunological assays such as flow cytometry for the expression of DC-specific or 
maturation surface markers or allostimulatory ability in a mixed lymphocyte reaction.  
Using extensive immunological assessment assays, the effect of different biomaterials on 
various aspects of DC phenotype and function have been assessed [6,111].  However, our 
conventional method would be time-consuming and require large quantities of reagents 
for the assessment of DC responses to large libraries of polymers.  Hence, the goal of this 
research was to develop and validate a HTP methodology to assess DC phenotype upon 
the contact with combinatorial libraries of biomaterials with graded material properties.   
The culture characteristics of DCs presented a unique challenge in that the DCs 
are loosely-adherent or non-adherent in culture; hence, a traditional cell-based Enzyme-
Linked ImmunoSorbent Assays (ELISAs) could not be used due to expected cell loss 
during wash steps.  To enhance the efficiency in sample processing and subsequent 
measurement, many cell-based assays have been processed in filter plates [168,169].  
Such plates are 96- or 384-well standard-sized plates with an individual filter membrane 
30 
 
welded in each well.  Because the fast and simple removal of supernatants is assisted by 
the application of a vacuum manifold, we expected that the filter plates would provide a 
suitable platform for the development of a HTP screening methodology for the 
simultaneous quantification of maturation markers of many DC samples.  By far, black 
96-well filter plates have offered the most promising means to rapidly wash the cell 
samples without any cell loss and offered fluorescence detection in situ.  Therefore, here, 
we present the validation of a 96-well filter plate-based HTP screening methodology for 
DC phenotype upon biomaterial contact.  Briefly, after treatment with biomaterials in a 
96-well plate, the DCs are transferred to a black 96-well filter plate and stained with anti-
CD86-PE and DC-specific anti-DC-SIGN-FITC monoclonal antibodies.  The ratio of 
CD86-PE/DC-SIGN-FITC, or “maturation factor”, is a DC number-independent 
parameter to represent DC maturation.  The supernatants can be easily collected into a 
96-well plate using a centrifuge, assayed for cytotoxicity, and stored for cytokine 
profiling.  Figure 4-1 illustrates the experimental scheme of the conventional assessment 





Figure 4-1: A schematic of the conventional method and the HTP method for analyzing DC response 
to biomaterials.  For both of the analysis methods, DCs were derived from human peripheral blood 
mononuclear cells (PBMCs) using the same procedures until day 5.  On day 5, for the conventional 
method, DCs were treated with biomaterials in a 6-well plate for 24 hours.  The cells after treatment 
are then collected and stained, and flow cytometry is performed to analyze the cell surface marker 
expression.  In contrast, for the HTP method, DCs are treated with biomaterials in a 96-well plate for 
24 hours.  On day 6, DCs are transferred to a 96-well filtration plate, fixed and then stained with 
anti-CD86-PE and anti-DC-SIGN-FITC antibodies for 1 hour and washed.  The relative fluorescence 
intensity is subsequently measured by a Tecan Infinite F500 microplate reader.  Simultaneously, the 
cell culture supernatants from each well can be aspirated into a collection plate and tested for 
cytotoxicity and stored for cytokine profiling using Multiplex technology. 
 
 
4.2. Materials and methods 
4.2.1. Derivation of immature DCs (iDCs) 
 Human blood was collected from donors with informed consent and heparinized 
(333 U/ml blood) (Abraxis Pharmaceutical Products, Schaumburg, IL) at the Student 
Health Center Phlebotomy Laboratory, in accordance with the protocol (No. H05012) of 
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the Institutional Review Board of Georgia Institute of Technology.  Dendritic cells were 
derived from human peripheral blood mononuclear cells (PBMCs) using a previously 
described method [170] with some modifications.  Briefly, the collected blood was 




-free phosphate buffer saline (D-PBS; 
Invitrogen, Carlsbad, CA), and peripheral blood mononuclear cells (PBMCs) were 
isolated by differential centrifugation using lymphocyte separation medium (Cellgro 
MediaTech, Herndon, VA).  After the lysis of erythrocytes with RBC lysing buffer (155 
mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) and washing steps, PBMCs were 
resuspended at a concentration of 510
6
 cells/ml in DC media, which was prepared by 
filter-sterilizing RPMI-1640 containing 25 mM HEPES and L-glutamine (Invitrogen), 
supplemented with a final concentration of 10% heat inactivated fetal bovine serum (h.i. 
FBS; Cellgro MediaTech, Herndon, VA) and 100 U/ml of Penicillin/Streptomycin 
(Cellgro MediaTech).   The cells were plated in a volume of 10 ml/plate in a Primaria 100
20 mm
2
 tissue-culture dish (Becton Dickinson, Franklin Lakes, NJ) and incubated for 2 
hours at 95% relative humidity and 5% CO2 at 37
o
C to select for adherent monocytes.  
After this incubation, the dishes were washed three times with warm DC media to 
remove non-adherent cells.  The remaining adherent cells were supplied with 10 ml/plate 
new warm DC media, supplemented with 1000 U/ml GM-CSF and 800 U/ml IL-4 
(PeproTech, Rocky Hill, NJ), and incubated for 5 days without changing the media to 
induce the differentiation of monocytes into iDCs.  Immature DCs were treated with 
biomaterial films in the wells of 6-well or 96-well plates (the HTP methodology) with 
assessment of resultant DC phenotype using flow cytometry or fluorescent plate reader, 
as described in sections 4.2.3 or 4.2.4, respectively.  As a part of culture characterization, 
DCs were purified using magnetic sorting based on manufacturer’s protocol (Miltenyi 
Biotec, Auburn, CA).  Briefly, the cell population harvested on day 5 of DC culture first 
underwent CD19
+
 B cell depletion (negative selection), followed by CD1c
+
 DC isolation 
(positive selection).  The purity of DC population was approximately 95% or above.   
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4.2.2. Preparation of PLGA and agarose film 
 Poly(DL-lactic-co-glycolic acid) (PLGA, molar ratio: 75:25, inherent viscosity: 
0.70 dL/g in trichloromethane, MW = 100,000 Da; Birmingham Polymers, Birmingham, 
AL) films were prepared by solvent casting without a porogen as previously reported 
[113].  Briefly, PLGA was dissolved 20% w/v in dichloromethane (DCM) overnight at 
room temperature and poured into a 50-mm Teflon dish (Cole-Parmer, Vernon Hills, IL) 
in a chemical fume hood.  After evaporation of the solvent and drying to form films (48-
72 hours), the PLGA films were punched to fit into the wells of a 6-well plate or a 96-
well plate, followed by three washing steps using endotoxin-free water (Cambrex, East 
Rutherford, NJ) and UV sterilization for 30 min on each side in the tissue culture hood 
before iDCs were plated on them.  Agarose (type V, high gelling, gel strength of   
800g/cm
2
 at 1.0%, MW unknown; Sigma, St. Louis, MO) was prepared to form 3% w/v 
aqueous solution by boiling of agarose in ddH2O in a microwave until the agarose was 
completely dissolved.  The films were prepared by dispensing 1 ml of agarose solution 
into a well of a 6-well tissue culture plate (Corning, Corning, NY), or 50 μl in a well of a 
96-well tissue culture plate (Corning).  The films were allowed to solidify at 4
o
C for at 
least 30 min and brought back to room temperature for another 30 min in a tissue culture 
hood without any further sterilization step prior to culturing iDCs on them.  The 
endotoxin content of PLGA and agarose films was measured using a chromogenic 
substrate (QCL-1000 LAL assay; Cambrex) and determined less than 0.l EU/mL, which 
is well below the FDA limit of 0.5 EU/ml [6,113].  Previous study showed that a 
minimum Escherichia coli endotoxin concentration of 100 EU/ml or 10 ng/ml was 






4.2.3 Treatment of DCs with biomaterials in 6-well plates with assessment of DC 
phenotype using Flow Cytometry 
After 5 days of cell culture, the PLGA films were placed into the wells of a 6-well 
plate with sterilized gaskets (Cole-Parmer, Vernon Hills, IL) to secure the films. Agarose 
films were prepared as described in Section 4.2.2 directly in the wells.  Non-adherent and 
loosely-adherent cells were collected, resuspended in new pre-warmed DC media at a 
concentration of 510
5
 cells/ml, and plated at the volume of 3 ml (1.510
6
 cells/well) in 
each well.  The cells were then supplemented with cytokines (1000 U/ml GM-CSF, 800 
U/ml IL-4).   Dendritic cells were treated for 24 hours with biomaterials with known 
effects on DCs (i.e., PLGA or agarose), treated with 1 μg/ml of lipopolysaccharide (LPS) 
(E. coli 055:B5; Sigma) to become mature DCs (mDCs; positive control), or left 
untreated to remain iDCs (negative control).  The levels of surface marker expression 
were monitored after 24 hours of biomaterial treatment by flow cytometry per the 
methods described previously [111] and compared to the controls.  The cells were 
collected by centrifugation at 1100 rpm for 10 min, resuspended in 0.1 % BSA and 2 mM 
EDTA in PBS, pH = 7.2 (cell-staining buffer), and stained with fluorescently-labeled 
antibodies CD40 (clone B-B20; mouse IgG1κ), CD86 (clone BU63; mouse IgG1κ) 
(Ancell Corporation, Bayport, MN), CD83 (clone HB15a; mouse IgG2aκ) (Immunotech, 
Marseille, France), CD80 (clone BB1; IgMκ), HLA-DQ (clone TU169; mouse IgG2aκ), 
HLA-DR (clone TU36; mouse IgG2aκ) (BD Biosciences), CD1c (clone AD5-8E7; mouse 
IgG2a) (Miltenyi Biotec, Auburn, CA), or DC-SIGN (clone 120507; mouse IgG2b) (R&D 
Systems).  The cells were stained for 1 hour at 4
o
C, and analyzed using a BDLSR flow 
cytometer (Beckton Dickinson, San Jose, CA).  Data analysis was performed using 
FlowJo (Tree Star, Ashland, OR) based on the differential shift of histograms compared 
to the controls unless otherwise indicated.  The “maturation factor” values were 
determined by dividing the gMFIs of CD86-PE by that of DC-SIGN-FITC.  The antibody 
binding capacity of CD86 expressed on DCs or B cells were determined by staining the 
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cells with anti-CD86-PE, gating the distinct DC and B cell populations on the scatter plot, 
measuring the gMFIs of the populations, and comparing the gMFIs to a standard curve 
created by beads with known number of CD86 antibody binding sites (Quantum Simply 
Cellular
®
 kit; Bangs Laboratory, Fishers, IN).  To quantify the percentage of DCs and B 
cells or B cells and T cells in the culture system, the cells were double-stained with anti-
CD19-APC (clone HIB19; mouse IgG1κ) (BD Biosciences) and anti-DC-SIGN-FITC or 
anti-CD19-APC and anti-CD3-PE (clone UCHT1; BD Biosciences).  The percentage of 
B cells (CD19
+
), T cells (CD3
+
) and DCs (DC-SIGN
+
) were analyzed using FlowJo 
based on the differential shift of cell populations in the dot plots.   
 
4.2.4 Treatment of DCs with biomaterials in the 6 or 96-well plate HTP format with 
assessment of DC phenotype using Fluorescent Microplate Reader 
 On day 5 of DC culture, the PLGA or agarose films were prepared as described in 
Section 4.2.2, and iDCs (3 ml, 510
5
 cells/ml) were plated onto each well in the 6-well 
plate.  In the 96-well format, the PLGA films were slightly wetted on one side with 
endotoxin-free water and adhered to the wells of the 96-well tissue-culture plate in 
triplicate, while agarose films were formed by dispensing 50 μl of agarose solution 
directly into the wells and solidified.  One hundred microliters of iDCs (510
5
 cells/ml) 
was plated onto each well in the 96-well plate, and secure adherence of the PLGA film 
was checked by visual inspection.   The wells for the negative control of iDCs remained 
untreated and those for the positive control of mDCs were treated with LPS.  The DCs 
cultured in a 96-well plate were pre-incubated at room temperature for 30 min to reduce 
the edge effect by minimizing thermal gradients in the edge wells [172].  Subsequently, 
the DCs were cultured in an incubator at 95% relative humidity and 5% CO2 at 37
o
C for 
24 hours.   On day 6, the DCs treated in the 6-well plate were harvested, and 100 μl of the 
cell suspension was transferred to wells of a 96-well black filter plate, while the DCs 
treated in the 96-well plate were transferred directly to other wells in the same filter plate.  
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The supernatants were then removed by a vacuum manifold (Millipore, Bedford, MA) 
with vacuum pressure pre-adjusted to 2–4 inHg.  To each well, 100 μl of cold working 
fixation solution (0.03 % paraformaldehyde) was added, and the plate was incubated for 
at least 30 min at room temperature on a microplate shaker at 600 rpm (VWR, West 
Chester, PA), followed by the removal of the fixative by the vacuum manifold.  
Subsequently, 100 μl of staining solution containing 1.5 μg/ml anti-CD86-PE and 1.5 
μg/ml anti-DC-SIGN-FITC (monoclonal antibodies as used for flow cytometry) was 
added into each well containing sample to be stained.  IgG1-PE (clone MOPC31C) 
(Ancell) and IgG2B-FITC (clone 133303) (R&D Systems) isotype-stained DCs were used 
for background fluorescence subtraction in separate treatment or control wells.  The 
plates were washed three times with 200, 250, and 300 μl/well of cell staining buffer.  
Again, the vacuum manifold was used for each supernatant removal.  The relative 
fluorescence units (RFUs) were measured with a Tecan Infinite F500 microplate reader 
(Tecan US, Durham, NC) using excitation filters of 535/25 and 485/20, and emission 
filters of 590/20 and 535/25, for PE and FITC, respectively.  Because no difference in the 
RFUs from the isotype controls among iDCs, mDCs, PLGA-treated, and agarose-treated 
DCs was observed, only the isotype control of iDCs was used for the subtraction from the 
raw data to eliminate the background fluorescence.  The ratio of background-subtracted 
CD86-PE to background-subtracted DC-SIGN-FITC from each well was determined, and 
the average ratio (“maturation factor”) was calculated from the triplicate.   
 
4.2.5. Assessment of Biomaterial-induced Cytotoxicity 
 Cytotoxicity associated with biomaterial treatment was assessed by measuring the 
release of cytosolic enzyme glucose-6-phosphate dehydrogenase (G6PD) into the media 
from cells cultured in the presence or absence of biomaterials.  G6PD is released from 
damaged or dead cells, and its presence was measured using the Vybrant Cytotoxicity 
Assay (Molecular Probes, Eugene, OR).  The supernatants were easily collected from 
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cells cultured with or without biomaterials of PLGA or agarose films or from controls 
from a 96-well plate filter plate into a 96-well collection plate by stacking the filter plate 
on top of the collection plate and centrifuging at 250g for 2 min.  Fifty microliters of 
the supernatants were assayed immediately according to the manufacturer’s protocol, 
because freeze-thawing the supernatants decreased the enzymatic activity substantially.  
The medium from cells lysed with 0.5% Triton X served as a positive control.  The 
fluorescence readings were taken after 30 min incubation at 37
o
C with excitation and 
emission filters 535/25 and 590/20, respectively.  This experiment was repeated 3 times.  
 
4.2.6. Statistical analysis 
 Two-sided pairwise student t-test was used to compare the sample group to the 
appropriate control group.  To observe any significant differences between all sample 
groups in pairs, pairwise general linear model of the two-way ANOVA with a mixed 
model and repeated measure followed by Tukey post test was used.  For all statistical 
methods, the Minitab software (Version 14, State College, PA) was used.  If otherwise 
indicated, the p-value equal to or less than 0.05 was considered significant.  
 
4.3. Results 
4.3.1. DC-SIGN was a suitable marker for the definition of “maturation factor”, which 
represents the degree of DC maturation 
 Biomaterials could not be cast onto the filter plates because the filter membranes 
would be clogged.   For this reason, the cell samples cultured on biomaterials in a regular 
96-well tissue-culture plate were required to be transferred to a 96-well black filter plate 
for staining and analysis.  Hence, the cell numbers in the wells in the filter plate may vary 
significantly and a cell number normalization method was required to account for the 
variations in cell number.   Cell number normalization by total DNA or a DC-specific 
surface marker was investigated. CD86, a costimulatory molecule, was used as the 
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maturation marker because of its high expression level and its large fold change upon DC 
maturation, including upon biomaterial treatment [6,111].   
 The conventional method was used to derive iDCs and mDCs, and the DC culture 
was previously determined to primarily consist of DCs and lymphocytes by day 5 and 
day 6 [173], and ≥ 90% of the lymphocytes were found to be CD19
+
 B cells based on 
dual antibody staining for CD3
+
 T cells and CD19
+
 B cells.  The same culture system was 
used in this study.  It was determined that the DC:B-cell ratios and B cell percentages 
changed significantly between iDCs and mDCs, and the B cell content varied 
significantly among different donors (Figure 4-2).  Such variations could introduce 
substantial noise in the analysis of the DC maturation results.  To eliminate the variability 
in the cell population ratios in the culture system, DCs were purified by magnetic sorting 
on day 5 prior to the LPS treatment.  However, the purified DCs were significantly less 
responsive to the LPS treatment than the unpurified population (Figure 4-3); hence 
purified DCs could not be used for treatment with biomaterials.  B cells were necessary in 
the culture system to achieve full responsiveness of DCs, possibly due to the profile of 
cytokines and natural antibodies produced by B cells even in the absence of support from 
T cells in the culture system [174-176].  A potential issue with B cell presence in the 
culture system is that they can also express the maturation marker, CD86 [177].  
However, it was determined that the B cells in this culture system expressed very low 
CD86 compared to the DCs.  Although approximately 9.4% and 7.3% of B cells were 
CD86
+
 in the iDC culture and mDC culture, respectively, the contribution of CD86 from 
B cells was less than 5% of the CD86 that is expressed on iDCs and less than 2% on 
mDCs (Figure 4-4).  Furthermore, no DNA stain was found to be compatible with the 
filter plate assay, primarily due to their broad excitation and emission spectra and the 
strong background fluorescence generated by the possible binding of the stain to the filter 
membrane.  Consequently, the strategy of data normalization by total DNA was not 




Figure 4-2: B-cell percentage in the iDC and mDC cultures by flow cytometric analysis.  The B cell 
percentages in the DC culture are shown with mean ± SEM, n=6 different donors.  *: p<0.05 and 
represents statistical difference between iDCs and mDCs. 
  
 
Figure 4-3: Dendritic cells purified by magnetic sorting were less responsive to LPS stimulation in 
comparison to unpurified counterparts.  On day 5 of DC culture, DCs were magnetically isolated by 
removing CD19
+
 B cells and then positively selecting CD1c
+
 DCs, treated with LPS for mDCs or left 
untreated for iDCs.  These purified DCs were analyzed for surface marker expression after 24 hrs 
and compared to the unpurified counterparts with mean ± range, n=2 donors. 
 
CD1c was initially considered as a normalization factor because some studies 
reported that CD1c expression only slightly increased during DC maturation [178] and 
because previously we observed negligible levels of CD1c expression on B cells in the 
culture system making it specific for DCs (data not shown).  However, here CD1c 
expression increased significantly upon DC maturation (Figure 4-5).  This may offset the 
increase in CD86 expression, if used as a normalization factor, which is undesirable.  
That is, when CD1c increases upon maturation along with CD86, the ratio of 
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CD86/CD1c may show no difference compared to iDCs.  As a result, CD1c was not 
suitable as a normalization factor.  
 
 
Figure 4-4: CD86 expression on DCs and lymphocytes in the culture system.  The antibody binding 
capacity of CD86 on DCs and B cells was measured by comparing the gMFIs of CD86 expression to a 
stardard curve created by beads that bound unknown number of antibodies using the BD FACSDiva 
software with mean ± SEM, n=6 donors.  *: p<0.05, lower than mDCs and higher than lymphocytes; 





Figure 4-5: Dendritic cell expression of CD1c and DC-SIGN by flow cytometric analysis.  The fold 
change of geometric mean fluorescence intensity (gMFI) for mDCs was compared to iDCs among 
donors with mean ± SEM, n=6 donors.  #: p<0.05, compared to iDCs and higher than iDCs; +: 
p<0.05, compared to iDCs and lower than iDCs. 
 
As an alternative marker for DC phenotype, C-type lectin DC-SIGN was then 
examined for its applicability as a normalization factor in the HTP assay.  Consistent with 
the literature [167], DC-SIGN expression level was lowered upon DC maturation (Figure 
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4-5).  Furthermore, DC-SIGN is only expressed by DCs in the culture system, and the 
ratio of CD86/DC-SIGN was DC number-independent in the assay.  Therefore, DC-
SIGN was used in the definition of “maturation factor”, the ratio of CD86/DC-SIGN, to 
represent DC maturation. 
 
4.3.2. Equivalent assessment of biomaterial effects on dendritic cells were observed 
validating the filter-plate method 
 To validate the 96-well filter plate-based method as far as DC treatment with 
biomaterials in the 96-well plate format and analysis of levels of CD86 and DC-SIGN 
expression using the fluorescent plate reader, a biomaterial study using biomaterials with 
known effects on DCs phenotype, namely, PLGA or agarose films, was conducted.  The 
results in Figure 4-6A showed that the trend for the fold change of “maturation factor” of 
the cell samples, whether treated with biomaterials in a 96-well or a 6-well tissue-culture 
plate, were similar; hence, the use of a 96-well format for biomaterial treatment on DCs 
was appropriate.  In addition, the samples from the 6-well plate were analyzed by the 96-
well filter plate format using the fluorescence plate reader or by the conventional flow 
cytometric analysis to yield similar trends, further confirming previous results [6,111], in 
which PLGA films induced DC maturation, but agarose films did not.  The flow 
cytometric analysis of other maturation markers such as CD40, CD80, CD83, CD86, 
HLA-DQ, and HLA-DR also confirmed differential DC maturation in response to 
different biomaterials treated using the 6-well format (shown for CD86 in Figure 4-6B; 
data for other markers were similar to previously published results [6]).  Collectively, this 
experiment validated the filter plate approach for assessing DC phenotype upon 
biomaterial contact.  Furthermore, in such experimental setup, the signal/background 
(S/B) and signal/noise (S/N) ratios for FITC ranged from 2.3 to 3.3 and from 52.3 to 
71.7, respectively.  The corresponding ratios for PE ranged from 3.5 to 8.8 and from 53.2 
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to 113.8.  Because of the large S/N ratios, signals could easily be distinguished from the 
background.   
  
 
Figure 4-6: Validation of the HTP methodology for assessing DC responses to biomaterials.  A) 
Treatment/control ratios of ‘maturation factor’ (defined as CD86/DC-SIGN) for DCs treated with 
biomaterials or controls in the 6-well format and analyzed by flow cytometry (set of black bars), in 
the 6-well format and analyzed by fluorescent plate reader (set of grey bars), and in the 96-well 
format and analyzed by fluorescent plate reader (set of white bars). B) Treatment/control ratios of 
CD86 expression for DCs treated and analyzed using the conventional format of 6-well plates and 
flow cytometry for DCs treated with biomaterials or controls.  Mean±SEM; n=8 (6 donors).  *: 
p<0.05, statistically different from iDCs and higher than iDCs.  Brackets: p<0.05, statistically 
different between two biomaterial treatments or between biomaterial treatment and mDCs. 
 
The use of filter plate puts biomaterial-treated DCs in contact with the filter 
membrane (another material) and therefore fixation of DCs is required to prevent any DC 
maturation effects due to the filter membrane.  Therefore, one issue was whether the level 
of surface molecule expression detected would be equivalent on the DCs with and 
without prior fixation.  Another issue was whether paraformaldehyde fixation in the filter 
plate would cause undesired cell bonding to the filter membrane, thereby affecting 
subsequent surface marker staining.  To address the first issue, it was demonstrated that 
the levels of CD86, DC-SIGN, and CD1c expression detected by flow cytometry were 
equivalent for DCs with and without fixation in an Eppendorf tube prior to staining with 
the monoclonal antibodies (Figure 4-7).  Furthermore, to address the second issue, 
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equivalent levels of these markers were determined by flow cytometry for DCs fixed and 
stained in filter plate as compared to DCs stained in Eppendorf tubes without fixation 























Figure 4-7: GMFIs of cells fixed and stained with 3 different schemes and compared to controls.  Std: 
unfixed cells were stained in Eppendorf tubes, which is the conventional staining method.  Std + fix: 
cells were fixed and then stained in Eppendorf tubes.  FP: unfixed cells were stained in filter plate.  
FP + fix: cells were fixed and stained in filter plate.  Non-TC + fix: cells were fixed in a 96-well non-
tissue-culture-treated polystyrene plate and then transferred to a 96-well filter plate for staining.  All 
the cell samples were collected and gMFIs determined by flow cytometry.  Three experiments with 
different donors were performed.  Fold changes of surface markers are shown with mean±SEM.  No 




4.3.3. Biomaterial-induced cytotoxicity 
 After 24 hr of treatment with biomaterials, cell supernatants were collected and 
assayed for the release of G6PD into the medium.  DCs treatment with PLGA films was 
found to induce higher levels of released G6PD into the media as compared to iDC 
(Figure 4-8).  This result is consistent with previous result in which DCs treated with 
PLGA induced higher annexin V staining than iDC but not mDC or agarose films (J. Park 
and J E. Babensee, unpublished observation).  As expected, the lysed iDC and mDC 






Figure 4-8: Effect of PLGA and agarose on DC glucose-6-phosphate dehydrogenase (G6PD) release.  
Dendritic cells were cultured with or without biomaterials PLGA or agarose films in a 96-well format 
for 24 h.  The supernatants were collected into a 96-well plate by centrifugation at 250g for 2 min 
and then measured for G6PD release using the Vybrant Cytotoxicity Assay at 37
o
C.  The 
fluorescence was measured at 30 min using a Tecan Infinite 500 microplate reader. Mean±SEM; n 




 A 96-well filter plate-based HTP methodology has been optimized and validated 
for the assessment of DC responses to biomaterials.  In this methodology, after treatment 
with biomaterials, DCs were transferred to a black 96-well filter plate, supernatant 
collected for analysis of soluble mediators/indicators of cell viability and remnant cells 
analyzed for expression of the “maturation factor”, CD86/DC-SIGN, using a fluorescent 
plate reader.   Using this methodology, DC responses to the biomaterials, PLGA or 
agarose films, were consistent with results obtained using conventional flow cytometry 
analysis.  Specifically, DCs treated with biomaterials in a 96-well or a 6-well tissue-
culture plate format yielded similar trends of maturation; therefore, a 96-well format was 
appropriate for DC treatment with biomaterials.  In addition, the DC samples from the 6-
well plate (conventional method) were analyzed in a 96-well filter plate format using the 
fluorescence plate reader or by the standard flow cytometric analysis and yielded similar 
trends, further confirming previous results, in which PLGA films induced DC maturation 
but agarose films did not.  Analysis of biomaterial-induced DC cytotoxicity by measuring 
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release of G6PD into supernatants by damaged cells showed that PLGA-treated DCs 
showed higher annexin V staining than iDCs consistent with independent experiments (J. 
Park and J.E. Babensee, unpublished observations).  Since unstained PLGA-treated DCs 
showed similar autofluorescence as iDCs, the observed PLGA-induced maturation and 
the resulting higher fluorescence signal were not due to the autofluorescence from 
apoptotic DCs or associated apoptotic bodies.  DC culture media supernatants can also be 
stored for cytokine profiling experiments using Multiplex technology. 
The HTP methodology developed herein offers several benefits for analyzing 
non-adherent or loosely-adherent DC responses to biomaterials as compared to other 
approaches.  Although flow cytometry is a powerful analytical tool, both sample 
preparation and data analysis are time-consuming, especially when a large number of 
samples are analyzed.  Automated sample loaders for 96-well plate or tubes for flow 
cytometry are available commercially (e.g. Guava Technologies) to address this issue, but 
these systems are usually very expensive, poorly accessible to most laboratories, and 
have long sampling times (approximately 1.5 to 2 hours for automated sampling a 96-
well plate) for a large number of samples.  The latter characteristic is prohibitive for 
living cells (particularly responsive leukocytes).  Although high-throughput biomaterial 
arrays exist for cell studies such as the nanoliter-scale biomaterial combinatorial arrays 
developed by Anderson et al. [142,143], these arrays are only applicable for adherent cell 
types and the cellular response to biomaterial differences was measured by immuno-
detection or ELISA-based methods which was possible because the cells were localized 
to a “spot”.  For DCs used herein, a filter plate-based method was necessary instead of a 
traditional cell-based ELISA due to the loosely-adherent or non-adherent nature of the 
cells, which would result in expected cell loss during washing steps using centrifugation 
and aspiration in a regular microplate during the ELISA analysis.  Furthermore, 
supernatant collection from a regular microplate is time-consuming and inaccurate due to 
the aspiration of supernatant from individual well with a pipette, while supernatants from 
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all the samples in a filter plate can be simultaneously collected into a collection plate 
without any cells being collected.  An efficient means of defining biomaterial “hits” in a 
combinatorial library of test polymers can be defined herein for this HTP methodology as 
a significant (p<0.05) increase or decrease in the value of the “maturation factor” as 
compared to iDCs.  Furthermore, the S/N and S/B ratios were sufficient for the analysis.   
 There were, however, complexities in the development of this HTP methodology 
for the analysis of DC responses to biomaterials which required attention.  The first 
complexity was the non-homogeneous cellular population i.e. presence of B cells.  As 
such, total DNA could not be used to normalize the fluorescent signal which was further 
justified by the vastly varied DC:B-cell ratios in the culture and the lack of a compatible 
DNA stain.  To consider whether DC responses to biomaterials could be assessed using 
purified DCs (no B cells) which would clearly make analysis easier, resident B cells in 
the culture were removed using positive selection and subsequent negative selection of 
DCs by magnetic sorting.  However, the purification of DCs significantly decreased their 
responsiveness to LPS, which may be explained by the important role of B cells in 
modulating DC maturation and function, possibly due to the release of cytokines or 
natural antibodies from B cells (even in the absence of T cells) in the culture system 
[175].  Although the results herein appear to be contrary to some reports that purified 
DCs respond well to LPS, it is important to note that the response of purified DCs may be 
highly dependent on the purification protocol.  For example, Jefford et al. reported that 
DCs differentiated from purified CD14
+
 monocytes or from CD1c
+
 peripheral blood DCs 
responded very differently to maturation stimuli [179].  Therefore, the DC types and 
culture methods should be considered for particular clinical applications.  DCs 
differentiated from purified CD14
+
 monocytes or from CD1c
+
 peripheral blood DCs, or 
from CD34
+
 cells from cord blood [180], are the most commonly employed purified DC 
types.  Herein, iDCs were purified (removal of resident B cells) on day 5 of culture after 
iDCs differentiation had been fully completed.  Purifying iDCs at this later stage, rather 
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than performing the purification step at the beginning of the culture for precursor cells, 
may render the purified iDCs less responsive to maturation stimuli.  The DC culture 
system in this study represents one of the most widely used and well-characterized DC 
culture systems [173], and without the DC purification step, less stress is exerted on the 
sensitive DCs.   
The second complexity was that given that the presence of B cells in the DC 
culture can be beneficial for DC function (as presented below) their contribution to the 
measured CD86 level needed to be minimal to none (as compared to the DCs).  B cells 
were found to release cytokine(s) (e.g. IL-16) and natural antibodies (e.g. CD40-reactive 
natural antibody) (in the absence of T cells) that aid in monocyte-derived DC migration, 
differentiation, and maturation [174,176], indicating that B cells can support DC function 
without T cell activation.  Furthermore, the presence of B cells in the culture system may 
better represent the physiological multicellular host response to biomaterials in vivo and 
presumably provides insight into how DCs specifically respond to biomaterials.  For the 
DC culture system used herein, MΦs were not present even though their cultures start 
with a common monocytic precursor [173], due to the presence of the cytokine IL-4, 
which induces DC differentiation but inhibits MΦ differentiation [181].  Thus, there 
would be no contribution from MΦs to the CD86 expression level in this study.  Of note, 
the B cells in our culture system expressed only less than 5% of the CD86 that is 
expressed on iDCs and less than 2% on mDCs.  Thus, the B cells in the culture negligibly 
contributed to the CD86 fluorescence signal.  In addition, previous research indicated that 
DCs are much more potent in stimulating T cells compared with B cells [182].  
Therefore, the presence of B cells is not expected to confound the analysis of DC 
maturation in this assay.  Results presented here indicated that although 9.4% and 7.3% B 
cells were CD86
+
 in the iDC and mDC culture, respectively, B cells expressed minimal 
level of CD86 as compared to DCs.  In addition, the expression of CD86 on B cells in the 
iDC and mDC culture was not different.  On the contrary, blood peripheral B cells have 
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been widely reported to express CD86 at low level (7% CD86
+
 of total B cells) in the 
resting population and at high level (30.3% CD86
+
 of total B cells) in the activated 
population [177].  In addition, B cells have also been reported to upregulate their CD86 
expression in response to LPS stimulation [183].  Human B cells are often isolated by 
FACS cell sorting or magnetic isolation, and then cultured in complete medium as used 
for DCs in the study herein but without the cytokines IL-4 and GM-CSF [174].  As such, 
although IL-4 induces CD86 expression on tonsillar B cells [184], presumably the 
presence of GM-CSF results in the low CD86 expression on B lymphocytes and their 
unresponsiveness to LPS in the DC culture system herein.  However, side-by-side 
comparison of CD86 expression by DCs and B cells has not been reported in the 
literature.   
 Given that total DNA was not a suitable normalization factor for CD86 expression 
the third complexity was identifying a suitable normalization marker.  Of the possible 
choices, CD1c functions to initiate adaptive immune responses against self or microbial 
lipid antigens [185-187] and is a characteristic of human DC populations [188].  In 
addition to DC populations, CD1c has been reported to be expressed on subsets of B cells 
[188].  Nonetheless, results here showed only a negligible level of expression of CD1c on 
B cells as compared to DCs (data not shown).  Furthermore, some studies reported that 
CD1c expression only slightly increased during DC maturation [178] and therefore was 
initially considered as a normalization factor.  However, our results showed that CD1c 
expression increased significantly upon DC maturation (Figure 4-5), which may offset 
the increase in CD86 expression.  Therefore, CD1c was not suitable as a normalization 
factor. 
 Another possible normalization factor considered was the DC-specific cell surface 
molecule, C-type lectin DC-SIGN.  DC-SIGN is a DC-specific adhesion and endocytic 
receptor [189] that is highly expressed on immature human monocyte-derived DCs 
[50,167].  Ideally, an invariant DC marker that is DC-specific and does not change upon 
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DC maturation would be preferred as a normalization factor.  However, since no such 
marker was found, we defined the parameter “maturation factor.”  Our rationale of using 
DC-SIGN were the following: 1) DC-SIGN is expressed on only the monocyte-derived 
DCs used in our system; therefore, the fluorescent signal measured is specific to the DCs 
in our culture; 2) The nature that DC-SIGN down-regulates upon DC maturation [167] 
causes the ratio of CD86/DC-SIGN to further increase, which may in fact give rise to a 
more sensitive assay for the assessment of DC maturation; 3) If a biomaterial changes 
DC-SIGN expression significantly while keeping CD86 expression unaltered, such 
material also becomes a “hit” (a false positive in the context of CD86 expression) and 
may be further studied due to the importance of DC-SIGN in immunity.  Thus, DC-SIGN 
serves as an additional marker for DC response to stimuli and was selected for defining 
the DC number-independent parameter – “maturation factor,” CD86/DC-SIGN.   
 To our knowledge, this is the first report describing a microliter plate-based HTP 
analysis of DC maturation which takes into account the non-adherent nature of these 
cells, the inherent heterogeneity of this culture, and the sensitivity of these cells.  Table 
4-1 compares the HTP filter plate and the flow cytometric methods.  The HTP 96-well 
plate format is superior to the 6-well format because it offers a number of advantages:  1) 
it provides much higher throughput in the assessment of DC response to biomaterials 
within the same experimental time frame;  2) this format allows for the simple collection 
of cell culture supernatants from the DC samples and their storage for multiple cytokine 
profiling using Multiplex technology;  3) the HTP assay significantly reduces the quantity 
of biomaterial samples and the time for sample preparation and measurement; 4) data 
acquisition requires a microplate reader, which is much less expensive and easier to 
maintain than a flow cytometer.  However, the HTP assay also has a few obvious 
disadvantages:  1) it only provides an average maturation signal from the well but not a 
distribution or histogram of the cells (more precisely, the events) provided by flow 
cytometry, so it is impossible to deduce the population or percentage of DCs that are 
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actually affected by the presence of the biomaterials; 2) the HTP assay requires highly 
expressed and movable markers, while flow cytometer can measure markers of much 
lower expression level.  Despite these disadvantages, the value of the HTP assay lies in 
its ability to allow for the screening of a large number of biomaterials in a combinatorial 
biomaterial array.  The biomaterial “hits” can be selected and their effects on DCs can 
then be further probed using conventional assays such as flow cytometry, mixed 
lymphocyte reactions, endocytosis assay, cytokine profiling, which have been used and 
continue to be used to analyze DC responses to biomaterials [6,190].   
 
Table 4-1: The comparison between the conventional flow cytometric method and the filter plate-
based HTP method. 
 Flow Cytometry Filter Plate 
Plate format 6-well plate 96-well plate 
Fixation step No generally Yes 
Equipment Flow cytometer Microplate reader 
Experimental time 3 hours (1 hr incubation) 2.5 – 3 hours (1.5 hr incubation) for 3 
plates 
# of materials 5 Up to 279 (or 135 if duplicate) in 3 plates 







Data acquisition time 30 – 60 min 30 – 60 second per plate, 2 fluorophores 
Data Expression of 6 surface markers 
with histograms and dot plots 
A ratio from the average expression of a 
limited set of surface markers 
Marker expression level  Very low to high (for markers 
with any expression level) 
Relatively high and movable (appropriate 
for markers with high expression level and 
huge fold change upon response) 
 
The discovery of compounds for new drugs has been dramatically changed with 
the advent of combinatory chemistry [191].  Similarly, combinatorial arrays of well-
controlled and characterized biomaterials are expected to enable the discovery of 
biomaterials that alter cell behavior.  A number of studies have used combinatorial 
libraries to study cellular response to biomaterial properties.  For example, Anderson et 
al. developed an impressive nanoliter-scale synthesis of biomaterial combinatorial array 
of different compositions and observed distinct differentiation of human embryonic stem 
cells (hESCs) on those materials [142,143].  Meredith et al. created a system with 
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continual changes of topography on glass slide using blends of poly(D,L-lactide) (PDLA) 
and poly(ε-caprolactone) (PCL) and identified preferred microstructural feature sizes for 
the attachment, spreading, and proliferation of UMR-106 (rat osteoblastic cell line) and 
MC3T3-E1 (mouse osteoblastic cell line) cells [145,146].  Mei et al. created surfaces 
with well-defined biocompatible polymer brush nanostructures by using varying graft 
density of poly(2-hydroxyethyl methacrylate) (PHEMA) and showed decreased fibroblast 
spreading and attachment with increased grafting density [149].  Brocchini et al. 
developed a polyarylate-based combinatorial array and showed that fibroblast 
proliferation was more sensitive to chemical structure than contact angle [157].  
However, most of these studies investigated basic cell functions such as adhesion or 
proliferation to well-defined combinatorial polymer libraries with the exception that 
Anderson’s system investigated biomaterial effects on the differentiation of hESCs.  
Furthermore, none of these HTP systems allow for the screening of loosely- or non-
adherent cells.  In contrast, the HTP assay developed and validated herein will be used to 
study the maturation of a highly sensitive and loosely- and non-adherent cell type, DCs.  
More importantly, correlations between DC phenotype and material properties can be 
drawn from the HTP assays using well-characterized combinatorial arrays.  Such 
correlations are highly advantageous due to their potential as a guide for 
immunomodulatory biomaterial design for both tissue engineering and vaccine delivery 
applications.  Clearly, thorough characterization of the members in the combinatorial 
array is important in the derivation of such correlations.  However, very few good HTP 
methodologies exist for polymer characterization [140].  As a result, the number of 
polymers in a well-characterized combinatorial array may be tens to a few hundred, 
which is well within the capability of the 96-well plate-based methodology developed 
and validated in this study.  Importantly, the success in such a HTP assay relies heavily 
on the sensitivity of the microplate reader.  As a final note, the sensitivity of this 
methodology may potentially be further improved by using time-resolved fluorescence or 
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miniaturized to a 384-well format with properly optimized conditions and fluorescent 
dyes to accommodate a larger combinatorial biomaterial library.  
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CHAPTER 5: DENDRITIC CELL RESPONSES TO 






As the most potent APCs, DCs are central in bridging the innate and adaptive 
immunity.  They are not only critical in mediating T cell polarization for effective 
immune response [58,192,193] but also pivotal in immunological self-tolerance by 
actively inducing the formation of Treg-cells [77].  In addition, DCs are also key players 
in osteoimmunology.  In particular, DCs have been identified in the synovial tissue and 
synovial fluid of joints in rheumatoid arthritis (RA) patients [194,195] and have been 
implicated in inflammation-induced osteoclastogenesis and bone loss [196].  Human or 
mouse activated CD4
+
 T cells induced by environmental stimuli were shown to up-
regulate surface-bound and soluble receptor activator of NF-κB ligand (RANKL), which 
is a prime regulator of osteoclast differentiation and activation [197].  The ligation of 
RANKL to its receptor, RANK, on osteoclast precursors resulted in inflammation-
induced bone loss in diseases such as RA and periodontitis [198-201].  Therefore, upon 
inflammation, DCs can become mature and initiate T cell activation, which in turn 
promotes the differentiation and survival of osteoclasts.   
Biomaterials commonly used in combination products were previously shown to 
differentially affect DC phenotype in vitro [5,6], and their effects could be translated to in 
vivo situations [3,202].  These studies demonstrated that biomaterials can be used to 
control the DC phenotype, thereby potentially modulating associated in vivo immune 
responses.  This potential of biomaterials to affect host response can be manipulated to 
                                                 
‡
  Adapted and modified from Kou PM, Schwartz Z, Boyan BD, Babensee JE. Dendritic cell responses to 
surface properties of clinical titanium substrates. Acta Biomaterialia. 7:1354-1363(2011) 
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either suppress immune responses induced by a tissue-engineered construct, or enhance 
the protective immunity induced by a biomaterial-based vaccine.  Elucidation of the 
biomaterial properties that control DC phenotype are expected to inform immuno-
modulatory biomaterial design.  However, due to the limitations of the biomaterials used 
in the previous studies, it was unclear which biomaterial properties determined distinct 
responses.  In order to delineate material property–DC phenotype relationships, a well-
defined biomaterial system with detailed material characterization is needed.  
In this study, clinical titanium (Ti) surfaces commercially available, including PT, 
SLA and modSLA, for dental implants were used to 1) analyze DC response to material 
properties and 2) determine the possible immunological outcomes induced by the 
different Ti substrates, using DC phenotype as an indicator of inflammatory response.  
These surfaces have been prepared to possess distinct microtopography and surface 
energy.  PT substrates were chemically polished to have a smooth finish; SLA surfaces 
were prepared by sand-blasting and acid-etching of the PT surfaces for increased 
roughness; modSLA surfaces had the same roughness as SLA, but were protected from 
contamination by hydrocarbons and carbonates naturally occurring in the atmosphere to 
maintain its high surface energy.  The surface material properties of these Ti substrates 
have been extensively characterized and were shown to induce distinct responses of 
human osteoblast-like MG63 cells, as well as normal human and rat osteoblasts 
[160,161,203].  The osteoblastic differentiation of MG63 cells was enhanced on rougher 
Ti surfaces such as SLA, and such differentiation was sensitive to both micron and 
submicron surface structures [204,205].  Furthermore, superior to PT or SLA, modSLA 
substrates promoted enhanced differentiation of osteoblasts and production of local 
osteogenic factors such as prostaglandin E2 (PGE2), transforming growth factor beta-1 
(TGF-β1) and osteocalcin, indicating that high surface energy and surface roughness 
synergistically support an osteogenic microenvironment [160].  In addition, modSLA 
implants significantly increased bone-to-implant contact in miniature pigs as compared to 
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SLA surfaces [206] and more rapid peri-implant bone formation in humans [207,208], 
consistent with the in vitro enhancement of osteoblast differentiation on modSLA 
surfaces.   
PT, SLA and modSLA surfaces were used to treat DCs and resulted in differential 
phenotype, which was then covaried to the surface properties of the Ti substrates, using 
principal component analysis (PCA).  Furthermore, the overall results indicated that 
modSLA may promote a more immature phenotype of DCs, which is anti-inflammatory, 
thereby potentially supporting osteoblast differentiation by suppressing local 
inflammation.  
 
5.2. Materials and Methods 
5.2.1. Ti substrates 
 Ti disks were prepared from 1-mm thick sheets of grade 2 unalloyed Ti (ASTM 
F67; “Unalloyed titanium for Ti for surgical implant applications”) and kindly supplied 
by Institut Straumann AG (Basel, Switzerland).  The Ti disks were punched to be 15 mm 
in diameter for snug fit in the wells of 24-well tissue culture polystyrene (TCPS) plates 
(Costar) (Corning, Corning, NY).  The methods used to produce the PT, SLA and 
modSLA Ti substrates were previously described [160,209].  The surface properties of 
the Ti substrates were previously extensively characterized and are summarized in Table 
1 for air-water contact angle, mean-peak-to-valley roughness (Ra) and surface chemical 
composition [161,210].   
 
5.2.2. Human dendritic cell culture 
 Human DC culture was performed in the same manner as in Section 4.2.1. in 
accordance with an updated protocol H10011 of the Institutional Review Board of 




5.2.3. Exposure of DCs to Ti substrates 
On day 5 of culture, loosely adherent and non-adherent cells containing iDCs 
were harvested and resuspended in DC media with 1000 U/ml GM-CSF and 800 U/ml 
IL-4 at 510
5
 DCs/ml.  One milliliter of cell suspension (510
5
 DCs) was plated on Ti 
disks in the wells of a 24-well plate, treated with 1 µg/ml LPS for the positive control of 
mDCs, or left untreated in TCPS plates for the negative control of iDCs.  Differentially-
treated DCs were collected after 24 h for analysis.  The loosely- or non-adherent fraction 
was collected by gentle pipetting of the cell suspension from the tissue culture plates.  
The cell culture supernatants were collected after centrifugation of the cell suspension at 
1100 rpm for 10 min and stored at -20°C until cytokine analysis.  To remove the adherent 
fraction, 0.5 ml warm cell dissociation buffer (Sigma) was added into each well and 
incubated at 37°C for 20 min.  The plate was gently tapped against the bench-top for 30 
times every 5 min to dislodge adherent cells.  The cell number of both fractions was 
quantified using a Multisizer
TM
 3 Coulter Counter (Beckman Coulter, Brea, CA).   
 
5.2.4. Flow cytometry for surface marker expression 
 After 24 h exposure to Ti substrates, DCs were harvested and analyzed for surface 
expression of DC maturation-associated markers, including CD83, CD86, and HLA-DQ, 
whose levels are up-regulated upon DC maturation.  CD83 is a DC maturation marker; 
CD86 is a co-stimulatory molecule; HLA-DQ is a major histocompatibility (MHC) class 
II molecule.  Twelve independent experiments were performed using DCs each derived 
from a different donor.  The levels of surface marker expression were monitored by flow 
cytometry using previously described methods [211].  The cells were collected by 
centrifugation at 1100 rpm for 10 min, resuspended in cell-staining buffer (0.1% BSA 
and 2 mM EDTA in D-PBS, pH 7.2), and stained with fluorescently-labeled antibodies, 
including CD83 (clone HB15a; mouse IgG2b) (Immunotech, Marseille, France), CD86 
(clone BU63; mouse IgG1κ) (Ancell Corporation, Bayport, MN), and HLA-DQ (clone 
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TU169; mouse IgG2aκ) (BD Biosciences, San Jose, CA).  The cells were stained for 30 
min at 4°C, and analyzed using a BD LSR II flow cytometer (Beckton Dickinson, San 
Jose, CA).  Data analysis was performed using FlowJo (Tree Star, Ashland, OR).   
 
5.2.5. Scanning electron microscopy (SEM) of adherent DCs 
 DCs were cultured on the Ti disks in a 12-well TCPS plate to ensure easy removal 
of the disks during SEM sample preparation.  After 24 h of culture, the disks were 
washed three times with warm D-PBS to remove the non- or loosely-adherent cells.  The 
cells/Ti samples were fixed with 1 ml 3.5% EM grade glutaraldehyde (Sigma) with 2% 
(w/v) tannic acid (Sigma) in 0.1 M Sorenson’s phosphate buffer (P-buffer) overnight.  
The cells were washed three times with P-buffer and were post-fixed with 0.5 ml 1% 
osmium tetroxide (OsO4, Sigma) in P-buffer for 1 h to impart partial conductivity [212].  
After three washes, the cells were treated with 1 ml 2% (w/v) aqueous tannic acid for 1 h 
(to preserve the fine structures of cells and aid in the subsequent OsO4 reduction at its 
binding sites).  After three washes, the cells were post-fixed again with 0.5 ml 1% OsO4 
in P-buffer for 1 h.  The cells were then dehydrated in a sequential series of increasing 
concentrations of acetone: 15%, 30%, 45%, 75%, 90%, and 100% acetone for 30 min at 
each concentration.  Subsequently, the samples were dried in an E3000 Critical Point 
Dryer (Quorum Technologies, Guelph, Ontario, Canada) and sputter coated with a thin 
layer (~5 nm) of gold (Polaron Sputter Coater SC7640; Quorum Technologies).  The 
micrographs were collected using Hitachi S-800 scanning electron microscope.  
 
5.2.6. Multiplex cytokine profiling 
 The supernatants collected from the cell culture medium in the presence of Ti 
substrates or controls were stored at -20°C and were thawed only once for multiplex 
cytokine analysis.  The levels of cytokines and chemokines in the cell culture 
supernatants were measured using Bio-Plex suspension array systems (Bio-Rad, 
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Hercules, CA) as per the manufacturer’s protocol.  Briefly, beads conjugated with capture 
antibodies for the target analytes were mixed and transferred to a 96-well filter plate 
(Millipore, Billerica, MA).  Supernatant samples were added to the wells for 30 min 
incubation.  After the beads were washed three times in the filter plate using a vacuum 
manifold (Pall Life Science, Ann Arbor, MI), the beads were incubated with biotinylated 
detection antibodies for 30 min.  After another three washes, the beads were incubated 
with streptavidin-PE for 10 min.  After three final washes, the beads were analyzed using 
a Bio-Plex 200 instrument with Bio-Plex Manager 4.0 software.  Through 12 independent 
experiments each with a different donor, 4-plex cytokine analysis was performed for 
TNF-α (pro-inflammatory), IL-1ra, IL-10 (anti-inflammatory), and MIP-1α (chemokine).  
The production of these cytokines was normalized by the cell number in the well.  
Because normalization did not affect the results in the 4-plex analysis, a wider panel of 
cytokines and chemokines [pro-inflammatory cytokines (IL-1β, IL-12p70, IL-15, IL-18 
and TNF-α), anti-inflammatory cytokines (IL-1ra and IL-10), a pleiotropic cytokine (IL-
16), and chemokines (IL-8, MCP-1, and MIP-1α)] were analyzed in a separate 
experiment with three different donors but were not normalized by the cell number.   
 
5.2.7. Statistical analysis 
To observe any significant differences between all sample groups in pairs, a pair-
wise general linear model of the two-way ANOVA with a mixed model followed by 
Tukey post test was used.  For all statistical methods, the Minitab software (Version 14, 
State College, PA) was used, and the p-value equal to or less than 0.05 was considered 
significant.  
 
5.2.8. Principal component analysis (PCA) 
 PCA was performed to analyze the phenotype and Ti substrate property data and 
to draw correlations between DC response and material properties.  PCA allows for the 
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simultaneous analysis of the original large set of variables by reducing the number of 
dimensions to a few principal components (PCs).  This is achieved by finding new axes 
to represent dimensions with maximal variability and highlight the global covariance 
patterns of the variables.  Typically, only two to three axes (PCs) are sufficient to capture 
most information from the data [213].   The phenotype variables included levels of 
surface markers, CD83, CD86 and HLA-DQ, and cytokine production of TNF-α, IL-1ra, 
IL-10 and MIP-1α; the material properties variables included air-water contact angle, 
surface roughness and surface chemical composition, % C, O, N and Ti.  The 
measurements from the experiments with twelve donors were organized into a data 
matrix, to which the PCA algorithm was applied to extract the latent correlations among 
the variables.  All data were pre-processed by log transformation, mean centering and 
unit-variance scaling [214].  Log transformation ensured Gaussian distributions of data, 
while mean centering and unit-variance scaling allowed the variances of different 
variables to have equal chances of being projected onto the PCs [215].  Despite the large 
variances, all data points were included, and the variances were accepted as natural 
variations of human primary immune cell responses.   
 Two PCAs were performed using different sets of variables for extracting 
different information from the multi-dimensional data.  The first analysis aimed to 
determine the overall effects of PT, SLA and modSLA on DC phenotype relative to the 
controls.  Average values of the phenotype variables and all of the five treatments, 
including PT, SLA, modSLA, TCPS and TCPS + LPS, were organized into a data matrix.  
The phenotype variables were organized in the columns of the matrix and the treatments 
in the rows of the matrix (Figure 5-7A).  The objective of the second analysis was to 
draw correlations between material properties of Ti substrates and DC phenotype.  For 
this analysis, individual values of the phenotype variables from the three biomaterial 
treatments (PT, SLA and modSLA) were used.  The material properties were also 
included in this data matrix.  The phenotype variables and the material properties were 
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organized in the columns and the treatments from each donor in the rows of the matrix 




5.3.1. The expression of DC maturation-associated markers was substrate-dependent 
 As shown in Figure 5-1, PT- and SLA-treated DCs both expressed higher CD86 
levels as compared to the TCPS-treated iDC control; however, no difference was found 
between PT and SLA treatments for CD86 expression in DCs.  In contrast, modSLA-
treated DCs expressed CD86 at a level similar to the iDC control.  However, DCs treated 
with modSLA substrates were still able to fully mature in response to LPS (Figure 5-2).  
LPS-treated DCs expressed higher CD86 levels compared to DCs treated with any of the 
substrates.  The expression levels of CD83 or HLA-DQ were not significantly affected 
upon treatments with the different Ti substrates.  Furthermore, SEM micrographs showed 
that DCs treated with PT or SLA substrates exhibited more dendritic processes associated 
with mDCs, while modSLA treated DCs were rounded, which is a morphology associated 
with iDCs (Figure 5-3A-C).   
 
 
Figure 5-1:Surface marker expression of DCs in response to treatment with different Ti surfaces (PT, 
SLA or modSLA) as compared to the iDC (TCPS) and mDC (TCPS+LPS) controls.  Geometric mean 
fluorescent intensities are shown for n = 12 donors (mean±SEM).  Brackets represent statistical 
significance among treatments with p≤0.05. 
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After a 24 h exposure to the Ti substrates, the percent DC recovery (recovered 
DCs / plated DCs) was similar for both the loosely- or non-adherent and adherent 
fractions of cells (Figure 5-4).  Percent DC recovery from the LPS-treated culture was 
higher than from DCs cultured on TCPS or treated with modSLA.  Furthermore, the 
percent adherent DCs (adherent DCs / recovered DCs) was not different among the 
different Ti substrates, but percent adherent DCs on TCPS was lower than on any of the 
substrates (Figure 5-4).  Low magnification (150x) SEM images of cells remaining on the 
substrates after non-adherent cells were washed away, indicating that the number of 
adherent DCs on these Ti substrates was similar (Figure 5-3D-F). 
 
 






Figure 5-3: SEM of DCs on Ti surfaces.  High magnification micrographs (1700x) show that DCs on 
PT (A, D) or SLA (B, E) exhibited highly dendritic morphology, which is associated with mDCs; DCs 
on modSLA (C, F) exhibited rounded morphology, which is associated with iDCs.  Low magnification 
scans (150x) (D, E and F) show that the different Ti surfaces adhere similar numbers of DCs.  Data 




Figure 5-4: Percent adherent cells on and percent DC recovery from the Ti substrates and controls.  
Left: Percent of cells (adherent DCs/recovered DCs) adherent to the different Ti surfaces (PT, SLA 
or modSLA) was not significantly different from each other.  Right: Percent DC recovery from 
modSLA was lower compared to mDC control (TCPS+LPS).  n=6 donors (mean±SEM).  Brackets 





5.3.3. Ti substrates induced differential cytokine production by DCs 
 Multiplex cytokine analysis showed that production of factors was substrate-
dependent.  PT surfaces induced higher levels of IL-1ra production by DCs compared to 
the negative control or modSLA substrates.   As expected, LPS-treated DCs released 
higher amounts of IL-1ra compared to the iDC control (Figure 5-5).  Although some 
trends in the production of TNF-α, IL-10 and MIP-1α were observed among the Ti 
substrates, the differences were not statistically significant.  LPS-treated DCs produced 
higher TNF-α, IL-10 and MIP-1α relative to any other treatments.   
 
Figure 5-5: Cytokine and chemokine release for DCs treated with Ti surfaces (PT, SLA or modSLA) 
as compared to the iDC (TCPS) and mDC (TCPS+LPS) controls.  The cytokine amount was 
normalized to the total cell number in the well.  n=12 donors (mean±SEM).  Brackets represent 
statistical significance among treatments with p≤0.05. 
 
The analysis of a wider array of cytokines and chemokines (Figure 5-6) indicated 
that SLA surfaces induced higher levels of IL-16 production by DCs compared to 
modSLA or TCPS, while PT-treated DCs released higher amounts of MCP-1 relative to 
the TCPS control and to a level not different from LPS-treated DCs.  LPS induced 
increased production of MCP-1 compared to TCPS, SLA or modSLA.  Furthermore, all 
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of these three Ti substrates induced minute productions of pro-inflammatory cytokines 
(IL-1β, IL-12p70 and IL-18) compared to LPS treatment of DCs.  Although the substrate-
induced production of IL-8 by DCs followed the trend of SLA > PT > modSLA, the 
differences were not significant.  In addition, LPS-treated DCs released higher IL-8 
compared to TCPS or any substrate treatment.  All Ti substrates induced IL-15 
production by DCs at levels below detection limit (data not shown).  Trends of TNF-α, 
IL-1ra, IL-10 and MIP-1α production were similar to Figure 5-5.  
 
Figure 5-6: Cytokine and chemokine release for DCs treated with Ti surfaces (PT, SLA or modSLA) 
as compared to the iDC (TCPS) and mDC (TCPS+LPS) controls.    The cytokine amount produced 
by the cells in the well is shown.  n=3 donors (mean±SEM).  Brackets represent statistical significance 
among treatments with p≤0.05.   The trends of production of TNF-α, IL-1ra, IL-10 and MIP-1α were 




5.3.4. PCA indicated differential levels of DC maturation were induced by Ti substrates  
  The first PCA analysis confirmed experimental data that extents of DC 
maturation were substrate-dependent (Figure 5-7).  The data set could be modeled using 
two PCs, which were able to represent 95.9% of the data.  The PCA biplot indicated that 
modSLA clustered with TCPS for its effects on DC responses, while SLA and PT formed 
another cluster that was closer to the LPS treatment.  As expected, LPS induced drastic 
phenotypic changes in DCs and was strongly associated with the phenotype variables 
along the far end of the first PC (PC1) (thick black ellipse in Figure 5-7).  Consistent with 
the experimental result, PT treatment was more strongly associated with IL-1ra 
production than the other two Ti treatments as shown along the second PC (PC2) (thin 
black ellipse in Figure 5-7).  Overall, SLA induced higher DC maturation as compared to 
PT because it was situated closer to the phenotype variables along PC1, while modSLA-
treated DCs were negatively associated with the phenotype variables (Figure 5-7).   
 
Figure 5-7: Confirmation of the relative effects of Ti substrates (PT, SLA or modSLA) on DC 
phenotype relative to the iDC (TCPS) and mDC (TCPS+LPS) controls using PCA.  (A) The 
organization of data into a matrix for PCA.  (B) PCA biplot of the DC phenotype variables, including 
surface marker expression of CD83, CD86 and HLA-DQ and production of TNF-α, IL-1ra, IL-10 
and MIP-1α, for PT, SLA, modSLA, TCPS and LPS treatments of DCs.  PC1 represents 80.5% of 
data variance, and PC2 explains 15.4% of data variance, which together capture 95.9% of data 
variance with little loss of information.  The red ellipses represent clustering of similar treatment 
groups (e.g. TCPS and modSLA form one cluster, while PT and SLA form another cluster).  The 
thick black ellipse indicates the location of phenotype variables, which is strongly associated with 
LPS-treated DCs along the far end of PC1.  The gray ellipse represents the association of PT 




Figure 5-8: Assessment of material property–DC phenotype relationships using PCA.  (A) The 
organization of the data into a matrix for PCA.  (B) PCA score plot and loadings plot for the first two 
PCs.  PC1 represents 38% of data variance, and PC2 explains 21% of data variance, which together 
capture 59% of data variance.  The red double-headed vector indicates that CD86 and Ra primarily 
influence PC1 and PC2, respectively, suggesting that roughness has little effect on CD86 expression.  
The blue dotted ellipse indicates that material properties of air-water contact angle (Theta), surface 
%C and %N are more associated with the phenotype variables.  Conversely, the black dotted ellipse 
shows that properties such as %O and %Ti are situated on the opposite side of the phenotype 
variables, suggesting that these material properties are more associated with an iDC phenotype.  The 
data set can be best modeled by 3 PCs that capture a total of 74.4% information.  However, because 
score plot and loading plots of PC1 and PC3 yield similar conclusions as those of PC1 and PC2, and 
because plots of PC2 and PC3 do not yield meaningful information, only the plots of PC1 and PC2 
are shown for simplicity. 
 
5.3.5. PCA suggested DC phenotype-material property relationships 
The second PCA analysis suggested DC phenotype–material property 
relationships (Figure 5-8).  The data set could be modeled by three PCs capturing a total 
of 74.4% of information.  The first 2 PCs (PC1 and PC2) were able to represent 59% of 
data variance.  Instead of a biplot, the score plot and loadings plot are shown for clarity.  
The relative locations of PT, SLA and modSLA in the score plot were consistent with the 
PCA biplot shown in Figure 5-8B.  In addition, in the loadings plot, CD86 expression and 
surface roughness (Ra) primarily contributed to PC1 and PC2, respectively, suggesting 
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that roughness had little effect on CD86 expression, which was consistent with the 
experimental result.  Furthermore, air-water contact angle (Theta), surface %C and %O 
were more associated with a mDC phenotype due to their clustering with phenotype 
variables that were up-regulated upon DC maturation (blue dotted ellipse in Figure 5-8B).  
Higher values of these surface characteristics were associated with PT and SLA 
substrates, which were shown to promote DC maturation.  In contrast, surface %O and 
%Ti, which were higher on modSLA substrates, were on the opposite side of the 
phenotype variables (black dotted ellipse in Figure 5-8B), indicating that these surface 
properties were associated with an iDC phenotype.  Interestingly, air-water contact angle 
was strongly associated with IL-10 production, and %C and %N were similar in their 
effects on DC phenotype.  Information from plots of PC1 and PC3 provided similar 
conclusions as PC1 and PC2, while plots formed by PC2 and PC3 resulted in 
meaningless covariations (data not shown).  
 
5.4. Discussion 
 The phenotype of DCs was differentially modulated by PT, SLA and modSLA 
surfaces.  Specifically, although the expression levels of DC maturation marker, CD83 
and MHC class II molecule, HLA-DQ, were not altered significantly, PT and SLA 
treatment of DCs induced higher co-stimulatory molecule, CD86, expression relative to 
DCs cultured on TCPS (iDC control).  DC treatment with modSLA did not affect CD86 
expression as compared to iDCs, presumably maintaining a non-inflammatory 
environment.  Our previous experience indicates that CD86 is the most sensitive marker 
for DC response to biomaterial treatments and is a valid variable for determining DC 
maturation levels [5].  Furthermore, both PT- and SLA- treated DCs exhibited much 
more extensive dendritic processes, a morphology associated with mDCs.  Consistent 
with the CD86 expression results, DCs treated with modSLA possessed a rounded 
morphology that is associated with iDCs.  Therefore, PT or SLA promotes an mDC 
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phenotype, whereas modSLA-treated DCs possess an iDC phenotype.  Despite the non-
stimulating nature of modSLA substrates, DCs treated on modSLA were able to fully 
mature upon LPS challenge, indicating that modSLA does not suppress DC’s capability 
to respond to bacterial stimuli, an important aspect for clearance of any device-associated 
infection.  
PT and SLA surfaces have very similar surface chemical composition, but differ 
in average peak-to-valley roughness (Ra) and surface air-water contact angle [161].  Both 
of these surfaces are hydrophobic; hence, the most important difference lies in the surface 
roughness between PT and SLA substrates.  The comparable levels of CD86 expression 
for DCs treated with PT or SLA surfaces suggested that surface roughness is not crucial 
in modulating DC phenotype.  Conversely, modSLA surfaces have the same surface 
roughness as SLA substrates, but were prepared to retain their high surface energy 
(approximately 0° air-water contact angle) by preventing surface contamination with 
atmospheric hydrocarbons and carbonates.  The results presented herein that modSLA-
treated DCs were non-stimulating indicated the importance of surface hydrophilicity as a 
material property that modulates DC phenotype.   
 Surprisingly, despite the vast differences in surface energy and cellular responses, 
as many DCs adhered to modSLA substrates as to PT or SLA surfaces, indicating that 
cell adhesion alone is not sufficient in inducing DC maturation.  Previous study 
demonstrated that distinct adsorbed ECM proteins on TCPS affected DC morphology, 
cytokine production, and allostimulatory capacity [122].  In addition, chemically-defined 
self-assembled monolayers were shown to present differential glycan profiles as well as 
induce distinct DC responses [7,115].  Therefore, the distinct DC responses induced by 
the Ti substrates were likely due to the differential protein adsorption profiles from the 
cell culture medium onto the Ti surfaces.  Although the adsorbed proteins allowed similar 
extents of DC adhesion to the different Ti substrates, the difference in the presentation or 
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conformation of these proteins presumably provided DCs with differential molecular 
patterns, resulting in distinct responses. This hypothesis will be tested in the future to 
understand which adsorbed protein profiles on the Ti substrates govern DC response.  
Specifically, it is necessary to understand the receptors and adsorbed matrix proteins 
critical for the modulation of DC responses to biomaterials. 
 In addition, DCs treated with Ti surfaces produced differential cytokine profiles.  
Contrary to the high expression level of CD86 and dendritic morphology, PT-treated DCs 
released higher amounts of anti-inflammatory cytokine, IL-1ra, compared to iDCs or 
modSLA-treated DCs.  Although some trends in the release of TNF-α, IL-10 and MIP-1α 
were observed, the differences were not statistically significant, primarily due to the large 
variances in the cytokine production by individual donors.  A wider array of cytokines 
and chemokines were subsequently analyzed in order to better delineate the cytokine 
responses upon DC treatment with Ti surfaces.  Treatment of DCs with PT surfaces 
promoted enhanced production of the chemokine MCP-1, compared to iDCs, and to a 
level similar to LPS-treated mDCs.  In addition, treatment of DCs with SLA surfaces 
induced higher levels of IL-16 production relative to iDCs or modSLA-treated DCs.  The 
production of pro-inflammatory cytokines such as IL-1β, IL-12p70 and IL-18 induced by 
DC treatment with Ti substrates were low and not different among each other.   
MCP-1 is a potent chemokine for monocytes and a variety of other immune cells 




 memory T cells [216].  Furthermore, MCP-1 was 
released at high levels by osteoblasts in the bone with associated inflammation [217].  
The elevated levels of MCP-1 production by DCs treated with PT surfaces are consistent 
with the enhanced expression of CD86 and mDC morphology observed for DCs treated 
with PT, indicating a pro-inflammatory DC phenotype.  Counter-intuitively, IL-1ra 
production was also enhanced by PT surfaces.  However, it is well-known that upon 
maturation, DCs naturally up-regulate the production of anti-inflammatory cytokines as a 
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negative feedback [218].  Therefore, the up-regulated IL-1ra production by DC treated 
with PT surfaces was presumably initiated by the activated DCs to alleviate the pro-
inflammatory response.  In addition, DC treatment with SLA substrates increased the 
production of IL-16, which is a pleiotropic cytokine that can have both pro- and anti-
inflammatory properties.  IL-16 has been shown to be a chemoattractant for CD4 
expressing peripheral immune cells, including CD4
+
 T cells, monocytes, eosinophils and 
DCs [219], and the elevated production of IL-16 was directly associated with airway 
inflammation [220].  In contrast, IL-16 was also demonstrated to inhibit mixed 
lymphocyte reaction by inhibiting TCR signaling [221], and that the administration of IL-
16 reduced the RA symptoms in a murine model [222].  Therefore, the functions of IL-16 
are likely dependent on the presence of surrounding cell types and cytokines in the 
microenvironment.  Because of the mature phenotype suggested by the enhanced CD86 
expression and dendritic morphology, SLA-treated DCs likely produce IL-16 as part of a 
pro-inflammatory response.  Collectively, the results indicate that treatment with PT or 
SLA surfaces promote a more mature phenotype of DCs, while treatment with modSLA 
surfaces does not affect DC phenotype. 
 PCA was performed in order to draw correlations between DC phenotype and 
material properties of Ti surfaces from the multi-dimensional dataset.  PCA was applied 
to the data in a blinded fashion to reduce the number of dimensions of the data, thereby 
facilitating the analysis of latent relationships.  Consistent with the experimental data, 
PCA results suggest that PT and SLA surfaces were pro-inflammatory for DCs, while 
modSLA appeared to promote a non-inflammatory environment (Figure 5-7B).  
Furthermore, along with air-water contact angle, surface % C and N were associated with 
a mDC phenotype, and higher values of these surface characteristics were associated with 
PT and SLA substrates.  In contrast, surface % O and % Ti contents were associated with 
a non-inflammatory DC phenotype and were detected at higher levels on modSLA 
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surfaces.  In addition, air-water contact angle was heavily associated with IL-10 
production as compared to other surface material properties.  The proximity of %C and N 
on the loadings plot indicated that their effects on DC phenotype were similar and 
presumably redundant.  Taken together, PCA not only suggested possible material 
property–DC response relationships, but it also further supported the experimental results 
that PT and SLA surfaces are pro-inflammatory, while modSLA surfaces are non-
inflammatory, for DCs.   
 Previous research demonstrated that the high surface energy and microtopography 
of modSLA surfaces synergistically enhanced the differentiation of osteoblasts and 
production of local osteogenic factors such as PGE2, TGF-β1 and osteocalcin [160].  In 
contrast to PT or SLA surfaces, the study herein showed that modSLA surfaces did not 
induce a pro-inflammatory environment due to its non-stimulatory effect on DC 
phenotype, thereby potentially minimizing the innate immune response.  Numerous 
studies have indicated the central role of DCs in osteo-immunology.  Elevated numbers 
of DCs have been found in joints of RA patients [194,195] and have been attributed to 
the bone loss induced by inflammation [196].  Furthermore, human or mouse activated 
CD4
+
 T cells induced by environmental stimuli were shown to up-regulate RANKL, 
which supports osteoclast differentiation and activation.  The over-activity of osteoclasts 
results in inflammation-induced bone loss [197,198].  Among APCs, DCs are the most 
potent in bridging innate to adaptive immunity by initiating and regulating T and B cell 
responses.  Activation or maturation of DCs by environmental stimuli, including 
biomaterial treatments, was shown to induce T cell proliferation [111].  Hence, upon 
inflammation, DCs can become mature and initiate T cell activation, which can in turn 
promote the differentiation and survival of osteoclasts.  Furthermore, PT-treated DCs 
were shown in this study to release elevated levels of MCP-1.  MCP-1 was previously 
demonstrated to induce the formation of multinucleated osteoclast-like cells from human 
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primary mononuclear precursors in vitro [223].  In another study, MCP-1 and RANKL 
synergistically promoted the differentiation of and fusion of mouse bone marrow cells 
into osteoclasts as well as enhanced the mineral dissolution in mouse bone marrow MΦ 
cultures on calcium phosphate disks [224].  In contrast, modSLA-treated DCs remained 
immature, evaluated by surface marker expression, morphology and cytokine profile.  
The ability of surface roughness and energy to induce osteogenesis and improve 
osseointegration is not only because of its effect on osteoblast and mesenchymal cells 
[205,206,210,225], but may also be due to its effect on the inflammation process.  As a 
consequence, a non-inflammatory implant material such as modSLA is expected to 
promote osteoblast differentiation by minimizing local inflammation and associated 
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DCs, the most potent APCs, are pivotal in both effective immunity and immune 
tolerance.  Upon challenge with pathogens or pro-inflammatory cytokines, DCs mediate 
T cell polarization for optimal immune response [58,192,193].  Simultaneously, DCs also 
actively maintain immunological tolerance towards self or non-harmful antigens by 
actively inducing the formation of Treg-cells [77].  Furthermore, the phenotype of DCs 
can be modulated by the biomaterials used to treat the DCs via a biomaterial adjuvant 
effect [6,113].  In CHAPTER 4, the biomaterial property-DC phenotype relationships 
began to be investigated using well-characterized biomaterial system implementing 
multivariate analysis such as PCA. In order to derive more detailed correlations, 
particularly for polymeric systems, more complex systems with a larger number of 
biomaterials are expected to be necessary.  
 Combinatorial and computational approaches in biomaterial design can 
potentially accelerate the discovery of new biomaterials and increase the diversity of 
promising polymeric structures for biomedical uses [140,226].  Quantitative structure-
property relationship (QSPR) modeling has long been used in drug discovery [227].  This 
approach was translated into predicting biological response to polymeric biomaterials.  
For instance, computation models, including artificial neural network (ANN), surrogate 
modeling, and partial linear squares regression (PLSR), were developed to successfully 
predict fibrinogen adsorption, rat lung fibroblast growth, and/or metabolic activity after 
                                                 
§
 Adapted and modified from Kou PM, Pallassana N, Cunningham B, Kohn J, Babensee JE. Predicting DC 
phenotype from material properties through multivariate analysis of DC responses to a polymethacrylate 
combinatorial library. In preparation to Biomaterials. 
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culture on a combinatorial library of 112 polyarylates from a number of material 
descriptor, including hydrophobicity, glass transition temperature (Tg), and chemical 
structure  [228-231].  Furthermore, computational modeling has been used successfully to 
create a large virtual library of 40,000 pMAs by the Kohn laboratory with predictable 
fibrinogen adsorption, fibroblast attachment, and fibroblast growth based on a selection 
of material descriptors [154].  These models allow for rational design of biomaterials 
before any polymers are synthesized or any biological experiments are performed and are 
expected to unprecedentedly expedite the discovery of biomaterials and advance the field 
of biomaterials.  
 Previously, a differential equation-based model has been developed to describe 
primary MΦ fusion in response to different common biomaterials [232].  However, this 
model did not directly predict host response based on material properties as the 
predictors.  Thus far, no computational models have been developed to describe or 
predict the response of human primary immune cells to biomaterial properties, which is 
of outstanding clinical relevance.  In this report, the biomaterial-mediated DC phenotype 
was assessed for a selection of the pMAs developed in Kohn laboratory.  This selected set 
of pMAs was previously shown to induce a wide range of biological response in terms of 
fibrinogen adsorption, fibroblast adhesion and growth [154].  The material properties of 
these pMAs were characterized and were shown to co-vary to different extents with 
phenotypic variables by PCA.  PLSR models were then built to predict DC response from 
different sets of material property predictors.  DC maturation based on surface marker 
expression could be predicted from the material properties with R
2
prediction   0.76.  
Interestingly, the prediction performance was maintained with R
2
prediction 0.80 when only 
theoretical chemical composition values were used as the predictor variables.  Taken 
together, the study herein demonstrates for the first time that immune cell response to 
biomaterials can be predicted from material properties and will expedite in silico rational 
design of future immuno-modulatory biomaterials.  
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6.2. Materials and Methods 
6.2.1. Synthesis pMA combinatorial library 
pMAs (Table 6-1) were prepared using chain-growth polymerization via free 
radical solution (FRS) and reversible addition-fragmentation transfer (RAFT) [233].  All 
chemicals were high purity, reagent-grade, or HPLC-grade and used as received except as 
noted: (i) AIBN was recrystallized from MeOH, (ii) Monomers (Figure 6-1) were 
purified through a column of alumina to remove inhibitors, and (iii) Solvents, solutions, 
and monomers were degassed with nitrogen or argon before use in free radical or RAFT 
polymerizations.   
 The polymerization was carried out using an automated parallel synthesizer.  
Briefly the synthesizer was inertized by five cycles of evacuation under vacuum at 120
o
C 
and degassed monomers (single or multiple monomers in desired mole ratios for desired 
target ratios), stock solutions of either AIBN (for FRS) or a co-solution of AIBN and 2-
cyanoprop-2-yl dithiobezoate (for RAFT) and solvents were charged to the reactors that 
were vortexed at 600 rpm at 70
o
C for 6 hours (FRS) or 20 hrs (RAFT) under Argon.  
More than 90 reactions were carried out in a single run.  The reactors were cooled to 
room temperature and the polymers were precipitated manually and dried under vacuum 
for more than 24 hours at 60
o
C.  The pMAs used in this study were selected from more 
than 150 members of the pMA library that were synthesized using this method and 
consisted of homo-, co- and ter-polymers.  Proton NMR was used to determine the 
composition and gel permeation chromatography for molecular weight determination 
[233].  Table 6-1 lists the pMAs and the corresponding abbreviations used in PCA and 




Figure 6-1: Chemical structure of the pMA monomers 
 
Table 6-1: List of pMAs that were used for the training set. 
pMA# Name Abbreviation 
1 Ethylene Glycol Methyl Ether MA EGMA 
2 Hydroxypropyl MA HP 
3 Isobornyl MA Isobornyl 
4 Methyl-EGMA Me-EGMA 
5 Methyl-hydroxypropyl MA Me-HP 
6 Methyl-tetrahydrofurfuryl MA Me-THFF 
7 Ethyl-Benzyl-TEGMA E-B-TEGMA 
8 Isobutyl-Benzyl-THFF MA I-B-THFF 
9 Lauryl-Isobornyl-Hydroxyethyl MA L-I-HE 
10 nButyl-Cyclohexyl-Undecyl MA nB-C-Undecyl 
11 Octyl-Isobornyl-Hydroxypropyl MA O-I-HP 
12 HEMA HEMA 
 
 
6.2.2. Coating of pMA in 96-well plate 
Each of the pMAs were dissolved 0.5% (w/v) in tetrahydrafuran (THF; Sigma), 
and the solutions were used to fill the wells of a 96-well polypropylene (PP) plate 
(Corning, Corning, NY) to ensure that the walls of the wells were coated.  The filled plate 
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was then transferred into an Isotemp vacuum oven (Fisher Scientific).  The temperature 
of the oven was increased 10°C/h from 40°C to 80°C.  Vacuum was generated at 80°C, 
and the solutions were dried under vacuum for 5 days until uniform coatings were 
formed.  Uniform coating of the wells, including the walls, was inspected by mixing the 
pMA solution with fluorescein to check for homogeneous fluorescence. 
 
6.2.3. Synthesis and coating of terpolymer combinatorial library 
The synthesis of terpolymers (Table 6-2) has been described previously [155].  
The monomers (Figure 6-2) hydroxyethyl methacrylate (ophthalmic grade) (HEMA or H), 
2-ethylhexyl acrylate (EHA or A), triethyleneglycol monomethylether monomethacrylate 
(TEGMA or T), N-ispropylacryamide (NIPAAM or N), glycidylmethacrylate (GMA or 
G), and azobisisobutyronitrile (AIBN) were purchased from either Sigma-Aldrich or 
Polysciences and used as received.  The polymers were synthesized by AIBN-initiated 
radical polymerization of the three monomers in DMF at 70°C. A typical reaction such as 
the synthesis of 40%HEMA-co-35%TEGMA-co-25%GMA was carried out as follows: 
HEMA (0.78 mL, 0.006 mols), TEGMA (1.29 mL, 0.005 mols), GMA (0.53 mL, 0.004 
mols), and AIBN (2.5mg, 0.015 mmol) were taken place in a round bottomed flask. 
Dimethylformamide (DMF) (12 mL) was added and the reaction was purged by a stream 
of nitrogen. The reaction was heated at 70°C for 6 h with rapid stirring. The polymer was 
precipitated in diethyl ether. The obtained polymer was re-dissolved and precipitated 2x, 
after which the polymer was dried for 2 days under vacuum.   Terpolymer coating 
procedure was carried out the same way as pMAs.  The terpolymers were used as the 
prediction set.  
 
6.2.4. Surface roughness and surface area measurements 
 All surface roughness was measured in pMA-coated 96-well wells after cutting 
off the walls of the wells.  Line roughness (Ra) of the pMA coatings were measured by 
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Wyko optical profilometer (Veeco, Plainview, NY) with a 5x objective.  Surface area, 
surface roughness (Sa), and other surface roughness variables (Table A1-2) were 
measured by LEXT OLS4000 3D material confocal microscope (Olympus, Center 
Valley, PA) using a 20x objective in an organic cleanroom in the Marcus 
Nanotechnology Building at Georgia Tech.   Two measurements were performed on each 
of three coatings for each pMA.  The value for each pMA was the average of the six 
measurements.  Representative surface images are shown in Appendix 9.  
 
 
Figure 6-2: Chemical structure of the monomers that made up the terpolymer prediction set. 
 
 
Table 6-2: List of terpolymers that were used for the prediction set 
terpolymer # Abbreviation Composition 
1 2A       A55T20G25 – 55%A-co-20%T-co-25%GMA 
2 2B       A40T35G25 – 40%A-co-35%T-co-25%GMA 
3 2D       A10T65G25 – 10%A-co-65%T-co-25%GMA 
4 5B       H40T35G25 – 40%H-co-35%T-co-25%GMA 
5 5C       H25T50G25 – 25%H-co-50%T-co-25%GMA 
6 5D       H10T65G25 – 10%H-co-65%T-co-25%GMA 
7 6A       A55H20G25 – 55%A-co-20%H-co-25%GMA 
8 6B       A40H35G25 – 40%A-co-35%H-co-25%GMA 
9 6C       A25H50G25 – 25%A-co-50%H-co-25%GMA 





6.2.5. Water-air contact angle and glass transition temperature (Tg) measurements 
 Polymers were coated on coverslips by solvent casting for contact angle 
measurements at Rutgers University.  Contact angles were determined on a Ramé-Hart 
goniometer equipped with a camera and DropImage software.  A drop of deionized water 
was placed on the polymer film and the contact angle measured within 1 – 3 s.  Tg was 
measured by differential scanning calorimetry (2910 Modulated DSC, TA Instruments) 
 
6.2.6. Surface chemical composition measurements by X-ray photoelectron spectroscopy 
(XPS) 
 XPS was performed on pMA-coated 96-well wells after cutting off the walls of 
the wells at the University of Toronto.  The samples were analyzed on the Thermo 
Scientific K-Alpha XPS spectrometer (ThermoFisher, E. Grinstead, UK) located at the 
University of Toronto. Measurements were obtained at a take-off angle (relative to the 
surface) of 90°. A monochromatic Al Kα X-ray source was used with a spot area of 400 
μm.  Charge compensation was necessary and was provided using the flood gun supplied 
with the instrument.  Survey spectra were obtained at low energy resolution (pass energy 
= 150 eV) in a scanned mode. Quantification was obtained from low resolution spectra 
acquired in a snapshot mode. The C 1s spectrum was also recorded at high resolution (PE 
= 25 eV) in a scanned mode. All data processing was performed using the software 
package supplied with the instrument (Avantage).  The high resolution peak fitting was 
independently performed at Georgia Tech, which included the basic C-C, O-C=O, and C-
O bonds (denoted as GT), and in University of Toronto, which included beta carbons and 
slight C=O contamination in addition to the three basic bonds (denoted as UT).  
Theoretical values were calculated based on polymer structures and molar ratios 





6.2.7. Human dendritic cell culture 
 Human DC culture was performed in the same manner as in Section 4.2.1. in 
accordance with an updated protocol H10011 of the Institutional Review Board of 
Georgia Institute of Technology. 
 
6.2.8. Exposure of DCs to coated pMAs or terpolymers in 96-well plate 
On day 5 of culture, loosely adherent and non-adherent cells containing iDCs 
were harvested and resuspended in DC media with 1000 U/ml GM-CSF and 800 U/ml 
IL-4 at 5105 DCs/ml.  150 µl of cell suspension (7.5104 DCs) was plated on pMA 
coatings in quadruplicate in the wells of a 96-well PP plate.  The extent of DC maturation 
was compared to the reference controls cultured on TCPS 96-well plate in parallel: 
untreated iDCs for the negative reference control and LPS (1 µg/ml)-treated mDCs for 
the positive reference control.  Four of the donors used in the pMA library experiment 
were used again in the terpolymer library experiment on different days.  
 
6.2.9. Maturation analysis with 96-well filter plate-based high throughput (HTP) method 
Differentially-treated and reference control DCs were harvested after 24 h for 
analysis using a HTP method previously described in CHAPTER 4 [211].  Briefly, all 
treated DCs and reference controls were transferred to a black 96-well filter plate, and the 
supernatants were immediately collected into a 96-well plate through the filters by 
stacking the filter plate on top of the collection plate and centrifuging at 250g for 2 min.  
A portion of the supernatants were used immediately for cytotoxicity assessment by 
measuring G6PD release from damaged cells (described in the following section), while 
the remaining portion was stored at -80°C for multiplex cytokine profiling.  The cells 
retained in the wells were assessed for maturation phenotype by immunostaining using 
antibodies anti-CD86-PE and anti-DC-SIGN-FITC.  CD86 is a costimulatory molecule 
that is upregulated upon DC maturation, and DC-SIGN an endocytic receptor that is 
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downregulated upon LPS-stimulated maturation.  The fluorescent intensities were 
measured with a Tecan Infinite F500 microplate reader, and the ratio of CD86/DC-SIGN, 
a cell number independent metric named “maturation factor (MF)”, was used to represent 
DC maturation.  
 
6.2.10. Cytotoxicity and Endotoxin Assessment 
Biomaterial-induced cytotoxicity was assessed by the release of G6PD into the 
media from cells cultured with or without biomaterials following the same procedures 
described in Section 4.2.5.  Briefly, 50 µl of the supernatants were assayed immediately, 
and the fluorescent intensity was compared to that of the medium from lysed cells.  The 
fluorescence signals were measured after 30 min incubation at 37
o
C with excitation and 
emission filters 535/25 and 590/20, respectively.  The endotoxin contents of the pMA 
coatings were measured using a chromogenic substrate (QCL-1000 LAL assay, Lonza) 
and determined to be less than 0.1 EU/mL, which is well below the FDA limit of 0.5 
EU/mL.  
 
6.2.11. Multiplex cytokine profiling 
 The supernatants collected from the cell culture media in the presence of pMAs or 
reference controls were stored at -80°C and were thawed only once for multiplex 
cytokine analysis as described in Section 5.2.6.  For the pMA training set, through six 
independent experiments each with a different donor, cytokine analysis was performed 
for pro-inflammatory cytokines (IL-1β, IL-12p70, IL-15, IL-18, and TNF-α), anti-
inflammatory cytokines (IL-1ra and IL-10), a pleiotropic cytokine (IL-16), and 
chemokines (IL-8, MCP-1, and MIP-1α).  For the terpolymer prediction set, cytokine 
analysis was performed for IL-1β, IL-ra, IL-8, IL-16, MCP-1, and TNF-α.  
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6.2.12. Statistical analysis 
To observe any significant differences between all sample groups in pairs, a pair-
wise two-way ANOVA followed by Tukey post test was performed using the GraphPad 
Prism 5 software (La Jolla, CA), and the p-value equal to or less than 0.05 was 
considered significant.  
 
6.2.13. Principal component analysis (PCA) 
 PCA was performed on the DC phenotype and pMA material property dataset to 
draw correlations between DC response and material properties.  PCA is a dimension 
reduction technique, which finds a few principal components (PCs) (new axes in the PC 
space) that represent dimensions with maximal variability and highlight the global 
covariance patterns of the variables [213].   The data matrix X   R72x29 consisted of both 
phenotypic and material variables (29 variables).  Phenotypic variables included MF 
(CD86/DC-SIGN) obtained in the HTP assay and production levels of seven cytokines 
and chemokines (IL-1β, IL-1ra, IL-8, IL16, MCP-1, MIP-1α, and TNF-α).  Values of IL-
10, IL-12p70, and IL-18 measurements were close to the detection limit, and IL-15 could 
not be detected; therefore these cytokines and chemokines were not included in the PCA 
analysis.  Material property variables included air-water contact angle (θ or Theta), Tg, 
line roughness, surface roughness, and surface chemical composition by XPS (Table A1-
1).  The 72 observations included six independent experiments with 12 different pMAs to 
generate the individual phenotypic variable values.  PCA algorithm was applied to the 
data matrix to extract the latent correlations among the variables.  All variables were pre-
processed by mean centering and unit-variance scaling [214,215].  Based on the 
distribution of the variables, some were log-transformed to ensure Gaussian distributions 
of data.   PCA was performed using the software SIMCA P+.  The performance of a PCA 
model can be summarized by two primary quantitative measures: goodness of fit of the 
model to the current dataset as given by R
2
 and goodness of prediction of the model for 
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predicting outcomes of future experiments as given by Q
2
, a measure of the cumulative 
fraction of the total variation of the X block that can be predicted by all PCs.  A high R
2
 
is required for a high Q
2
, and a Q
2
 of > 0.5 is considered good [234].  
      
   
            
 
      
     
            
 
Where SSXtot.corr.is the total sum of squares of X matrix (i.e. total variation in the X 
block), RSS is the fitted residual sum of squares, and PRESS is the predictive residual 
sum of squares calculated from cross-validation and is defined as  




where     is the experimental values of the variables,  ̂   is the predicted values of the 
variables from the reduced models during cross validation,   is the row position of data 
matrix, and   is the column position of the data matrix.  The suitable number of PCs is 
determined by the optimal balance between fit and predictive ability (see reference [234-
236] for details).  
 
6.2.14. Partial Least Square Regression (PLSR) Modeling  
 PLSR is a powerful computational method that expresses a set of dependent 
variables (outcomes) in terms of linear combinations (principal components) of the 
independent variables (predictors).  PLSR is very similar to PCA with an added algorithm 
for maximizing the correlations between the X (independent or predictor variable) and Y 
(dependent or outcome variable) blocks in the PC space.  The dataset used for PLSR 
included all the variables in PCA as well as additional roughness variables and was 
divided into two matrices: X   R72x119, consisting of the material property measurements 
as the predictor variables, and Y   R72x1, containing only one DC response variable, MF.  
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The material variables were copied six times for the six donor trials as they were the 
same for each donor.  Table A1-2 summarizes the variables included for each 




Y.  A 
Q
2
Y of > 0.5 is considered good [234].  Analogous to PCA, 
      
   
            
 
      
     
            
 
where SSYtot.corr.is the total sum of squares of Y matrix (i.e. total variation in the Y 
block), RSS is the fitted residual sum of squares, and PRESS is defined as:  




where     are the experimental values of the Y variables,  ̂   is the predicted values of 
the variables from the reduced models during cross validation,   is the row position of 
data matrix, and  is the column position of the data matrix.  The PCs derived from the 
PLSR model result in linear combinations of the predictor variables optimized for the 
maximum covariance with the dependent DC phenotypic variable.  From this initial 
model, a pruning step was performed to remove variables with low variance influence on 
projection (VIP < 0.7) and low reliability as determined by jack-knifing [236].  PLSR 
modeling was performed using SIMCA P+.   
The model performance was determined by how well the predicted values 
matched the observed values by evaluating the regression coefficient, R
2
prediction.  Because 
with more explanatory terms in a model, the model fit generally tends to improve with an 
inflated R
2




prediction) is also presented here to penalize the 
use of more PCs in the models.   ̅2 is defined as: 
 ̅          
   




where n is the sample size, which is 72 (6 donors   12 treatments) in all the models, and 
p is the number of explanatory terms, which is equivalent to the number of principal 
components necessary for the model.  In addition, CV-ANOVA (cross validation-
ANOVA) was performed for significance testing of the models.  This technique results in 
F-statistcs and p-values, which are useful for evaluating the significance of the model, i.e. 
whether the model is developed merely by chance. 
 
6.3. Results 
6.3.1. pMAs induced differential DC response 
 The results of material characterization of the twelve pMAs are summarized in 
Table 6-3.  DCs responded differentially to this set of polymers.  There is a trend of 
increasing DC maturation as shown by the metric CD86/DC-SIGN for the ordering of 
polymers used to treat DCs, as represented on the x-axis (Figure 6-3A).  When keeping 
the ordering of polymers the same, the release of pro-inflammatory cytokine, TNF-α 
(Figure 6-3B), and chemokine, IL-8 (Figure 6-3D), by treated DCs appeared to follow the 
same trend with pHEMA inducing the lowest amount of TNF-α and IL-8 production in 
DCs.  In contrast, pHEMA induced the highest amount of IL-16 secretion from DCs, 
which was statistically different from iDC and mDC reference controls as well as all the 
other pMA treatments examined (Figure 6-3C).  Furthermore, this set of pMAs induced 
differential levels of cytokine secretion.  In particular, poly(isobutyl-benzyl-THFF)MA 
(pIBTMA) induced the highest levels of TNF-α (Figure 6-3B) and IL-8 (Figure 6-3D) 
relative to all the other pMAs, while poly(isobornyl)MA induced the most IL-16 after 
pHEMA (Figure 6-3C).  Other cytokines and chemokines assayed did not appear to 
follow as a clear trend (Figure 6-4), but they induced differential levels of IL-1β (Figure 
6-4A), IL-1ra (Figure 6-4D), IL-10 (Figure 6-4E), IL-18 (Figure 6-4C), and MIP-1α 
(Figure 6-4G) production.   Generally, the pMAs on the left of the plots induced low 
amounts of the cytokines or chemokines from treated DCs, while the pMAs on the right 
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induced relatively higher amounts.  Again, pIBTMA induced the highest amounts of pro-
inflammatory cytokines and chemokine such as IL-1β (Figure 6-4A), IL-18 (Figure 
6-4C), and MIP-1α (Figure 6-4G).  The pMAs did not induce significant cytotoxicity in 
treated DCs.  Interestingly, pHEMA induced lower cell death as compared to all the other 
pMAs (Figure 6-5).  
 
 
Table 6-3: Summary of material property measurements for the 12 pMAs (the training set). The 
pMAs are ordered the same way as in Figure 6-3. 
 

















Theta 69.5 71.2 17.2 73.8 21.5 70.5 20.8 29.0 62.8 29.2 28.7 39.0 
Tg 87.6 83.8 55.8 90.7 15.2 91.3 1.6 -7.7 27.3 130.2 30.9 148.9 
Si2p (E) 0.1 0.3 2.0 0.1 0.5 0.2 2.2 1.0 0.5 0.4 0.3 3.0 
C1s (E) 84.6 78.7 75.3 91.5 91.7 95.7 78.4 87.0 86.3 90.4 91.5 81.2 
O1s (E) 15.3 21.0 22.7 8.4 7.8 4.1 19.4 12.1 13.2 9.2 8.2 15.8 
C1s (T) 66.7 70.0 75.4 72.5 70.0 72.5 78.3 87.0 85.1 87.5 78.5 87.8 
O1s (T) 33.3 30.0 24.6 27.5 30.0 27.5 21.7 13.0 14.9 12.5 21.5 12.2 
C-C (UT) 63.9 62.3 54.9 71.7 82.2 68.5 64.7 76.8 64.5 74.5 84.0 75.8 
C-O (UT) 20.8 14.7 22.8 10.7 7.7 11.8 19.3 10.0 17.3 5.9 6.6 11.4 
O-C=O 
(UT) 5.6 8.1 11.8 4.8 2.6 5.6 7.0 4.3 9.1 2.6 3.3 3.9 
Beta C 9.7 11.5 10.5 12.8 7.5 13.1 9.0 9.0 7.6 14.9 6.1 4.9 
C=O 0.0 3.4 0.0 0.0 0.0 1.1 0.0 0.0 1.6 2.0 0.0 4.0 
C-C (GT) 73.6 76.4 64.9 84.9 88.9 75.5 73.8 89.2 70.8 87.9 91.3 90.3 
C-O (GT) 19.8 13.8 18.5 8.0 7.3 18.9 19.0 5.0 19.5 7.0 5.9 3.6 
O-C=O 
(GT) 6.6 9.8 16.6 7.1 3.8 5.8 7.2 5.8 9.7 5.2 2.8 6.1 
C-C (T) 0.50 0.57 0.51 0.58 0.43 0.62 0.58 0.85 0.83 0.86 0.73 0.86 
C-O (T) 0.33 0.29 0.33 0.27 0.43 0.14 0.31 0.09 0.10 0.07 0.12 0.07 
O-C=O 
(T) 0.17 0.14 0.17 0.16 0.14 0.24 0.11 0.06 0.08 0.07 0.16 0.07 
Ra 0.23 0.84 0.44 0.25 0.59 1.05 0.13 0.45 0.24 0.13 0.81 0.44 
Sq 0.85 0.70 0.94 0.37 0.55 0.51 0.31 0.33 0.23 0.72 0.30 0.30 
Ssk 1.49 0.07 1.37 -0.13 0.51 5.45 -0.53 3.68 1.84 -1.02 2.29 4.89 
Sku 22.17 10.96 29.49 16.1 47.70 134.5 30.64 129.5 48.1 7.91 66.83 111.96 
Sp 10.89 9.06 12.35 7.26 12.67 13.46 6.16 9.10 5.71 6.46 6.98 8.98 
Sv 4.13 4.92 8.39 3.13 8.96 5.47 4.31 3.94 1.74 6.87 4.06 3.56 
Sz 15.02 13.98 20.74 10.4 21.63 18.93 10.46 13.04 7.45 13.33 11.04 12.54 
Sa 0.66 0.53 0.63 0.27 0.34 0.31 0.20 0.20 0.17 0.54 0.21 0.18 
Sk 2.05 1.45 1.52 0.73 0.82 0.87 0.51 0.54 0.53 1.40 0.64 0.54 




Table 6-3 continued: 
Svk 0.67 0.97 1.19 0.60 1.13 0.55 0.64 0.51 0.22 1.28 0.32 0.31 
SMr1 11.17 9.62 13.62 10.1 9.92 10.44 9.47 10.21 10.1 7.85 10.16 10.62 
SMr2 89.95 85.03 87.48 86.5 86.15 87.60 87.68 88.30 88.7 82.45 89.23 89.89 
Sxp 1.73 1.30 1.52 0.63 0.70 0.75 0.43 0.45 0.45 1.24 0.55 0.45 
Vvv 0.09 0.10 0.12 0.06 0.10 0.06 0.06 0.04 0.03 0.13 0.03 0.03 
Vvc 1.01 0.71 0.90 0.35 0.40 0.43 0.24 0.26 0.25 0.65 0.31 0.26 
Vmp 0.05 0.03 0.07 0.02 0.03 0.04 0.01 0.02 0.01 0.02 0.02 0.02 
Vmc 0.72 0.59 0.62 0.28 0.31 0.32 0.19 0.19 0.19 0.59 0.23 0.19 
Sal 146.1 5.61 82.17 70.5 8.29 59.30 4.14 25.59 70.9 3.10 51.71 72.18 
Str 0.45 0.59 0.38 0.64 0.54 0.56 0.85 0.61 0.59 0.82 0.65 0.53 
 
 
Figure 6-3: DC responded differential to the pMAs. A) Maturation factor (CD86/DC-SIGN). Release 
of B) pro-inflammatory cytokine TNF-α, C) anti-inflammatory cytokine IL-16, and D) chemokine IL-
8 was represented by the fold change against iDC.  *: p<0.05 different from iDC; #: p<0.05 different 
from HEMA and hydroxypropyl; ■: p<0.05 higher than mDC; □: p<0.05 lower than mDC; brackets: 






Figure 6-4: Cytokine and chemokine profiles induced by pMA treatments of DCs.  This set of 
cytokines and chemokines analyzed did not follow as clear trend of increasing DC maturation along 
the same ordering of polymers listed in the x-axis.  A) IL-1β, B) IL-12p70, and C) IL-18 are pro-
inflammatory cytokines; D) IL-1ra and E) IL-10 are anti-inflammatory cytokines; F) and G) are 






Figure 6-5: pMAs did not induce significant cytotoxicity of DCs.  Brackets: p < 0.05 between 
treatments.  !! indicates the signal was beyond upper limit for this assay. 
 
 
6.3.2. PCA indicated differential DC maturation induced by the pMAs and represented 
correlations between DC phenotype and material properties 
 A five-component PCA model was determined by cross-validation to be the most 
optimal for representing this dataset with R
2
 = 0.78 and Q
2
 = 0.61, meaning that this 
model can capture 78% of the information in the original data space with good 
predictability.  The five components could individually capture 33.5%, 18.2%, 10.9%, 
9.6%, and 6.1% of data information, respectively.  No major outliers were identified by 
the Hotelling’s T
2
 statistic, which is a multivariate generalization of the Student’s T 
distribution.  The score plots showed a wide spread nature of the projection of the 
observations, indicating that the pMAs induced a wide range of DC responses (Figure 
6-6A).  Furthermore, pMAs that induced low DC maturation in experiments, such as 
pHEMA and pHPMA, segregated to the left of the PC1, while pMAs that induced high 
DC maturation, such as pIBTMA and p(nB-C-Undecyl)MA, located to the right of PC2, 




Figure 6-6: Score and loading plots showing the projection of the treatments and variables on the PC 
space.  PC1 captures 33.5% and PC2 captures 18.2% of the data, which together represent >50% of 
the original data information.  A) Score plot shows the projection of the pMA treatments, each with 
six data points obtained from six independent experiments with different donors.  B) Loading plots 
shows the projection of the variables on the PC space.  See text for detailed interpretation of the 
plots. The following color code is used for the loading plot: Blue: phenotypic variables; black: 
chemical composition; red: contact angle; orange: roughness; green: Tg; pink: surface area.  The 
interpretation of the combination of PC1 with other PCs resulted in similar conclusion; therefore 
these plots are omitted for simplicity. 
 
 
The loading plot represent how the material properties and DC phenotypes 
correlate to each other (Figure 6-6B).  First, all the phenotypic variables measured 
strongly clustered and mostly located in a quadrant diagonally opposite from IL-16. 
Overall, the theoretical values of C-C, C-O, and O-C=O bond composition mostly 
clustered with experimental values (both fitted in U of Toronto and Georgia Tech), and 
they were situated away from DC maturation variables and were associated with an 
immature DC phenotype.  Although there was difference in the projection of theoretical 
and experimental values of C1s onto the other PCs, these variables were always 
associated with the maturation phenotypic variations along PC1 (data not shown).  Most 
importantly, the projection of O-containing bonds in the loading plots was always 
diagonally opposite to that of C only bonds (Figure 6-6B).  In addition, contact angle and 
surface roughness (Sa) were located away from the maturation variables. Interestingly, 
line roughness (Ra), Tg, and surface area were consistently situated close to the origin of 
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the plots except that Tg had influence on PC3, and surface area had influence on PC3 and 
PC5, neither of which captured more than 10% of data information (data not shown).  
The overall results were very similar regardless of the combinations of PCs.  Although 
the model was best fitted with five PCs, MF and most of the surface chemical 
compositions could be well modeled by only two PCs (Figure 6-7A). However, after five 
PCs were applied (Figure 6-7B), many of the cytokines and chemokines, along with Tg, 
Ra, and surface area, were still poorly modeled, with low R
2









> 0.3).  
 
 








6.3.3. Surface material properties could predict the relative effects of pMAs on DC’s MF 
level  
After pruning the initial PLSR model to remove variables of low importance and 
reliability (e.g. C=O contamination, Tg, Ra, surface area, etc.), the resulting X   R
72x91
 
data matrix was fitted with a two-component model with R
2
Y = 0.63 and Q
2
 = 0.58.  CV-
ANOVA determined that the model is significant with p-value = 4.41 10-12 (Table 6-4).  
Consistent with PCA, the score plot segregated pMAs that induced less DC maturation to 
the left of PC1, but segregated pMAs that induced high DC maturation to the right of the 
PC1; therefore, PC1 could also be defined as the “maturation axis” for this PLSR model 
(Figure 6-8A).  PC1 could correlate material properties to MF with R
2
Y = 0.52 and Q
2
 = 
0.50, while PC2 could draw additional correlation with R
2
Y = 0.12 and Q
2
 = 0.17.  
Predictor variables that were highly correlated or anti-correlated with the outcome 
variable, MF, could be visualized by their relative placement in the loading plot (Figure 
6-8B).  Again, surface carbon, along with Si contamination, was strongly correlated to 
DC maturation, MF, whereas surface oxygen was strongly anti-correlated to DC 
maturation.  The analysis of the loading weight of the variables (w*c) and the VIP 
underscored the importance of surface chemical composition, particularly the theoretical 
values, on predicting DC responses (Table A1-3–4).  Specifically, among chemical 
composition variables, C-C (T), C1s (T), and MF had the strongest weight along positive 
PC1, while O1s (T), C-O (T), and OC=O (T) had the strongest weight along negative 
PC1 (Figure 6-8C), where “T” indicates theoretical values.  As expected, the C bonds 
were positively weighted on PC1, while O-containing bonds were negatively weighted on 
PC1.  Interestingly, most of the roughness structures were negatively weighted on PC1 
(Figure 6-8C).  In contrast, contact angle (Theta) was weighted negatively and most of 




Figure 6-8: Maturation factor prediction from surface material properties using a PLSR model. A) 
Score plot showing the projection of the pMAs onto the PC space. B) Loading plot showing the 
projection of the material properties (predictor variables) onto the PC space. C-D) loading weight of 
the variables in PC1 (C) and PC2 (D). E) Prediction of MF induced by a different set of acrylate- and 
methacrylate-based polymers in six independent experiments with different donors. The error bars 




The robustness of this model was tested by applying it to predict the MF levels in 
DCs induced by the prediction set, which was derived from the experiments using a 
different set of acrylate- and methacrylate-based terpolymers averaged from six 
independent experiments with six donors.  Linear regression on the prediction resulted in 
R
2
prediction = 0.76 (Figure 6-8E) and  ̅
2
prediction = 0.75 (Table 6-4), indicating that the model 
was able to predict future experiments well, at least with methacrylate and acrylate-based 
polymers.  The detailed phenotypic analysis and material characterization are described 
in Appendix 6. 
Interestingly, by removing the experimental XPS values either obtained with (in 
UT) or without beta carbon fitting (in GT) still resulted in strong predictive models with 
R
2
 prediction = 0.71 and  ̅
2
prediction = 0.70 if beta carbon fitting is included (i.e. remove XPS 
values at GT) (Figure A1-1A) or with R
2
 prediction = 0.77 and  ̅
2
prediction = 0.77 if beta 
carbon is not included (i.e. remove XPS values at UT) (Figure A1-1B, Table 6-4). 
Analogous models were constructed to predict the cytokine levels and were found 
to have R
2
Y < 0.55 and Q
2
< 0.4.  These models were also unable to predict future 
experiments with low R
2
prediction< 0.3.   Due to the high correlation among the maturation 
variables as shown by the PCA model, a full Y block containing all these variables were 
expected to be reduced to a few dimensions.  Therefore, a PLSR model with a full Y-
block: Y   R72x8 was also constructed with R2Y = 0.37 and Q2 = 0.33 (3 PCs), which was 
still effective in predicting MF (R
2
prediction = 0.71) but ineffective in predicting cytokine 
profile outcomes in future experiments with R
2
prediction< 0.15.  
 
6.3.4.Theoretical chemical composition alone was sufficient in predicting the relative 
effects of pMAs on DC’s MF level 
 A PLSR model was built using only the theoretical values of chemical 
compositions of the pMAs.  A three-component model was fitted for this X   R72x5 data 
matrix with R
2
Y = 0.61 and Q
2
 = 0.58 during cross-validation (Figure 6-9) and a p-value 
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= 2.3 10-10 based on CV-ANOVA (Table 6-4).  PC1 can correlate material properties to 
MF with R
2
Y = 0.43 and Q
2
 = 0.41, PC2 can draw additional correlation with R
2
Y = 0.12 
and Q
2
 = 0.18, and PC3 can capture the remaining covariance with R
2
Y = 0.07 and Q
2
 = 
0.13.  Similar to the previous PLSR model, PC1 could be used to roughly segregate the 
effects of the materials that induced differential levels of DC maturation (Figure 6-9).   
Consistent with both PCA and previous PLSR models, surface carbon (C1s) was strongly 
associated with DC maturation by locating the same quadrant as MF, while surface 
oxygen was found to associate with an immature DC phenotype by situating oppositely to 
MF.  In addition, surface carbon was strongly positively weighted in PC1, but surface 
oxygen was strongly negatively weighted in PC1 (Figure 6-9C).  In contrast, C1s and O-
C=O along with MF had positive influence on PC2, C-C and O1s had negative influence 
on PC2, and C-O had little influence on PC2 (Figure 6-9D).  All five variables had strong 
influence on the model (Table A1-5–6).  This simple model could effectively predict the 
MF levels in DCs induced by the prediction set (Table 6-2) with R
2
prediction = 0.80 and 
 ̅2prediction = 0.79, indicating strong predictive robustness (Figure 6-9E, Table 6-4).  
Similar to the previous PLSR model, analogous models aimed at predicting the 
cytokine levels had low model performance with R
2
Y < 0.45 and Q
2
< 0.4 and were 
unable to predict future experiments with low R
2
prediction< 0.15.   In addition, a PLSR 
model with a full Y-block: Y   R72x8 also resulted in a poorly performing model R2Y = 
0.37 and Q
2
< 0.33 (3 PCs), which, consistent with previous PLSR model, was still 
effective in predicting MF with R
2
prediction = 0.79 but ineffective in predicting cytokine 
profile outcomes in future experiments with R
2
prediction< 0.1. 
In contrast, when experimental XPS values were used alone, the predictability of 
the models was much poorer.  PLSR models derived from a) both experimental XPS 
values analyzed with (in UT) or without (in GT) beta carbon fitting, b) only experimental 
XPS values with carbon fitting, and c) only experimental XPS values without carbon 
fitting all performed poorly with R
2





prediction  0.32 and  ̅
2
prediction  0.31 with p-values at least five magnitudes lower 
than the model developed using only theoretical values (Table 6-4).  These models were 
developed with the removal of Si contamination and C=O contamination on the surfaces 
because the effects of these minute contamination were amplified in PLSR modeling, 
where each variable is given equal weight to the problem at hand. When Si and C=O 
were maintained in the models, although the model fit would be improved due to the 
addition of two more PCs, the resulting models made even poorer prediction for MF.  
Alternatively, a multiplier of smaller than 1 could be manually set for variables that are 
not expected to contribute significantly to the modeling due to their small quantities.  
This approach did not result in improved models. 
 
Table 6-4: Summary of model performance (all models have undergone pruning steps except for the 
model based on only theoretical or experimental XPS) 








prediction F p-value 
Full set of material properties  0.63 0.58 0.76 0.75 23.3 4.4 10-12 
Theoretical XPS only  0.61 0.58 0.80 0.79 14.4 2.3 10-10 
Experimental XPS only (both 
GT and UT) 
0.21 0.19 0.26 0.25 8.3 5.8 10-4 
Experimental XPS without beta 
carbon fitting only (GT only) 
0.19 0.17 0.24 0.23 7.2 1.5 10-3 
Experimental XPS with beta 
carbon fitting only (UT only) 






Figure 6-9: Maturation factor prediction from theoretical surface chemical composition alone using a 
PLSR model. A) Score plot showing the projection of the pMAs onto the PC space. B) Loading plot 
showing the projection of the material properties (predictor variables) onto the PC space. C-D) 
loading weight of the variables in PC1 (C) and PC2 (D). E) Prediction of MF induced by a different 
set of acrylate- and methacrylate-based polymers in six independent experiments with different 





The phenotype of DCs was differentially modulated by the 12 pMAs.  The pMAs 
induced a wide range of DC response as represented by the MF metric (Figure 6-3).  
Interestingly, many of the pMAs induced higher level of DC maturation upon treatment 
represented by this metric as compared to LPS stimulation (TCPS mDC) (Figure 6-3A).  
When the ordering of pMAs was kept consistent throughout the other plots, the 
production of TNF-α and IL-8 by DCs induced by the pMAs appeared to follow roughly 
the same trend with pHEMA inducing the least amount of TNF-α and IL-8 release by 
DCs.  In contrast, pHEMA induced the highest amount of IL-16 production that is 
significantly different from iDCs, mDCs and all other pMA treatments (Figure 6-3B, C, 
and D).  TNF-α is a pro-inflammatory cytokine, and IL-8 is a chemokine, both of which 
are released upon DC maturation.  IL-16 has been shown to be a pleiotropic cytokine that 
can have both pro- and anti-inflammatory properties.  The functions of IL-16 are likely 
dependent on the presence of surrounding cell types and cytokines in the 
microenvironment [237].  Because pHEMA induced very low maturation marker 
expression and low secretion of cytokines and chemokines that are typically elevated in 
inflammation, the pHEMA-treated DCs likely produced IL-16 as a part of anti-
inflammatory response.   
The production of the other seven cytokines by DCs did not follow a clear trend 
based on the same ordering of pMAs in the x-axis (Figure 6-4), but the low amounts of 
cytokine release are clustered to the left while the higher amounts clustered to the right, 
which is consistent with the DC maturation represented by MF.   Particularly, this set of 
pMAs induced differential levels of IL-1β (Figure 6-4A), IL-1ra (Figure 6-4D), IL-10 
(Figure 6-4E), IL-18 (Figure 6-4C), and MIP-1α (Figure 6-4G) secretion.  Most notably, 
besides TNF-α (Figure 6-3B) and IL-8 (Figure 6-3D), pIBTMA induced the highest 
levels of IL-1β, IL-18, and MIP-1α production by treated DCs relative to all other pMA 
treatments.  Since pIBTMA-treated DCs also expressed high level of MF, it can be 
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concluded that pIBTMA potentially induced the highest level of DC maturation among 
these pMAs examined.  Anti-inflammatory cytokines IL-1ra and IL-10 increased with 
enhanced DC maturation as well.  Most likely, these anti-inflammatory cytokines have 
been naturally up-regulated as a negative feedback to modulate the inflammatory 
response [218].   Interestingly, pHEMA induced very low levels of all these cytokines 
and chemokines; in some cases, the levels were even lower than those induced by iDCs.  
IL-15 was only detectable in one of the six donors and the data were not shown.  
 PCA was applied to the dataset that contains both the DC phenotype and material 
property information to draw correlations among the variables.  PCA reduced the 
dimensions of the dataset into lower dimension space to facilitate the analysis of latent 
relationships.  Most of the cytokine variables were log-transformed due to the multi-
magnitude differences induced by the pMA treatments.  A five-component PCA model 
was the most optimal to represent the original dataset in the new principal component 
space with R
2
 = 0.78 and Q
2
 = 0.61.  These values are excellent for this dataset, which 
contains many phenotypic and material property variables (29 variables) and large donor-
to-donor variations, particularly in the cytokine profiles.  pMAs were spread along PC1 
in the score plot roughly based on their effects on DC maturation, so PC1 was coarsely 
defined as the “maturation axis” (Figure 6-6A).  PCA allows the multi-dimensional data 
to be projected onto this reduced PC space for easy visualization of the correlations 
among the variables.  
 The loading plots represent the correlations among the variables (Figure 6-6B).  
Consistent with the experimental results, all the phenotypic variables associated with DC 
maturation formed a cluster and located diagonally opposite from IL-16 (Figure 6-6B).  
The strong association of the phenotypic variables suggests that high redundancy exists, 
and potentially only a few of these variables need to be assayed to obtain general 
phenotypic information about DCs.  Overall, all the carbon bonds located at positive PC1 
but the oxygen bonds at negative PC1 (Figure 6-6B).  As expected, theoretical XPS 
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values mostly clustered with experimental values regardless of whether beta carbons 
were taken into account during peak fitting.   Material properties such as Ra, Tg, and 
surface area located primarily close to the origin of the loading plots, indicating that these 
variables are not important in predicting DC response.  In contrast, high Sa is associated 
with lower DC maturation in this pMA library (Figure 6-6B).  Sa is computed across the 
entire area in the field of view, while Ra only measures the roughness along some 
arbitrary line across a surface.  For a uniform surface, Ra and Sa are expected to be very 
similar, but this may not be the case for a heterogeneous surface.  Since the pMAs were 
solvent cast into the PP plates, the formation of the films was not homogeneous, and 
therefore Sa should be a better roughness variable for such surfaces.  Generally speaking, 
the carbon bonds located in a quadrant was diagonally opposite from the oxygen bonds in 
all the loading plots (Figure 6-6B), indicating that surface carbon and oxygen anti-
correlated each other in terms of inducing DC maturation.  Interestingly, increase in 
contact angle was associated with low DC maturation for this set of pMAs.  It is 
important to note that the range of contact angle for this set of polymers was 17.2 – 71.2°.  
Therefore, the conclusion drawn in the PCA model is only valid for this range of contact 
angles.  The higher contact angles (close to 71.2°) are similar to that of TCPS [238], 
which is known to be suitable for most cell cultures and may be approximately the 
optimal contact angles for maintaining DC immature state.  However, close inspection of 
Table 6-3 indicated that no strong correlation exists between DC maturation and contact 
angle, but pMAs with higher contact angles do group towards the left of Table 6-3 with 
pMAs such as pHEMA and pHPMA that caused low DC maturation.   
 Figure 6-7 indicated that although the model was best fitted with five PCs, the 
variations in MF and most of the surface chemical composition variables were well-
captured by the first two PCs (Figure 6-7A).  In contrast, most of the cytokines and 
chemokines were still poorly modeled after five PCs (Figure 6-7B), presumably due to 
the large high donor-to-donor variations that introduced significant noise to model.  
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 Subsequently, predictive models were constructed in an attempt to predict DC 
phenotype using PLSR.  PLSR is very similar to PCA; the major difference is that in 
finding the optimal PCs to describe the variations in the X-block, the algorithm also 
maximizes the correlations between the X- and Y-blocks, and the resulting model can be 
used to predict outcomes of future experiments.  Because MF was determined from PC as 
the best DC phenotypic variable that could be modeled (Figure 6-7), a PLSR was first 
developed to correlate material properties and MF variations.  To begin the modeling, all 
material variables were included into the X-block.  From this initial model, pruning steps 
were implemented to exclude variables that have little importance or reliability to reduce 
the X-block, including C=O contamination, Tg, Ra, surface area, and a few others.  Such 
procedures were successful in creating a model with R
2
Y = 0.63 and Q
2
 = 0.58 with 
model significance of p-value = 4.4 10-12, which was able to predict future experiment 
with a high R
2
prediction = 0.76 and  ̅
2
prediction = 0.75 (Figure 6-8E and Table 6-4).  As 
expected, the score (Figure 6-8A) and loading (Figure 6-8B) plots resulted in similar 
conclusions as in the PCA model, with MF being the most strongly associated with 
surface carbon due to its proximity with carbon bonds in the loading plot (Figure 6-8B).  
In addition, MF were anti-correlated with surface oxygen by locating at opposite 
quadrants (Figure 6-8B). 
Interestingly, theoretical values for XPS were weighted more heavily to the PC 
space (Figure 6-8C-D) with higher VIP (Table 3S-4S) as compared to the experimental 
values.  A possible explanation is that XPS has large inherent errors (30 – 50%), which 
affects the projection of these variables onto the PC space.  Since this set of pMA films 
was prepared from bulk materials without further modification, the surface chemical 
composition should be similar to the bulk composition unless serious contamination is 
present.  The theoretical values might actually reflect a more accurate estimation of the 
surface composition, while the experimental values contained extra instrumental errors 
that affect their projection onto the model.  However, XPS was still valuable to ensure 
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that the material surfaces were not contaminated during regular storage.  If surface 
modification was implemented, XPS must be performed to obtain a better estimation of 
surface chemical composition for model development.    
After removing either set of experimental XPS values, the model was improved to 
have prediction regression coefficient of R
2
prediction = 0.71 and  ̅
2
prediction = 0.70 (if the set 
of experiment XPS values without beta carbon fitting [GT] was removed) and R
2
 prediction 
= 0.77 and  ̅2prediction = 0.77 (if the set of experimental XPS values with beta carbon 
fitting [UT] was removed), respectively.  This further supports the hypothesis that 
experimental XPS values could deteriorate the predictive power of this PLSR model, and 
that the theoretical values of surface composition may be the most informative.  
However, experimental XPS is expected to be necessary to determine the actual surface 
composition if surface modification is performed on the materials. 
Analogous models for cytokine and chemokine level prediction were found to be 
poor in performance with R
2
Y < 0.55 and Q
2
<0.4 and were not able to predict outcomes 
in future experiments, likely due to the high donor-to-donor variations in cytokine 
profiles.   
PCA indicated that a strong covariance exists among the phenotypic variables that 
are associated with DC maturation, suggesting their strong redundancy and that a Y-
block that contains all the DC response variables would be suitable (because it can be 
reduced to lower dimensions).  However, a PLSR model built with a full Y-block resulted 
in a poor model (R
2
Y = 0.37, Q
2
 = 0.33).  Although this model has poor predictive power 
for the cytokines and chemokines, it was quite effective in predicting MF (R
2
prediction = 
0.71).  Again, this confirms that MF was the only predictable phenotypic variable among 
those assayed.  
Since theoretical XPS values appeared to be the most important in predicting DC 
response for the pMA library, a simple model with only these variables as the X-block 





Y = 0.61 and Q
2
 = 0.58 with model significance of p-value = 2.3 10-10.  This 
model could predict MF levels in future experiments with R
2
prediction = 0.80 and  ̅
2
prediction 
= 0.79 (Figure 6-9E and Table 6-4).  Similar to the previous PLSR model, cytokine and 
chemokine levels were not predictable in analogous models.  In addition, a model with a 
full Y-block was able to predict MF (R
2
prediction = 0.79) but not cytokines and chemokines.  
When experimental XPS values were used alone to construct the model, the 
resulting models performed prediction poorly (Table 6-4).  If both sets of experimental 
XPS values (i.e. experimental XPS values with beta fitting [UT] and without beta fitting 
[GT]) were used, the model could only predict future outcomes at R
2
prediction = 0.26 and 
 ̅2prediction = 0.25.  If the set of XPS values without beta carbon (fitted in GT) was used 
only, the predictability was merely R
2
prediction = 0.24 and  ̅
2
prediction = 0.23.  If the set of 
XPS values with beta carbon (fitted in UT) was used only, the predictability was 
improved to R
2
prediction = 0.32 and  ̅
2
prediction = 0.31.  Furthermore, the p-values for these 
models were at least five magnitudes lower than the previous models.  Therefore, at least 
in this study, theoretical XPS values were the most informative for the prediction of DC 
response based on material characteristics. 
Altogether, these results demonstrated co-variations exist between DC response 
and material properties as demonstrated by PCA with surface chemistry being the most 
influential in resultant DC response.  More importantly, DC response can be predicted by 
basic material properties.  However, not all phenotypic variables are predictable.  In this 
study, MF was a predictable variable, while none of the cytokines and chemokines was 
predictive.  A potential explanation for the lack of predictability of cytokines and 
chemokines could be that these molecules are the most downstream in the inflammatory 
response and are subjected to very complex post-transcriptional control [239] as well as 
degradation upon release into the culture medium.  Large donor-to-donor variations 
might be caused by the individuals’ unique network of mechanisms that regulate cytokine 
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release.  These non-specific variations cannot be projected onto the PLSR models well 
and distort the model; therefore, they cannot be used for future predictions.   
This study also demonstrated that an overall DC response represented by MF can 
be predicted using only theoretical chemical composition values.  This has very 
significant implications for future biomaterial design.  Researcher may potentially design 
a polymer based on the optimal ratios of chemical bonds to achieve a certain target DC 
phenotype and save many research dollars that would otherwise be spent on the testing of 
unnecessary polymer formulations.  It is important to note that these models did not 
differentiate aromatic rings from single C-C bonds (as in XPS).  A model with more 
complex chemical structure information is expected to have more predictive power. 
A combined model with the Ti data from Chapter 5 did not result in a usable 
model, because the Ti dataset contain much fewer variables as compared to the pMA or 
terpolymer set, which led to a large number of non-random missing values in the data 
blocks.  In addition, the measured outcome for the Ti set (CD86) and for the pMA or 
terpolymer set (MF) were different variables that cannot be combined.  In the future, 
consistent variables should be measured for all the materials before a comprehensive 
model can be constructed for the desired set of experimental outcomes as based on 
material properties, consistent for all samples.  
Several limitations of the models exist.  First, the models were able to 
differentiate the relative DC response that can be induced by a set of polymers, but they 
do not suggest a particular level of DC response.  Therefore, these models are the most 
useful for theoretically predicting the effect of a set of polymers on DCs, from which the 
researcher can choose materials that induce low, medium, or high DC maturation and 
perform further experimentation to verify the prediction.   Second, the models were tested 
on acrylate- and methacrylate-based materials that contain only carbon and oxygen with 
strong predictive robustness.  The models were not as effectively in predicting DC 
response to PP surface (data not shown) or materials from a different category.  A model 
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can only predict what it is trained on.  Therefore, predictive PLSR models are expected to 
be required for different classes of polymers, although a model developed with very large 
dataset composed of different classes of materials may be explored for its predictive 
power.  Third, this model did not take into account other important material properties 
such as polymer swelling, which could be an important material property that directs DC 
response.  It is noteworthy that pHEMA did noticeably absorb cell culture medium to a 
greater extent than other pMAs, which could have contributed to its non-inflammatory 
properties.  However, polymer swelling is often measured using bulk materials and the 
results might not be applicable to coated thin films.  More reliable evaluation methods for 
the swelling of polymer thin film should be employed.  Finally, immune response is very 
complex with different polarization, including Th1, Th2, Th17, and Treg [72,240-242], DC 
response based on surface marker expression can only capture a part of the response.   
Despite the limitations, these predictive models can assist future biomaterial 
design for the applications in tissue engineering, vaccine delivery, or cancer therapy, 
where effective and appropriate immune response is required.  Potential immune 
response approximated by DC maturation factor can be predicted based on polymer 
formulation before any experimentation is performed, which is expected to expedite the 




CHAPTER 7: DIFFERENTIAL POLYMETHACRYLATE-
INDUCED DENDRITIC CELL PHENOTYPES ARE 






DCs are critical in mediating T-cell polarization for optimal immune response by 
creating the proper cytokine microenvironment for T-cell priming [58,192,193].  The 
different cytokine profiles have been long known to be mediated through the specific 
ligation of different TLRs with distinct types of pathogenic molecular motifs [69].  For 
instance, DCs triggered through TLRs 7, 8, and 9 produced both IL-12 and interferon 
(IFN)-α; DCs triggered through TLR-3 produce mostly IFN-α; DCs triggered through 
TLR-5 produce mostly IL12p70; DCs triggered through TLR-4 produce mostly IL-12p70 
and a little IFN-α.  All of these TLRs induce Th1 immunity and CTL responses.  In 
contrast, DCs stimulated through TLR-2 produce little IL-12p70 but copious IL-10, 
shifting the balance towards Th2/Treg profile [69].  Although TLR ligands are widely 
considered to promote protective immunity against pathogens, the ligation of certain 
ligand, such as zymosan, with TLR-2 on DCs supports the induction of Tregs rather than 
Th1 or Th17 cells via TLR-2 but induces Th1 and Th17 autoimmune responses when 
signaled via dectin-1 [243].  
TLR agonists polarize DCs to induce distinct Th responses via differential 
modulation of signal transduction [69,244,245].  For example, TLR-4 and TLR-5 
agonists, LPS and flagellin respectively, signal through p38 and c-Jun N-terminal kinase 
                                                 
**
 Adapted and modified from Kou PM, Patel R, Cunningham B, Pallassana N, Kohn J, Babensee JE. 
Polymethacrylates mediated differential dendritic cell phenotype through distinct transcription factor 
activation profiles. In preparation to Biomaterials. 
107 
 
1/2, while TLR2 agonist, Pam3cys, stabilize the transcription factor (TF) c-Fos [245].  
Different stimuli, including IFN-γ, ATP, ADP, CrO, and LPS, induce differential and 
dynamic TF activation in XS106 murine DC line [246].  Therefore, DCs respond to the 
environment through the sensing of PRRs that trigger differential modulation of signaling 
pathways, the combination of which determined the polarization and outcome of the 
immunity.  
Previously, the phenotype of DCs was shown to be modulated by the biomaterials 
used to treat the DCs via a biomaterial adjuvant effect, and more importantly, the in vitro 
observations were translated into in vivo responses [3,4].  These studies suggested that 
biomaterials can be used to modulate DC phenotype, thereby controlling associated in 
vivo immune response to the biologic components in combination products such as 
tissue-engineered constructs and vaccines.   
Although integrins [121], TLR-2, TLR-4, and TLR-6 [247] have recently been 
shown to play a role in mediating DC response, the exact mechanisms by which DCs 
recognize and respond to biomaterials remain to be elucidated.  The effects of 
biomaterials of DCs are directed via the presentation of proteins adsorbed on the 
biomaterials, which then interact with the DCs to trigger differential responses [248].  
Understanding the mechanistic basis of how DCs respond to different biomaterials is 
expected to facilitate the selection or design of materials that direct a desired immune 
response.  For instance, biomaterials may be tuned to trigger Th1 or Th17 responses for 
maximal protective immunity against a vaccine, or induce Treg for host acceptance of 
donor cells in tissue-engineered constructs.  In this study, two different pMAs, pHEMA 
and pIBTMA, with previously observed opposite effects on induced DC phenotype 
(CHAPTER 6, [249]) were used to treat DCs for various time points and were found to 





7.2. Materials and Methods 
7.2.1. Synthesis of pMAs  
pHEMA was purchased from Sigma Aldrich and used as is.  pIBTMA was 
synthesized in house at the Kohn laboratory at Rutgers University, using reversible 
addition-fragmentation transfer (RAFT) [233].  The polymerization was carried out using 
an automated parallel synthesizer.  Briefly the synthesizer was inertized by five cycles of 
evacuation under vacuum at 120
o
C, and degassed monomers in desired molar ratios, 
stock solutions of AIBN and 2-cyanoprop-2-yl dithiobezoate and solvents were charged 
to the reactors that were vortexed at 600 rpm at 70
o
C for 20 hrs under Argon.  The 
reactors were cooled to RT and the polymers were precipitated manually and dried under 
vacuum for more than 24 h at 60
o
C.   
 
 
Figure 7-1: pHEMA and pIBTMA were selected from a previous study, where pHEMA was shown to 
induce a low level of DC maturation, whereas pIBTMA induced a high level of DC maturation as 







These two pMAs were selected from a set of twelve pMAs, which was previously 
found to induce differential DC phenotype [249], because they induced the two extremes 
of DC maturation (CHAPTER 6).  Specifically, pHEMA induced the least mature DC 
phenotype, whereas pIBTMA induced highly mature DCs based on surface maturation 
marker expression (Figure 7-1).  Furthermore, cytokine profiles induced by pHEMA and 
pIBTMA also supported this polymer selection.  pHEMA induced low levels of all the 
cytokines and chemokines, except IL-16, analyzed, while pIBTMA induced high levels 
of all the maturation-associated cytokines and chemokines but induced low levels of IL-
16 (Figure 6-3 and Figure 6-4 in Chapter 6).  
 
7.2.2. Coating of pMA in 96-well plate 
The coating procedure was performed as described in Section 6.2.2. 
 
7.2.3. Human dendritic cell culture from purified monocyte population 
 PBMCs were isolated in the same manner as in section 4.2.1. in accordance with 
an updated protocol H10011 of the Institutional Review Board of Georgia Institute of 
Technology.  To generate a pure DC culture, monocytes were isolated from PBMCs 
using CD14 microbeads (Miltenyi Biotec, Auburn, CA) following the manufacturer’s 
instructions.  The purity of monocytes was routinely >95% by monoclonal CD14 
antibody (clone TÜK4, mouse IgG2a; Miltenyi Biotech) staining.  Ten milliliters of 
monocytes were plated in a Primaria 10020 mm
2
 tissue-culture dish at a concentration 
of 110
6
 cells/ml in DC media.  After 2 h of incubation at 95% relative humidity and 5% 
CO2 at 37°C, the dishes were washed 1 – 2 times with warm DC media to remove the 
dead cells caused by the isolation procedure.  The remaining adherent monocytes were 
incubated with 10 ml/plate fresh warm DC media, supplemented with 1000 U/ml GM-
CSF and 800 U/ml IL-4, for 5 days to induce the differentiation of monocytes into 




) was consistently >95% by 
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dual staining with monoclonal CD1a (clone HI149, mouse IgG1,κ; Biolegend, San 
Diego, CA)) and DC-SIGN (clone 120507, mouse IgG2b; R&D Systems, Minneapolis, 
MN) antibodies and analyzing by flow cytometry (Appendix 2).  
  
7.2.4. Exposure of DCs to coated pMAs in 96-well plate 
On day 5 of culture, DCs were harvested and resuspended in DC media with 1000 
U/ml GM-CSF and 800 U/ml IL-4 at 510
5
 DCs/ml.  150 µl of cell suspension (7.510
4
 
DCs) was plated on pMA coatings in each well of a 96-well PP plate.  The reference 
controls were cultured on TCPS 96-well plate in parallel: untreated iDCs for the negative 
reference control and LPS (100 ng/ml)-treated mDCs for the positive reference control.  
In order to collect enough cells for nuclear extraction, 12 wells for each treatment were 
used.  Separate 96-well plates were used for different time points: 3, 6, and 11h.  
 
7.2.5. Cell imaging 
 DC morphology was captured in the 96-well plates at the indicated time points 
immediately prior to cell harvest for nuclear extraction.  Images were collected with 
Olympus IX71 inverted microscope (Olympus, Center Valley, PA) and Image-Pro 
Express software (MediaCybernetics, Bethesda, MD). 
 
7.2.6. Nuclear extraction of DCs  
 All procedures were performed on ice unless specified.  At each time point, DCs 
were collected from the 96-well plates and pooled into 15-ml conical tubes according to 
treatments.  The wells were washed 1x with 150 µl ice-cold D-PBS and the residual cells 
were collected into the corresponding tubes.  To remove the adherent DCs, 50 µl of ice-
cold cell dissociation buffer (Sigma) was added into each well and incubated for 15 min, 
with gentle tapping of the plates at 5 min intervals.  The cells were pelleted at 500 g at 
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4°C and were transferred to Eppendorf tubes.  After one wash with D-PBS, nuclear 
extraction of the differentially treated DCs was performed using the Panomics Nuclear 
Extraction Kit (Affymetrix, Santa Clara, CA) following the manufacturer’s protocol.  
Briefly, Buffer A was used to disrupt the cell membrane and release cytosolic contents 
and nuclei.  After removing the cytosolic portions, the nuclei were incubated with Buffer 
B for 1 h to disrupt nuclear membranes and release nuclear contents.  The nuclear 
extracts were stored in small aliquots at -80°C immediately.  One of aliquots from each 
treatment was thawed for protein quantification.  Although the manufacturer recommends 
using the Bio-Rad DC Protein Assay, the dynamic range of this assay was found to be 
narrow in Buffer B, and it routinely over-estimated the protein amounts.  Instead, the 
protein contents were quantified using Bradford Reagent (Sigma), which was found to 
not interfere with the Buffer B in the nuclear extracts.  
 
7.6.7. Transcription factor (TF) Plex Assay 
 A customized Procarta Transcription Factor Plex (Affymetrix) was used to 
evaluate the profile of the transcription factor activation of DCs upon treatment with 
different biomaterials following the manufacturer’s instructions.  The TFs analyzed in 
this study included NF-κB (nuclear factor kappa-light-chain-enhancer of activated B 
cells), ISRE (interferon-stimulated responsive element), AP-1 (activator protein-1), E2F-
1, CREB (cAMP response element-binding), GR/PR (Glucocorticoid / progesterone 
response element), NFAT (nuclear factor of activated T-cells), and HSF (heat shock 
factor).  Briefly, the nuclear extracts were incubated with 10 µl probe mix containing 
biotin-labeled double stranded oligonucleotides (TF binding site).  TFs bound to these 
oligonucleotides were recovered, and the biotin-labeled probes were eluted, denatured, 
and then hybridized to beads conjugated with the complementary oligonucleotides. 
Subsequently, the beads were incubated with PE-conjugated streptavidin.  The samples 
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were analyzed using a Bioplex 200 instrument with Bio-Plex Manager 4.0 software.  The 
signal of each TF was normalized to TFIID, a ubiquitous TF complex.  
 
7.6.8. Surface marker expression by flow cytometry 
 On Day 5, DCs were treated with pMA coated PP plates or TCPS reference 
control plates with eight wells used for each treatment.  After 24h, the DCs were 
collected in the same manner as for nuclear extraction and resuspend in filter-sterilized 
0.1% BSA and 2mM EDTA in PBS, pH 7.2 (cell-staining buffer).  The cells were stained 
for 30 min with fluorescently-labeled monoclonal antibodies for CD83 (clone HB15a, 
mouse IgG2a,κ; Immunotech, Marseille, France), CD86 (clone BU63, mouse IgG1,κ; 
Ancell corporation, Bayport, MN), DC-SIGN (R&D Systems), CCR7 (clone TG8/CCR7, 
mouse IgG2a,κ; Biolgend).  CD83 is a maturation marker, CD86 is a costimulatory 
molecule, and CCR7 is a chemotatic receptor responsible for homing to the lymph 
organs.  These surface markers are typically up-regulated upon DC maturation.  DC-
SIGN is an endocytic receptor that is down-regulated in response to LPS-stimulated 
maturation [250].  For Annexin V and propidium iodide staining, DCs were stained in 
Annexin V binding buffer following manufacturer’s protocol (all from Biolegend).  The 
samples were analyzed using a BD LSR flow cytometer (Beckton Dickinson, San Jose, 
CA) and FlowJo software (Tree Star, Ashland, OR). 
 
7.6.9. Statistical analysis 
To observe any significant differences between all sample groups in pairs, a pair-
wise one-way ANOVA followed by Tukey post test was performed using the GraphPad 






7.3.1. Contact with different pMAs induced distinct DC morphologies 
 As shown in Figure 2, iDCs cultured on TCPS exhibited a rounded morphology, 
whereas mDCs (TCPS+LPS) possessed extended cellular projections.  When in contact 
with pIBTMA, DCs exhibited some extended processes consistent with a mature 
phenotype, though not to the extent as LPS-induced maturation.  DCs treated with 
pHEMA were even more rounded than those cultured on TCPS.  Interestingly, in the 
presence of pHEMA, the effect of LPS on DC morphology was completely abolished.  
DCs treated with pHEMA with LPS exhibited the same morphology as compared to 
those cultured on pHEMA alone.  These morphologies were observed by 3 h and 
maintained through the time course of the study until 11 h.  
 
7.3.2. pMAs differentially affected surface marker expression on DCs 
CD86 expression on pIBTMA-treated DCs was significantly higher as compared 
to pHEMA-treated DCs (Figure 7-2), which is consistent with the NF-κB activation 
results.  The expression of CD83, CCR7, and DC-SIGN by DCs was not different among 
the iDC reference control and the two pMAs examined for DC treatment.   As expected, 
LPS treatment alone induced significant up-regulation of CD83, CD86, and CCR7 
expression but not DC-SIGN expression.  Interestingly, consistent with the results from 
TF profiling, the presence of pHEMA completely abolished the effect of LPS stimulation 
on DCs, and maintained surface marker expression of these DCs at levels similar to 






Figure 7-2: Surface expression of maturation markers by DCs treated with different pMAs as 
compared to the reference controls. Geometric mean fluorescent intensities (gMFI) are shown for n = 
3 donors (mean ± SEM).  **: p<0.01, ***: p<0.001. 
 
 
7.3.3. pMAs induced different TF activation profiles in DCs 
 Treatment of DCs with pIBTMA induced the activation of NF-κB as compared to 
treatment with pHEMA by 6 h, and the statistical significance of the difference increased 
by 11 h (Figure 7-4A).  Although NF-κB levels induced by pHEMA treatment were not 
statistically different from TCPS-treated iDC by 6 h or 11 h, treatment of DCs with 
pHEMA appeared to suppress NF-κB by 6 h.  As expected, LPS strongly activated NF-
κB in treated DCs by 6 h and the levels of activation increased over time (Figure 7-4A).  
As expected, LPS induced higher levels of AP-1 activation by 6 h as compared to TCPS 
and pHEMA, but the difference became insignificant by 11 h time point (Figure 7-4C).  
pIBTMA did not affect any other TFs examined. 
 pHEMA also induced the activation of a number of other TFs, including TFs that 
have been associated with pro-inflammatory response such as ISRE (Figure 7-4B) and 
HSF (Figure 7-4D), TFs that have been linked to suppression of DC maturation such as 
E2F-1 (Figure 7-4E) and GR/PR (Figure 7-4F), as well as cell-cycle-related TFs such as 
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NFAT (Figure 7-4G).  Treatment of DCs with pHEMA induced higher ISRE (Figure 
7-4B) activity as compared to TCPS or pIBTMA by 6 h, and induced higher HSF (Figure 
7-4D) and E2F-1 (Figure 7-4E) activation as compared to TCPS, LPS, or pIBTMA.  The 
activation of these TFs maintained high levels of activation through to the 11 h time 
endpoint of the experiment.  In addition, pHEMA treatment of DCs induced higher levels 
of GR/PR activation by 6 h time point compared to LPS stimulation, and the activation 
was maintained by 11 h (Figure 7-4F). pHEMA treatment induced a higher levels of 
NFAT compared to TCPS only at 11 h time point (Figure 7-4G).   The activation of 
CREB was not affected by any of the treatments (Figure 7-4H).   
Interestingly, the effect on the TF activation on DCs from the presence of 
pHEMA was dominant over maturation stimulus, LPS.  DCs treated with either pHEMA 
or a combination of pHEMA and LPS exhibited nearly identical TF profiles, which were 
distinct from LPS-induced TF profile in DCs (Figure 7-4).  The effects of the different 





Figure 7-3: DC exhibited distinct morphologies after cultured with different treatments.  TCPS 
treated iDCs exhibited a rounded morphology, while LPS treated mDCs have extended cellular 
processes. Both pHEMA and pHEMA+LPS maintained a rounded DC morphology, while pIBTMA 
promoted a morphology more similar to mDCs.  These morphologies were maintained throughout 






Figure 7-4: Activation of TFs of differentially treated DCs.  A) NF-κB, B) ISRE, C) AP-1, and D) 
HSF, E) E2F-1, F) GR/PR, G) NFAT, and H) CREB.  N = 3 donors (mean ± SEM). *: p<0.5, **: 
p<0.01, ***: p<0.001. 
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Table 7-1: Summary of the effects of different treatments on TF activation of DCs as compared the 
TCPS-treated iDC reference control at different time point.  The three time points (3, 6, or 11 h) are 
each indicated by an arrow sequentially, respectively. 
 




NF-κB ↔↑↑ ↔↓↓* ↔↔↔ ↔↑↑* 
ISRE ↔↔↔ ↔↑↑ ↔↑↑ ↔↔↔ 
AP-1 ↔↑↔ ↔↔↔ ↔↔↔ ↔↔↔ 
HSF ↔↔↔ ↔↑↑ ↔↑↑ ↔↔↔ 
E2F-1 ↔↔↔ ↔↑↑ ↔↑↑ ↔↔↔ 
GR/PR ↔↔↔ ↔↑↑ ↔↑↑ ↔↔↔ 
NFAT ↔↔↔ ↔↑↑ ↔↑↑ ↔↔↔ 
CREB ↔↔↔ ↔↔↔ ↔↔↔ ↔↔↔ 
*: the NF-κB activation was not significant compared to iDC; however, with the decrease of NF-κB 
induced by pHEMA and increase of NF-κB induced by pIBTMA, statistical significance was seen between 
pHEMA and pIBTMA.  
 
 
7.3.4. pHEMA, but not pIBTMA, induced apoptosis of DCs 
 After 24 h of treatment with the biomaterials, pHEMA treatment of DCs resulted 
in more annexin V single positive DCs, which were apoptotic DCs, as compared to iDC, 
mDC, or pIBTMA-treated cells (Figure 7-5A).  Furthermore, the pHEMA-treated cell 
populations also had more annexin V/PI double positive cells, which were late-stage 
apoptotic or necrotic cells, as compared to iDC, mDC, or pIBTMA-treated cell 
populations (Figure 7-5B).  Over 80% of the pHEMA-treated DCs were annexin V/PI 
double positive after 24 h, suggesting this time point was too long to capture early 
apoptotic events.  However, Figure 7-5A suggested DCs treated with pHEMA underwent 







 cells as compared to pHEMA treatment alone.  No 
difference in the levels of apoptosis was observed among iDC, mDC, and pIBTMA-




Figure 7-5:  pMAs induced differential levels of cell death by 24 h.  DCs were treated with the 
indicated treatments for 24 h and were harvested for double-staining of Annexin V-FITC and PI.  A) 
Annexin V single positive early apoptotic DCs and B) Annexin/PI double positive late apoptotic or 
necrotic DCs were quantified with n = 3 different donors (mean ± SEM).  Brackets indicate p < 0.01 




 DC phenotype was previously shown to be differentially modulated by treatment 
with twelve distinct pMAs in a combinatorial library (CHAPTER 6).  Two pMAs, one 
induced a highly mature DC phenotype and the other promoted an immature DC 
phenotype, were selected from the library for this study.  Differentially treated DCs were 
imaged for their morphology, and then the nuclear extracts were prepared from the cells 
at various time points.  As expected, throughout the time course of the study, DCs treated 
with pIBTMA exhibited extended cellular processes similar to the DCs treated with LPS 
(mDCs).  In contrast, DCs treated with pHEMA coatings of a round morphology, and in 
fact, more rounded than TCPS-treated iDC reference control, suggesting their lack of 
maturation.  Surprisingly, DCs treated with pHEMA and LPS exhibited morphology 
similar to the DCs treated with pHEMA alone.  Furthermore, the expression of surface 
maturation markers by DCs was consistent with the differential morphologies induced by 
the different treatments.  Specifically, CD86 expression on pIBTMA-treated DCs was 
significantly higher as compared to pHEMA-treated DCs (Figure 7-2).  Similar to the 
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morphology results, the presence of pHEMA completely abolished the activating effect 
of LPS on DCs and maintained the levels of surface marker expression similar to 
pHEMA treatment alone.  Therefore, consistent with previous results, pIBTMA, but not 
pHEMA, promoted DC maturation, and the presence of pHEMA prevented DC’s 
response to LPS. 
It is interesting to note that the effect of pIBTMA was not as strong on the DCs 
derived from a purified culture (Figure 7-2) as compared to the DCs derived from a 
heterogeneous culture that also contained B cells (Figure 7-1).  This result was as 
expected because B cells have been found to release cytokines and natural antibodies that 
aid in monocyte-derived DC migration, differentiation, and maturation, suggesting that B 
cells can support DC function [174,176,211].  However, a purified cell culture was 
needed in this study for nuclear extraction to obtain DC-specific activation of TFs.  
 To correlate the differential effects of biomaterials to DC phenotype, TF 
activation profiles of DCs treated with these different pMAs were analyzed and compared 
to the TF profiles of the iDC and mDC reference controls (Figure 7-4).  By 6 h of 
biomaterial treatment of DCs, though not statistically significant, pHEMA appeared to 
induce less, while pIBTMA induced more, NF-κB activation compared to the levels for 
iDCs.  However, DC treatment with pIBTMA induced NF-κB activation, which was 
significantly higher than that induced by pHEMA treatment, and this difference became 
more significant by 11 h.  As expected, DC treatment with LPS induced strong NF-κB 
activation, which increased over time during the time course of the study (Figure 7-4A).  
DC maturation was previously shown to be associated with the NF-κB pathway [251] and 
is required for STAT-4 expression, critical in IL-12 mediated Th1 polarization, during DC 
maturation [252].  Furthermore, NF-κB signaling is induced by LPS stimulation and 
supports survival and maturation of monocyte-derived DCs [253-255].  NF-κB also plays 
an important role in the production of CCL19 [256], a chemokine whose production is 
enhanced in mDCs, regulating migration of mDCs, and is involved in naïve T cell 
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recruitment to the vicinity of mDCs in the T cell zones in lymph nodes [257,258].  
Therefore, consistent with phenotypic outcomes, the NF-κB profiles indicated that 
pIBTMA treatment induced DC maturation, at least in part, through the NF-κB pathway.  
In contrast, treatment of DCs with pHEMA resulted in lower NF-κB activation levels, 
which might be partially responsible for maintaining the iDC phenotype of pHEMA-
treated DCs.  The lower activation levels of NF-κB may cause the imbalance of TFs that 
controls DC survival, which resulted in the increased apoptosis of DCs (Figure 7-5A).   
 AP-1 has previously been shown to be involved in the increase in MHC class II 
expression in DCs after LPS stimulation [259] and regulate the expression of IL-23 p19 
promoter activation in MΦs [260].  IL-23 is released by MΦs and DCs upon microbial 
infection and is critical for the generation of Th17 immune response [261-263].  Thus, 
AP-1 is generally associated with DC maturation and is consistent with our experimental 
result that LPS induced higher AP-1 activation by 6 h (Figure 7-4C).  Although not 
significant, pIBTMA-treated DCs appeared to induce increased AP-1 activation by 6 h.  
However, no difference was observed by 11 h among the various treatments (Figure 
7-4C).  
 ISRE is a specific DNA motif that, in response to interferon (IFN) stimulation, 
binds transcription complexes formed by homo- or heterodimerized STATs (signal 
transducers and activators of transcription) and p48, a member of the IRF (IFN regulatory 
factor) family [264].  ISRE has been shown to play a role in up-regulating CCL19 
transcription via IFN signaling in human DCs [256], inducing IL-12p35 gene activation 
through binding of IRF-3 to ISRE in RAW 264.7 cells stimulated by LPS or PolyI:C 
[265], and regulating IL-12 production in bone marrow-derived DCs [266].  Therefore, it 
seems counterintuitive that pHEMA-induced DCs enhanced ISRE activity (Figure 7-4B) 
because pHEMA treatment resulted in low CD86/DC-SIGN ratio (Figure 7-1) as well as 
rounded morphology (Figure 7-3).  However, ISRE also plays a key role in mediating 
apoptosis [267].  ISRE is responsible for IFN-α-induced up-regulation of programmed 
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death-1 (PD-1) expression in MΦs [268], which leads to apoptosis.  As a result, pHEMA-
treated DCs possibly enhanced the activation of ISRE-binding transcription factors to 
induce an apoptotic response, which is consistent with the decrease in NF-κB activity.  
 The expression heat shock proteins (HSPs) is increased when cells are exposed to 
elevated temperatures or other stress (chemical or physiological) and is primarily 
regulated by a family of TFs, HSFs [269].  HSPs and HSFs have been mostly studied in 
DCs in the context of thermoregulation.  Heat shock induces DC maturation by 
enhancing transient phagocytosis, expression of CD86 and MHC II molecules, pro-
inflammatory cytokine release, localization to draining lymph nodes, and T cell 
stimulation [270].  However, heat shock-induced DC maturation appears to be 
independent of HSF-1 or extracellular HSPs [271,272].  Recently, endogenous HSP90 
was shown to have a pivotal role in cross presentation at normal conditions [273].  Heat 
shock associated with increase in temperature during inflammation or fever has been 
associated with enhanced survival from infection and immunological functions [270].  
HSPs are molecular chaperones that protect proteins from denaturation and misfolding, 
rendering them resistant to stress-induced cell damage.  In addition, HSPs and their 
cofactors are responsible for inhibiting the apoptotic and necrotic pathways [274].  
Interestingly, biomaterials have been reported to differentially influence HSP mRNA 
expression in HeLa S3 cells [275].   The authors found that hydrophilic surfaces (contact 
angles   20°C – 65°C) induced higher expression of HSP70A, HSP70B, HSP90, and 
HSP70 in HeLa S3 cells as compared to hydrophobic surfaces (contact angles   70°C – 
120°C) [275].  In the current study, pHEMA and pIBTMA were measured to have 
contact angle of 69.5°C and 28.7°C – both are in the hydrophilic category but induced 
significant variation in HSF activation.  It is unclear why pHEMA but not pIBTMA 
induced higher HSF activation (Figure 7-4D).  Potentially, due to the apoptotic response 
the DCs experienced via the other signaling pathways, DCs produced HSF as a natural 
defense against cell death.  
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 The E2F family consists of a number of activators and repressors, including E2F-
1, E2F-2, E2F-3, E2F-4, and E2F-5.  E2Fs play critical roles in the regulation of cell 
cycle progression, differentiation, development, tumor formation, and apoptosis [276].  
Combined loss of E2F-1, E2F-2, and E2F-3 completely abrogates the cell cycle 
progression and proliferation of mouse embryonic fibroblasts [269], and E2F-3b is 
sufficient to support mouse embryonic and postnatal development [277].  E2Fs are also 
pivotal in the induction of apoptotic pathways in cells [278].  For example, mice deficient 
in E2F-1 have a defect in thymocyte apoptosis resulting in an excess of mature T cells 
[279].  E2Fs also sensitizes cells to pro-apoptotic stimuli by the disruption of NF-κB 
signaling via E2F-1’s competition with p50 for RelA/p65 binding, thus inhibiting NF-κB 
DNA binding activity [280].  Recently, the role of E2F-1 in DCs was studied and was 
found to suppress DC maturation [281].  The expression of E2F-1 is transiently down-
regulated during LPS-induced maturation of both human monocyte-derived DCs and a 
mouse DC cell line, DC2.4.  Down-regulation of mRNA occurs between 3 – 18 h, while 
down-regulation of protein level occurs roughly between 9 – 18 h.  Phenotypic and 
functional maturation was observed in DC2.4 cells with the knockdown of E2F-1 by 
siRNA in the absence of LPS stimulation [281].  Therefore, this finding is consistent with 
our results that treatment of DCs with LPS or pIBTMA did not affect E2F-1 activation 
and that pHEMA treatment enhanced E2F-1 binding by 6 h as compared to the level 
observed for iDCs  (Figure 7-4E).  Down-regulation of E2F-1 activation in DCs treated 
by LPS was not observed in our study, potentially due to the short time course of the 
study.  pHEMA treatment significantly enhanced E2F-1 binding likely to suppress DC 
maturation.  The increase in E2F activity may also partially explain the decrease in NF-
κB (Figure 7-4A) and the induction of apoptosis of pHEMA-treated DCs (Figure 7-5A). 
 GR/PR binding element is designed to monitor the induction of glucocorticoid 
response element (GRE) through the signaling transduction pathway mediated by GR or 
PR.  Glucocorticoid effects are mediated through GR, a TF, and result in reduction of IL-
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12p70 and TNF production and impairment of T cell stimulatory function in DCs [87] via 
the inhibition of NF-κB and AP-1 [282].  Progesterone has been shown to have immune 
suppressive properties in human and rodents and inhibits mature rat DCs through PR 
[283].  Furthermore, progesterone hinders murine DC activation through the inhibition of 
STAT1 pathway [284].  Interestingly, progesterone modulates TLR-3- and TLR-4-
mediated murine DC maturation differentially [285].  Specifically, progesterone reduced 
DC production of IL-6 entirely via GR, while IL-12p40 production via either GR or PR.  
Furthermore, progesterone inhibited TLR-3- but not TLR-4-induced CD40 expression 
[285].  Glucocorticoid also induces apoptosis of plasmacytoid DCs (pDCs) in patients 
and healthy donors, which decreases the levels of circulating pDCs [286]. Therefore, 
coherent evidence has confirmed the important role of GR/PR in mediating immune 
suppression.  In the current study, treatment with pHEMA induced higher GR/PR 
activation in DCs by 6 h until 11 h (end of experimental time course) as compared to 
iDCs (Figure 7-4F), which is consistent with the lack of maturation of the DCs treated 
with pHEMA and suggests that pHEMA has immuno-suppressive property that 
modulates DC functions.  In contrast, treatment of DCs with LPS or pIBTMA did not 
induce significant increase in GR/PR activation.  
 NFATs can be induced by several signaling pathways, including calcineurin and 
protein kinase C [287].  NFAT has been shown to play different roles in DC biology.  For 
example, NFAT is activated in murine DCs and MΦs in response to yeast and zymosan 
stimulation via ligation of Dectin-1, which results in the up-regulation of pro-
inflammatory mediators such as cyclooxygenase-2 (COX-2), IL-2, IL-10, and IL-12p70 
[288].  Recently, spontaneous Ca
2+
 oscillations were found to occur in human monocyte-
derived iDCs resulting in calcineurin-dependent NFAT translocation into the nucleus.  
Such high frequency oscillations are lost during DC maturation and therefore NFAT 
activation may be an endogenous characteristic to maintain DCs in the immature state 
[289].  Interestingly, another study shows that LPS stimulation induces the Src-family 
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kinase and phospholipase Cγ2 activation, influx of extracellular Ca
2+
 and calcineurin-
dependent nuclear NFAT translocation exclusively via CD14 in murine DCs.  NFAT 
activation in mDCs results in apoptosis of terminally differentiated DCs, which is critical 
in maintaining self-tolerance and preventing autoimmunity [290].  Our study showed that 
DCs treated with pHEMA had higher NFAT activation as compared to iDCs by 11 h of 
culture (Figure 7-4G).  pHEMA treatment may trigger NFAT to maintain iDC phenotype 
or induce DCs to undergo apoptotic death, both of which are consistent with the 
phenotypic data.  However, treatment of DCs with LPS, as well as with pIBTMA, did not 
induce NFAT activation in human monocyte-derived DCs over the time course of the 
study.  
 Several pathways are associated with CREB binding, including Jun N-terminal 
kinase (JNK), p38, and protein kinase A (PKA) [291].  CREB activity is associated with 
calcium/calmodulin kinases and CRE coactivators, the activity of which depends on Ca
2+
 
and cyclic AMP levels [292]. Calcium-calmodulin-dependent kinase IV (CaMKIV) is 
expressed in DCs and links TLR signaling with the control of human and murine DC 
survival by regulating the temporal expression of Bcl-2.  This CaMKIV signaling cascade 
controls the activation of CREB and accumulation of Bcl-2 necessary to support DCs 
from apoptosis.  CaMKIV null mice have a decreased number of DCs in lymphoid tissues 
and are short-lived in response to LPS [293].  Furthermore, CREB has been shown to be 
involved in the up-regulation of IL-10 in human DCs in response to zymosan, even 
though zymosan also strongly activates NF-κB, which is a negative regulator of IL-10 
[294].  Hence, CREB activity is important in modulating immune response.  In the 
current study, the treatments on DCs did not induce significant difference in the context 
of CREB activation (Figure 7-4H).  Our results suggest that the pMAs in question do not 
actively support apoptosis or modulate immune response through the activation of CREB 
during the time course of the study.  
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The roles and functions of the TFs analyzed in this study are summarized in Table 
7-2.  Overall, DC treatment with pIBTMA induced maturation, at least through the NF-
κB pathway.  Treatment of DCs with pHEMA induced the activation of TFs that have 
been found to possess immunosuppressive properties such as E2F-1 and GR/PR, 
consistent with the rounded morphology of these DCs (Figure 7-3) and immature 
phenotype (Figure 7-1 and Figure 7-2).  Treatment of DCs with pHEMA also induced the 
activation of an array of TFs that have been linked to apoptosis, including ISRE, E2F-1, 
GR/PR, and NFAT, suggesting that pHEMA triggered strong apoptotic signals.  
Interestingly, HSF, which is induced as a stress response to protect cells from death, was 
also induced in DCs by pHEMA treatment.  DCs treated with pHEMA potentially 
activated HSF as a natural defense against the other apoptotic signals; the balance of 
these signals may be critical in determining the fate of the DCs.  Presumably, the 
apoptotic signals overrode the survival signals, rendering DCs to undergo apoptosis in 
response to pHEMA, but not pIBTMA, treatment (Figure 7-5).  DC apoptosis is pivotal 
in the maintenance of immune tolerance [295].  Defective DC apoptosis leads to the 
accumulation of DCs, chronic lymphocyte activation, and systemic autoimmunity [296].   
In addition, the uptake of apoptotic DCs induces iDCs to secret TGF-β1 and promotes the 
differentiation of naïve T cells into Foxp
3+
 regulatory T cells [297].  However, the 
evidence of apoptosis from annexin V/PI staining alone in Figure 7-5 is not sufficient to 
definitively prove the hypothesis that pHEMA-treated DCs are apoptotic.  Therefore, 
additional experiments are underway to probe for the caspase 3/7 activity, which is a 
prominent apoptotic pathway, and DNA fragmentation by TUNEL, which is an end-stage 
apoptotic event [115].  
Surprisingly, for DCs in the presence of pHEMA, the effects of LPS on TF 
activation profiles were completely abolished.  Instead, DCs treated with LPS in the 
presence of pHEMA exhibited very similar TF profiles compared to DCs treated with 
pHEMA alone.   
127 
 
 In summary, two polymers from the same class of material can exert very 
different effects on DC phenotype, which are mediated through distinct TF activation 
profiles, and very likely through distinct receptors and signaling pathways.  In fact, recent 
research using MyD88 and TLR knock-out mice showed that DCs use TLR-2, TLR-4, 
and TLR-6 for the responses to a group of chemically and physically diverse biomaterials 
[247].  Potentially, pHEMA and pIBTMA presented differential profiles of proteins to 
DCs and triggered different receptors for distinct responses.  For instance, DCs triggered 
through TLRs 7, 8, and 9 produced both IL-12 and IFN-α; DCs triggered through TLR-3 
produce mostly IFN-α; DCs triggered through TLR-5 produce mostly IL12p70; DCs 
triggered through TLR-4 produce mostly IL-12p70 and a little IFN-α.  All of these TLRs 
induce Th1 immunity and CTL responses.  Although TLR ligands are widely considered 
to promote protective immunity against pathogens, the ligation of certain ligand, such as 
zymosan, with TLR-2 on DCs supports the induction of Tregs rather than Th1 or Th17 
cells via TLR-2 but induces Th1 and Th17 autoimmune responses when signaled via 
dectin-1 [243].   
In order to effectively elucidate the molecular mechanism of DC response to 
biomaterials, additional experiments should be carried out to confirm the effects of the 
TFs.  For example, blocking or siRNA knock-down experiments should be performed to 
decifer the effect, contribution, or time course of each TF in the DC response process.  
Furthermore, tracking experiments (e.g. with fluorescent marker) should be performed to 
validate that activated TFs indeed translocate into the nucleus to exert the observed 
effects.  
To our knowledge, this is the first study that demonstrated that biomaterials can 
modulate DC response through activation of distinct TFs.  In addition, biomaterials such 
as pHEMA were shown to be strong immunomodulators capable of overriding the effects 
of soluble factors and may represent a non-pharmacological strategy for inducing DC 
tolerance for applications in regenerative medicine and organ transplantation.     
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Table 7-2: Summary of specific functions of TFs in the context of DC biology based on the literature 
cited in the discussion section 
TFs General roles Specific functions 
NF-κB DC maturation 
Cell survival 
- LPS-induced maturation of monocyte-derived DCs [254] 
- Required for STAT-4 expression during DC maturation [252] 
- Supports cell survival and rescues cells from apoptosis [253-255] 
- Induces production of CCL19 [256] 
AP-1 DC maturation 
Apoptosis 
- Enhances MHC class II expression after LPS stimulation in DCs 
[259] 
- Regulates the expression of IL-23 p19 promoter activation in 
MΦs [260] 
ISRE DC maturation 
Apoptosis 
- Up-regulates CCL19 transcription [256] 
- Up-regulates IL-12p35 gene activation and IL-12 production 
[265,266] 
- Mediates apoptosis [267,268] 




- Regulates production of HSPs [269] 
- HSPs induce DC maturation [270] 
- Heat shock-induced DC maturation is independent of HSF-1 or 
extracellular HSPs [271,272].   
- Endogenous HSP90 plays a pivotal role in cross presentation at 
normal conditions [273].   
- HSPs inhibit apoptotic and necrotic pathways [274] 
E2F-1 Suppression of 
DC maturation 
Apoptosis 
- Regulates cell cycle progression, differentiation, development, 
tumor formation, and apoptosis [276].   
- Controls the progression and proliferation of mouse embryonic 
fibroblasts [269] and mouse embryonic development [277].   
- Induces apoptotic pathways in cells [278-280].   
- Suppresses DC maturation in both human monocyte-derived DCs 
and a mouse DC cell line, DC2.4 [281].   





- Glucocorticoids reduce IL-12p70 and TNF production and impair 
T-cell stimulatory function in DCs [87] via the inhibition of NF-
κB and AP-1 [282].   
- Progesterone hinders murine DC activation through the inhibition 
of STAT1 pathway [284].   
- Progesterone modulates TLR-3- and TLR-4-mediated murine DC 
maturation differentially [285].     
- Induces pDC apoptosis [286]. 
NFAT DC maturation 
Apoptosis 
- Activated in murine DCs and MΦs in response to yeast and 
zymosan stimulation via ligation of dectin-1, resulting in the up-
regulation of pro-inflammatory mediators [288].   
- Activated in human iDCs as a result of spontaneous Ca2+ 
oscillations and may be linked to the maintenance of DCs in the 
immature state [289].   
- Induces apoptosis of terminally differentiated DCs, which is 
critical in maintaining self-tolerance and preventing 
autoimmunity [290].   




- Support human and murine DC survival by regulating Bcl-2 
expression downstream of TLR signaling [293].   
- Up-regulates IL-10 in human DCs in response to zymosan [294].   
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CHAPTER 8: CONCLUSION AND FUTURE WORK 
 
Understanding how biomaterials affect DC phenotype is crucial to the design and 
selection of biomaterials for tissue engineering or vaccine delivery applications, where 
appropriate and effective host immune response is necessary.  In particular, elucidating 
the material properties that are critical in determining DC phenotype as well as the 
molecular mechanisms directing the distinct DC responses to biomaterials are of 
significant importance to material selection for tissue-engineered constructs or vaccine 
delivery vehicles. Therefore, the material property-DC phenotype relationships and 
mechanistic basis for DC response to biomaterials were investigated.  
Although flow cytometry is a powerful analytical tool for assessing DC 
phenotype, both sample preparation and data analysis are time-consuming, especially 
when a large number of samples are analyzed.  Due to DC’s non- and loosely-adherent 
nature, traditional cell-based ELISA approaches were not appropriate because of the 
expected cell loss during washing steps.  To enhance the efficiency in sample processing 
and subsequent measurement, a HTP 96-well filer plate-based methodology was 
developed to allow for the screening of DC phenotype induced by a large number of 
biomaterials, particularly from combinatorial libraries (Figure 4-1). In this methodology, 
after treatment with biomaterials, DCs were transferred to a black 96-well filter plate, 
where supernatants were collected conveniently and the cells remained in the wells were 
analyzed for the levels of DC number-independent “maturation factor” (MF), defined as 
CD86/DC-SIGN, using immunostaining and fluorescent microplate reading.  The 
supernatants could be used immediately for the analysis of cytotoxicity via the release of 
a cytosolic enzyme, G6PD, and stored for multiplex cytokine profiling experiments.  
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Therefore, this methodology allowed for the measurements of three cellular outcomes 
from a single cell culture.  
Using proof-of-concept validation experiments, DC responses to biomaterials, 
PLGA or agarose films, were reproducibly found to be consistent using this filter plate-
based methodology as compared to the conventional flow cytometry analysis (Figure 
4-6).  This HTP method was also successfully down-scaled to a 384-well filter plate 
platform with consistent results by Nathan Hotaling in the Babensee laboratory.  Besides 
biomaterials, this method is expected to expedite screening of DC response to various 
other stimuli, including soluble factors, and facilitate the discovery of treatments that 
promote or suppress DC maturation.  Furthermore, the analysis of other loosely- and non-
adherent cell populations will also find this method beneficial since no cells would be lost 
during the assessment of phenotype.  This methodology is also amenable to 
quantification of other endpoints such as intracellular signaling molecules in prepared 
cell lysates.  
Very well-defined and controlled surfaces were needed to derive the correlations 
between material properties and DC phenotype.  Hence, a set of clinical Ti substrates, 
including PT, SLA, and modSLA, were one system initially chosen to study DC response 
as shown in CHAPTER 4.  A major finding of this study was that treatment with PT or 
SLA promoted a more mature DC phenotype, while DC treatment with modSLA 
possessed an immature DC phenotype, as determined by the expression of surface 
maturation marker CD86 (Figure 5-1) and the production of maturation-associated 
cytokines and chemokines (Figure 5-5 and Figure 5-6).  These results also indicated 
another benefit of modSLA surfaces for promoting bone formation and integration by 
providing a local non-inflammatory environment.  Furthermore, PCA was used to reduce 
the multi-dimensional data space to facilitate the analysis of co-variations between 
material properties and DC phenotype (Figure 5-8).  The primary conclusion from this 
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study was that surface chemistry was the most critical material property in determining 
DC phenotype induced by the Ti substrates.  In particular, the increase in surface %C and 
%N were associated with enhanced DC maturation, while the increase in %O and %Ti 
contributed to an iDC phenotype.  Furthermore, this particular material system suggested 
that the increase in surface hydrophilicity was also co-varied with less DC maturation.  
However, line roughness (Ra) was not important in determining DC response (Figure 
5-8B).  This finding not only offered guidelines for Ti implant design, but it also 
suggested that DC response could be correlated to material properties using multivariate 
analytical methods.  Such methods are necessary because it is near impossible to vary 
only one material property at a time for any biomaterial systems.  Whenever one property 
(e.g. roughness) is changed, other material properties (e.g. surface energy) also change 
inevitably.  This challenge causes many traditional ways that attempt to isolate a single 
biomaterial property that dictates cell response futile as the relationships generated are 
typically not specific to a particular material property.  Therefore, in order to confirm the 
relationships generated with this set of Ti substrates using PCA, separate sets of well-
defined biomaterials should be used for the analysis of DC phenotype.  The material 
property-DC response relationships generated by multivariate analysis can then be 
compared to those derived from the Ti substrates.  
To generate polymeric material property-DC phenotype relationships, a more 
broad-based biomaterial system was used.  This biomaterial system included twelve 
different pMAs, selected from a combinatorial pMA library.  The material properties for 
these polymers were extensively characterized for surface chemical composition, air-
water contact angle, Tg, surface roughness (Ra and Sa), and surface area (Table 6-3).  
These pMAs were shown to induce differential DC response upon treatment based on the 
expression of MF derived using the HTP methodology (Figure 6-3A).  In addition, when 
the ordering of these pMAs was kept the same in the x-axis for comparison, the 
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production of pro-inflammatory cytokine, TNF-α (Figure 6-3B), and chemokine, IL-8 
(Figure 6-3D), appeared to roughly follow the same trend, while pHEMA induced higher 
anti-inflammatory cytokine, IL-16, production compared to any other treatments (Figure 
6-3C).  This major result indicates that materials can be used to fine tune DC response, 
and carefully selected biomaterials can potentially direct desired immune responses by 
modulating DC phenotype.   
Another major outcome from this study was that DC response could be correlated 
to material properties by PCA (Figure 6-6).  More importantly, consistent with the results 
from the Ti substrate study, surface chemical composition was most useful in 
determining DC response.  Specifically, surface oxygen and oxygen-containing bonds 
such as -C-O- and -O-C=O are strongly associated with an iDC phenotype, while surface 
carbon and carbon only -C-C- bonds are strongly associated with a mDC phenotype.  In 
contrast, Tg, Ra, and surface area had little influence on DC phenotype (Figure 6-6B).   
The most significant contribution of this study was that DC phenotype could be 
predicted based on the properties of the materials used to treat the DCs using PLSR, a 
multivariate analysis method.  PLSR performs projection of the data from the original 
multi-dimensional data space onto a reduced principal component space in a similar way 
compared to PCA.  In addition, it contains an added algorithm that also optimizes the 
correlations between the X matrix (containing predictor variables) and the Y matrix 
(containing outcome variables).  A model was constructed based on the pMA library (as 
the “training set”) and could predict DC response to a new set of methacrylate- and 
acrylate-based terpolymers (called the prediction set) in terms of the expression of MF 
with R
2
prediction of 0.76 and  ̅ prediction = 0.75 (Figure 6-8E).  Furthermore, theoretical 
values of the chemical composition of the bulk materials were sufficient in the prediction 
with even a higher R
2
prediction of 0.80 and  ̅ prediction = 0.79 (Figure 6-9E).  However, when 
using experimental XPS values alone, the model performance was very poor.  It was 
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important to note that the models did not predict the exact level of DC maturation, but the 
relative levels of DC maturation induced by a set of polymers.  However, this is a 
significant result because DC maturation is a relative term, and it is a continuum of, but 
not discrete, phenotype.  The fact that DC response can be predicted from theoretical 
chemical composition will have unprecedented impact on biomaterial design because 
rational design and selection of immune-modulatory biomaterials can be performed prior 
to lengthy polymer synthesis and material characterization procedures.  However, 
cytokine and chemokine levels were not predictable variables, presumably due to the 
large donor-to-donor variation in their production by DCs as well as their degradation in 
the cell culture medium.   
From the two studies with Ti substrates and pMA library, it was consistent that 
biomaterial surface chemistry is the most important property that determines DC 
response.  It is hypothesized that chemistry is the underlying property that dictates the 
other properties of the biomaterials, including hydrophilicity, Tg, etc., and more complex 
chemical information about the material surface may offer better prediction for DC 
response.   
Although biomaterial chemistry is the most critical material property for 
predicting DC response in vitro, many previous studies have also shown that despite the 
differential levels of protein adsorption and short-term leukocyte infiltration induced by 
varied surface chemistries, similar long term inflammatory outcome of fibrous capsule 
formation was achieved in vivo.  For example, polyethylene terephthalate (PET) surfaces 
functionalized with -OH, -NH2, or -CF3 induced different extents of adsorption and 
denaturation of fibrinogen.  Although these materials also induced different numbers of 
total adherent phagocytes depending on the functionality (-NH2> -CF3> -OH) after short 
term implantation, the chronic fibrotic outcome was similar among these different 
chemistries [298].  In another study, tetrafluoroethylene-hexafluoropropylene-copolymer 
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(FEP) films were plasma polymerized with tetraglyme to minimize fibrinogen adsorption 
on the surfaces.  However, in vivo studies showed that FEP films with or without 
polymerized tetraglyme provoked similar levels of fibrous encapsulation [299].  
However, Thevenot et al. hypothesized that the ineffectiveness of surface chemistry on in 
vivo long-term fibrotic reactions might be due to inefficient interactions between the cells 
and surface functional groups [300].  By enhancing the cell-surface interaction using 
microspheres with different functionalities, Kamath et al. showed surfaces with -OH and 
-NH2 groups induced stronger fibrotic reaction in comparison to -CFx and -COOH 
surfaces [301]. Therefore, in order to translate the in silico predictions into in vivo host 
response, biomaterials that cause extremes of DC phenotype should be selected based on 
the predictions generated by the computational model.  Then, these biomaterials would 
first be used to validate the induced DC phenotype upon treatment in vitro.  
Subsequently, scaffolds or microspheres of these biomaterials would be created to 
maximize the interactions between the host and the material for optimal biomaterial 
effects in vivo.  These biomaterial scaffolds or microspheres with optimal architecture for 
host interaction are expected to differentially modulate host response against the 
implanted devices according the biomaterial chemistry.  
Although CHAPTER 6 demonstrated that a generalized DC phenotype 
represented by the expression of CD86 and DC-SIGN can be readily predicted from 
biomaterial properties, several major limitations exist in this model: a) only relative 
levels of DC maturation can be predicted, b) not containing additional important material 
properties such as polymer swelling, c) only as good as what material set the model is 
trained on for making future predictions, and d) prediction of a generalized response 
based on surface marker expression without consideration of immune response 
polarization.   However, this model represents the first step into predicting immune cell 
response.  Because a model can only predict what it is trained on, the models in 
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CHAPTER 6 based on pMAs with the same chemical backbones and simple elemental 
composition (only C and O), are not sufficient in predicting DC response induced by a 
different class of materials (e.g. pMAs containing nitrogen or polypropylene).  Future 
work should aim to develop a more comprehensive model encompassing several classes 
of materials with more diverse chemical composition, including elements and functional 
groups.  These polymers will be used to determine DC response in terms of the 
expression of MF and will be the Y matrix (outcome) in the PLSR model.  More detailed 
theoretical chemical compositions, including aromatic rings and double bonds, should be 
calculated and used as the X matrix (predictors) in the model.  The multivariate model 
with added chemical information is expected to have stronger predictive power for more 
diverse polymers.   It is expected that in order for such models to perform satisfactorily, 
many members of each class of materials need to be included to account for the 
covariances.  This kind of model would be ideal because it can offer universal guidelines 
for future biomaterial development.  Alternatively, it is also possible that separate models 
need to be developed for the DC response prediction induced by different classes of 
materials.  In this case, one may need to select a particular computational model suitable 
for the biomaterials of interest.  Currently, these computational models can only predict 
induced DC response in vitro.  Ideally, the in vitro responses should be translated into in 
vivo responses, and the in vivo health outcomes can in turn be predicted.  Therefore, 
additional work needs to be carried out to address the potentials of computational 
modeling for immune response prediction.  
Furthermore, although the HTP method is useful for screening a large number of 
treatments to identify “hit” biomaterials that promote or suppress DC maturation, it may 
not be as appropriate for modeling purposes.  For modeling, more variables are desired to 
build the data matrix as a basis in order to identify the variables that can be predicted.  
Therefore, though slower, conventional flow cytometry is preferred over the HTP method 
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because it can generate additional information such as cell size (from forward scatter) and 
the distribution of cells being investigated for a specific marker.  For example, the 
expression level as well as the distribution of cells (e.g. percentage of positive cells) for 
several surface markers that are associated with DC maturation should be measured, 
including CD86, DC-SIGN, and CCR7 (chemokine receptor).  Simultaneously, DCs 
treated with different biomaterials can be analyzed for cell size distribution using the 
forward scatter generated by flow cytometry.  Since cell shrinkage can be an indicator for 
apoptosis [302], material properties that potentially induce apoptosis may be identified 
and used to predict biomaterial formulation that can cause apoptosis.   
Another major finding from this thesis research was that biomaterials induced 
differential DC responses via the activation of distinct TFs as described in CHAPTER 7.  
From the study using the pMA library, two pMAs were selected for DC treatment 
because they induced the two extremes of DC maturation (CHAPTER 6).  These pMAs 
were pHEMA and pIBTMA, which caused the least and most mature DC phenotype, 
respectively (Figure 7-1 and CHAPTER 6).  The different DC phenotype induced by the 
two pMAs was consistent with the surface expression CD86 (Figure 7-2) and with the 
morphology (Figure 7-3) of DCs treated with these pMAs.  Treatment of DCs with 
pHEMA and pIBTMA were shown to induce activation of distinct TFs.  Specifically, 
pIBTMA induced higher activation levels of NF-κB compared to pHEMA (Figure 7-4A).  
In contrast, pHEMA induced the activation of immuno-suppressive TFs such as E2F-1 
(Figure 7-4E) and GR/PR (Figure 7-4F).  Furthermore, pHEMA-treated DCs activated 
the multiple TFs of the apoptotic pathways, including ISRE (Figure 7-4B), NFAT (Figure 
7-4G), and E2F-1 (Figure 7-4E), suggesting that pHEMA maintained iDC phenotype by 
promoting DC apoptosis, which is known to induce DC tolerance [295].  To verify this, 
DCs were stained for apoptotic marker, annexin V, after treatment with pHEMA or 
pIBTMA for 24 hrs.  The number of early apoptotic cells (shown by annexin V-FITC 
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single positive population) induced by pIBTMA was similar to the iDC and mDC 
reference controls.  However, DC treatment with pHEMA induced higher number of 
apoptotic cells (Figure 7-5).  Interestingly, in the presence of pHEMA, the effects of LPS 
on DC morphology (Figure 7-3), surface expression of maturation markers (Figure 7-2), 
and the activation of certain TFs (Figure 7-4) were eliminated.  This result indicates that 
biomaterials can override the effects of soluble factors and can be powerful tools for 
modulating DC response.  The results shown in CHAPTER 7 demonstrated that two 
polymers from the same class of materials can exert very different effects on DC 
phenotype via the activation of distinct TF profiles, and very likely through distinct 
receptors and signaling pathways.  This study shed light on the understanding of the 
molecular mechanisms that underlie DC response to biomaterials.   However, additional 
evidence is needed to show that pHEMA-treated DCs are apoptotic; therefore, 
experiments to measure caspase activity and DNA fragmentation, both hallmarks of 
apoptosis, will be carried out. 
The TF activation profile of DCs induced by the pHEMA also appeared to be 
consistent with the cytokine profile of pHEMA-treated DCs.  pHEMA induced low 
production levels of all the maturation-associated cytokines and chemokines but high 
level of pleiotropic cytokine, IL-16 (CHAPTER 6).  Consistently, pHEMA induced the 
activation of two potent immuno-suppressive TFs, namely E2F-1 [281] and GR/PR [282], 
both of which have been shown to reduce the expression of TNF-α and IL-12 as well as 
IL-6.  Furthermore, GR could decrease MCP-1 production by altering MCP-1 mRNA 
stability [311].  Contradictorily, ISRE [265,266] and NFAT [288] have also been 
demonstrated to support the production of IL-12.  Therefore, the production levels of 
cytokines most likely resulted from the balance of the effects of all these TFs.  NF-κB is a 
strong activator of a number of pro-inflammatory cytokines, including TNF-α, IL-1, IL-
12 [254].  Altogether, the cytokine profiles induced by pIBTMA and pHEMA (CHAPTER 6) are 
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consistent with the TF activation profiles induced by the respective pMAs (CHAPTER 7).  
Potentially, pHEMA might present ligands that trigger the destabilization of the mRNAs of TNF-
α, MCP-1, and IL-1ra, leading to the even lower production of these cytokines as 
compared to the iDC reference control [239].  Future work should explore the ligand 
presentation by pHEMA and its link to mRNA destabilization, possibly through 
interference of HuR binding to the cytokine mRNAs [239]. 
Additionally, several TFs appeared to have conflicting effects on DC response 
(CHAPTER 7).  For example, NFAT has been shown to induce DC maturation, maintain 
immature DC phenotype, as well as induce apoptosis; ISRE can induce apoptosis as well 
as DC maturation.  Future work should aim to elucidate the effects of the activation of 
each TF on DC phenotype.  In particular, blocking or siRNA known-down experiments 
should be performed to examine the effects of each of the TFs and verify their 
contribution and effects, further elucidating the mechanistic basis of DC response to 
biomaterials. Furthermore, tracking experiments such as with fluorescent markers are 
required to validate that TFs indeed are activated and translocate from the cytosolic 
environment into the nucleus to exert the observed effects. 
Given the wide range of applications of pHEMA in clinical settings as a 
biocompatible biomaterial, it is of great interest to understand why and how pHEMA 
would induce such drastically different DC response from any other pMAs tested.  
Furthermore, DCs treated by pHEMA or TCPS possessed an iDC phenotype, but these 
two materials are very different. Understanding the similarities and differences in 
pHEMA and TCPS induced DC phenotype may allow for the identification of important 
properties that are important for biocompatibility.  The Babensee lab has previously 
shown that DC adhesion to biomaterial is required for maturation, partially through the 
interaction via integrins [121].  However, adhesion is not sufficient to cause maturation 
as shown in CHAPTER 5, where modSLA adhered similar numbers of DCs as compared 
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to PT and SLA but did not affect DC phenotype.  Therefore, further work should be 
carried out to elucidate pHEMA’s ability to maintain an iDC phenotype.  Potentially, 
such immuno-suppressive ability of pHEMA is caused by very low level of DC adhesion.  
Alternatively, pHEMA may present proteins in certain conformations that mimic 
immuno-suppressive ligands such as zymosan, whose interaction with TLR-2 has been 
shown to induce Treg formation [243].  Furthermore, additional apoptosis assays may 
shed light on whether pHEMA suppressed DC maturation through induction of apoptosis 
of DCs, which is a strong activator of immune tolerance.  Understanding how pHEMA 
induced suppressed DC response could guide future design of biocompatible materials 
for clinical applications.  Specifically, one may design a biomaterial that adheres certain 
profiles or numbers of immune cells, directs certain presentation or conformation of 
serum proteins, and/or triggers apoptosis of DCs surrounding the implant material.  
Insights from these studies will facilitate the synthesis, discovery, or manipulation of new 
class of clinically-relevant biocompatible materials. Further studies are also needed to 
translate the in vitro effects induced by pHEMA into in vivo host responses as described 
next.     
In addition to the in vitro elucidation of how DCs respond to biomaterials, 
understanding how pHEMA and pIBTMA, which induced extremes of DC phenotype in 
vitro, differ in modulating adaptive immune response in vivo would be of significant 
interest.  These pMAs would be fabricated into scaffolds loaded with a model antigen 
(e.g. OVA) or allogeneic cells for implantation in wild type mice or CD11c.DTR 
transgenic mice.  CD11c.DTR transgenic mice contain diphtheria toxin receptor (DTR) 
expressed under the CD11c promoter.  In these mice, efficient DC depletion can be 
achieved over prolonged periods of time by multiple injections of diphtheria toxin (DT) 
[309].  The adjuvant effect of these pMAs would be assessed by quantifying the amount 
of antibodies in the serum.  In addition, Foxp3
+
 Tregs would be quantified in the mice to 
140 
 
determine whether pHEMA could exert a tolerogenic effect in vivo against allogeneic 
cells or OVA.  This study would not only translate the in vitro findings of these pMAs 
into in vivo outcomes, but it would also uncover the potential of pHEMA as an 
immunosuppressive treatment, potentially for allografts, xenografts, or tissue-engineered 
constructs that contain immunogenic biologics.  In addition, these experiments would be 
performed in CD11c.DTR transgenic mice as compared to wild type mice to assess if 
DCs are central in the biomaterial-induced adjuvant effect or tolerance in vivo.  
This thesis research can lead to multiple future directions, including elucidating 1) 
the adsorbed protein profile on the pMAs, 2) receptor/ligand pairs, and 3) signaling 
pathways that are central in mediating the biomaterial effects on DCs.  An activating 
material such as PLGA was shown previously in the Babensee laboratory to induce 
increased DC adhesion, while a non-activating material such as agarose did not promote 
DC adhesion.  The activating nature of PLGA was linked to its high contact angle, 
whereas agarose is extremely hydrophilic.  It was anticipated that PLGA would induce 
more adsorption of serum proteins in comparison to agarose [121].  In this research, 
pIBTMA coating had very low contact angle (28.7º) in comparison to pHEMA coating 
(69.5º).  However, pIBTMA was clearly an activating material, but pHEMA appeared to 
be a passivating material by the induction of DC apoptosis.  Therefore, the effect of 
biomaterials on DCs is not directly linked to the hydrophobicity of the materials.  The 
differential effects of these pMAs on DC phenotype were most likely mediated through 
different presentation or conformation profiles of the adsorbed protein layer.  Elucidating 
the protein presentation is not an easy task; one of the most popular approaches is to 
spike 10% serum with single radiolabeled serum proteins such as fibronectin and 
vitronectin.  After incubation of the spiked serum with the biomaterials, the surfaces 
would then be rinsed vigorously with PBS and the amount of radiolabeled proteins 
measured by a scintillation counter.  This subtraction approach is expected to be 
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insensitive and variable and therefore might not yield meaningful results.  Other 
approaches include surveying the protein conformation on biomaterials adsorbed with 
10% serum proteins using atomic force microscopy (AFM).  With this approach, an 
antibody specific to a serum protein (e.g. fibronectin) would be conjugated to the AFM 
scanning tip and used to measure the presence and orientation of fibronectin by rastering 
the tip over a defined surface.  This experiment would yield insight into the conformation 
and presentation of different serum proteins.  Furthermore, time-of-flight secondary ion 
mass spectroscopy (ToF-SIMS) can be used to simultaneously identify the presence of 
multiple proteins on an adsorbed protein layer.  Previously, 16 different single protein 
films adsorbed on mica were used for ToF-SIMS analysis, and PCA was able to classify 
the proteins using only two principal components [303].  In this approach, control protein 
layers adsorbed from single serum protein solutions would be used for the controls.  
pHEMA or pIBTMA would be adsorbed with 10% serum, and the protein layers would 
be subjected to ToF-SIMS analysis and compared to the controls to identify the proteins 
that are adsorbed to the surfaces.  
Systems biology approach is currently being explored in the Babensee lab to 
elucidate the receptors DCs employ for recognition of and response to biomaterials.  The 
phosphorylation of signaling molecules will be measured after treatment of DCs with 
ligands known to be specific for certain receptors.  The signaling network will then be 
modeled using PCA and PLSR for correlating activation of signaling molecules with 
receptor engagement.  After quantifying the activation of signaling molecules in DCs 
upon treatments with certain biomaterials, such computational model will then be used to 
predict the receptors that are used by DCs to respond to biomaterials. 
The receptors that are predicted to be involved in DC response to biomaterials can 
potentially be identified by silencing signaling molecules that are immediately 
downstream to the receptors using siRNA.  For instance, MyD88 could be a target for 
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many toll-like receptors (TLRs), including TLR2, 4, 5, 6, and 10 on the cell membrane 
[304].   The target for C-type lectin, Dectin-1, would be Syk [305].  Other receptors of 
interest include the TNFαR1, which signals through the TNF receptor-associated death 
domain (TRADD) [306], and the integrin α4β1, which signals via the integrin-linked 
kinase (ILK) [307].  These signaling molecules can be silenced through the delivery of 
siRNA to primary DCs.  As shown in Appendix 4, DC transfection was effective only by 
electroporation.  Electroporation of DCs with DNA plasmids induced significant cell 
death by 40 h post transfection, which is not amenable to the silencing of signaling 
molecules because it usually takes up to 48 h for effective silencing to occur.  However, 
transfection with siRNA using electroporation has been shown to successfully 
knockdown molecules in human primary DCs, potentially due to the small size of siRNA.  
For instance, syndecan-3 was identified as an HIV-1 attachment receptor on human 
primary DCs by using siRNA [308].  Therefore, conditions of electroporation will need 
to be optimized for delivering siRNA to human primary DCs using Amaxa Nucleofector 
(Lonza).  Other than electroporation, a new family of biodegradable α-amino acid 
poly(ester amide)s (AA-PEAs) have been synthesized by Dr. C.C. Chu’s laboratory at 
Cornell University.  These AA-PEAs were found to be superior in transfecting primary 
cells as compared to commercial reagents (personal communication) and may potentially 
be used for delivering siRNA to DCs to improve DC viability post transfection.   
Furthermore, silencing of combination of receptor-specific signaling molecules is 
expected to be necessary due to their redundancy.  
The detailed signaling pathways can be identified by measuring key signaling 
molecules, including p38, JNK, Akt, ERK1/2, and others.  Multiplex phosphoprotein kits 
(from Millipore or Bio-rad) can be customized to measure the level of phosphorylated 
signaling molecules at different time points.  Since signaling is expected to occur soon 
after the ligation of receptors and their ligands, this study should focus on early time 
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points beginning at 15 min until 2 or 3 h.  This study, together with the elucidation of 
adsorbed protein profiles and receptors mediating the differential biomaterial effects on 
DCs will provide mechanistic insights into the rational design of biomaterials for 
modulating DC phenotype, thereby potentially directing desired immune responses in 
vivo.  
The research presented in this thesis aimed to identify the material properties that 
are the most important in determining DC response by using multivariate analysis 
approach.  Furthermore, DC phenotype was successfully predicted from polymer 
chemical composition and was shown to be mediated through distinct TF activation 
profiles.  Altogether, these results allow for improved rational design of biomaterials that 












Figure A1-1: Prediction results using PLSR models similar to first PLSR model built with surface 
material properties but with high resolution experimental surface chemical composition fitted (A) at 
GT (no beta carbons and C=O) removed from the X-block, and (B) at UT (with beta carbons and 
C=O) removed from the X-block. After pruning steps, prediction of MF induced by the prediction set 
terpolymers in six independent experiments with different donors was determined. The error bars 
indicate the standard errors of the experimental values. 
 






MF Maturation factor (CD86/DC-SIGN) Mean 1 
IL-1β Interleukin-1β Mean 1 
IL-1ra Interleukin-1 receptor antagonist Mean 1 
IL-8 Interleukin-8  Mean 1 
IL-16 Interleukin-16 Mean 1 
MCP-1 Monocyte chemotactic protein-1 Mean 1 
MIP-1α MΦ inflammatory protein-1α Mean 1 
TNF-α Tumor necrosis factor-α Mean 1 
Tg Glass transition temperature Mean 1 
Theta Air-water contact angle Mean 1 
Si2p (E) Experimental Si2p Mean 1 
C1s (E) Experimental C1s Mean 1 
O1s (E) Experimental O1s Mean 1 
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Table A1-1 continued: 
C1s (T) Theoretical C1s Mean 1 
O1s (T) Theoretical O1s Mean 1 
C-C (UT) Experimental C-C in U of T (fitted with beta carbon) Mean 1 
C-O (UT) Experimental C-O in U of T (fitted with beta carbon) Mean 1 
O-C=O (UT) Experimental O-C=O in U of T (fitted with beta carbon) Mean 1 
Beta C Experimental Beta C in U of T(fitted with beta carbon) Mean 1 
C=O Experimental C=O in U of T Mean 1 
C-C (GT) Experimental C-C in GT (No beta carbon) Mean 1 
C-O (GT) Experimental C-O in GT (No beta carbon) Mean 1 
O-C=O (GT) Experimental O-C=O in GT (No beta carbon) Mean 1 
C-C (T) Theoretical C-C Mean 1 
C-O (T) Theoretical C-O Mean 1 
O-C=O (T) Theoretical O-C=O Mean 1 
Ra Line roughness Mean 1 
Sa Arithmetic mean height Mean 1 
SurfArea Surface Area Mean 1 
Total   29 
 






Tg Glass transition temperature Mean 1 
Theta Air-water contact angle Mean 1 
Si2p (E) Experimental Si2p Mean 1 
C1s (E) Experimental C1s Mean 1 
O1s (E) Experimental O1s Mean 1 
C1s (T) Theoretical C1s Mean 1 
O1s (T) Theoretical O1s Mean 1 
C-C (UT) Experimental C-C in U of T (fitted with beta carbon) Mean 1 
C-O (UT) Experimental C-O in U of T (fitted with beta carbon) Mean 1 
O-C=O (UT) Experimental O-C=O in U of T (fitted with beta carbon) Mean 1 
Beta C Experimental Beta C in U of T(fitted with beta carbon) Mean 1 
C=O Experimental C=O in U of T Mean 1 
C-C (GT) Experimental C-C in GT (No beta carbon) Mean 1 
C-O (GT) Experimental C-O in GT (No beta carbon) Mean 1 
O-C=O (GT) Experimental O-C=O in GT (No beta carbon) Mean 1 
C-C (T) Theoretical C-C Mean 1 
C-O (T) Theoretical C-O Mean 1 
O-C=O (T) Theoretical O-C=O Mean 1 
Ra Line roughness Mean 1 
Sa Arithmetic mean height Mean 1 
Sq Root mean square Mean 1 
Ssk Skewness Mean 1 
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Table A1-2 continued: 
Sku Kurtosis Mean 1 
Sp Maximum peak height Mean 1 
Sv Maximum pit depth Mean 1 
Sz Maximum height (Sp+Sv) Mean 1 
Sk Level difference for a core part Mean 1 
Spk Reduced peak height Mean 1 
Svk Reduced valley height Mean 1 
SMr1 
Load area ratio to separate between a reduced peak part 
and a core part 
Mean 1 
SMr2 
Load area ratio to separate between a reduced valley part 
and a core part 
Mean 1 
Sxp Load area ratio from 97.5 to 50% Mean 1 
Vvv The void volume at valley region (load area ratio 80%) Mean 1 
Vvc 
The void volume at a core part (load area ratio from 10 
to 80%) 
Mean 1 
Vmp The actual volume at a peak region (load area ratio 10%) Mean 1 
Vmc 
The actual volume at a core part (load area ratio from 10 
to 80%) 
Mean 1 
Sal Auto-correlation length Mean 1 
Str Texture aspect ratio Mean 1 
SurfArea Surface Area Mean 1 
Total   39 
 
 
Table A1-3: Prediction of maturation factor from surface material properties: Variable influence in 







C1s (T) 1.51272 0.108265 
O1s (T) 1.47516 0.118783 
Theta 1.34927 0.257581 
C-O (T) 1.24508 0.221662 
Sk 1.21549 0.124656 
Vvc 1.20151 0.099618 
Sxp 1.18454 0.104798 
Vmc 1.18306 0.129637 
C-C (T) 1.17573 0.168358 
Sa 1.17381 0.101057 
Sq 1.13387 0.095736 
Si2p (E) 1.12296 0.429882 
Spk 1.077 0.041625 
Vmp 1.07638 0.045283 
C-O (UT) 0.949676 0.161907 
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Table A1-3 continued: 
Sv 0.936893 0.135325 
C-O (GT) 0.932527 0.217767 
C-C (UT) 0.921093 0.113291 
Vvv 0.896861 0.07768 
C-C (GT) 0.870228 0.110673 
Svk 0.827719 0.100776 
Sz 0.807782 0.149195 
O-C=O (T) 0.799988 0.084244 
Str 0.758573 0.148316 
Sp 0.737861 0.029967 
Sku 0.721398 0.229052 
O-C=O (GT) 0.657158 0.122984 
O-C=O (UT) 0.656134 0.122939 
O1s (E) 0.592469 0.400198 
SMr1 0.588059 0.111076 
Beta C 0.581602 0.099062 
SMr2 0.490808 0.439456 
 
 
Table A1-4: Prediction of maturation factor from surface material properties: loadings of each 
variable on each of the 2 PCs of the PLSR model. 
Variables w*c[1] w*c[2] 
MF 0.19797 0.190915 
Theta -0.173138 -0.461222 
Si2p (E) 0.163364 0.34822 
O1s (E) -0.113471 -0.0756812 
C1s (T) 0.270195 0.317214 
O1s (T) -0.265351 -0.300718 
C-C (UT) 0.179885 0.0228189 
C-O (UT) -0.180422 -0.134749 
O-C=O (UT) -0.128291 -0.0270437 
Beta C -0.0979554 0.09951 
C-C (GT) 0.168911 -0.00437626 
C-O (GT) -0.179336 -0.111298 
O-C=O (GT) -0.122494 0.0537237 
C-C (T) 0.226236 0.138868 
C-O (T) -0.230384 -0.219871 
O-C=O (T) -0.147673 0.0749068 
Sq -0.212846 0.0819662 
Sku 0.139873 0.0710063 
Sp -0.133832 0.0829999 
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Table A1-4 continued: 
Sv -0.0444854 0.365612 
Sz -0.105982 0.223176 
Sa -0.227223 0.0158695 
Sk -0.237384 -0.0302944 
Spk -0.186433 0.163962 
Svk -0.102861 0.24049 
SMr1 -0.0886776 0.13429 
SMr2 0.00385639 -0.201951 
Sxp -0.229197 0.017557 
Vvv -0.149658 0.158688 
Vvc -0.232394 0.0190704 
Vmp -0.183968 0.173644 
Vmc -0.231098 -0.0316889 
Str 0.144711 -0.0353204 
 
 
Table A1-5: Prediction of maturation factor from theoretical chemical composition alone: Variable 





C1s (T) 1.07802 0.078199 
O1s (T) 1.02384 0.055541 
O-C=O (T) 1.0185 0.115368 
C-O (T) 0.946235 0.146714 
C-C (T) 0.925699 0.058274 
 
 
Table A1-6: Prediction of maturation factor from theoretical chemical composition alone: loadings of 
each variable on each of the 3 PCs of the PLSR model. 
Variables w*c[1] w*c[2] w*c[3] 
MF 0.315287 0.696938 0.499077 
C1s (T) 0.520489 0.439407 0.725786 
O1s (T) -0.51116 -0.34823 -0.59166 
C-C (T) 0.435808 -0.2265 -0.64242 
C-O (T) -0.4438 -0.09625 0.538043 







A.2. Isolation of human monocytes for a purified DC culture used for transcription 
factor profiling 
 
A heterogeneous DC culture, with B cells as the major contaminating cell type, 
has been conventionally used in the Babensee laboratory to assess DC response to 
biomaterials.  The B cell percentage in this culture can range from 9 – 25% depending on 
the donors.  The presence of B cells in the culture has been shown to contribute to the full 
response of DCs to biomaterials [211].   
In order to determine DC-specific TF activation upon biomaterial treatment, 
human monocytes were purified from freshly collected peripheral blood mononuclear 
cells (PBMCs) using CD14
+
 magnetic bead (MACS) isolation.  These beads positively 
selected CD14 expressing monocytes.  Following isolation of monocytes using MACS, 
the purity was assessed via flow cytometry through the expression of CD14 (Figure A2-
1), and the viability of cells was assessed by propidium iodide (PI) staining (Figure A2-




 cells was determined pre- and post-isolation.  
Routinely, >95% of cell population post-isolation was CD14
+
.  Typically, >80% isolated 
monocytes were viable.  After incubation of isolated monocytes for 2 h to allow for 
adhesion of the cells to the cell culture dish, the dish was washed gently 1 – 2 times to 
remove any non-viable cells.  The purified monocytes were then cultured in the presence 
of IL-4 and GM-CSF for 5 days for the differentiation into DCs.  On Day 5, the purity of 
DCs were checked by double-staining the cells with monocyte-derived DC markers 
CD1a (Biolegend) and DC-SIGN (R&D Systems).  CD1a and DC-SIGN double positive 
cells were determined as DCs (Figure A2-3).  Routinely, >95% of the cell population on 








              
Figure A2-1: Purification of monocytes using CD14 microbead isolation. Pre-isolation (A) and post-
isolation (B) levels of CD14-FITC expression are shown.  Cells were stained with CD14-FITC 
monoclonal antibody (Miltenyi Biotec).  Following isolation, cell population was generally >95% 
CD14
+
 for the generation of a purified DC population.   
 
              
Figure A2-2: Viability of cells pre- (A) and post-isolation (B) using CD14
+
 microbeads.  Typically, 
>80% isolated monocytes were viable.  After incubation of isolated monocytes for 2 h to allow for 




Figure A2-3: Purity of DCs derived from a purified population of monocytes.  Cells were double-
stained with CD1a-AlexaFluor 647 (labeled as APC) and DC-SIGN-FITC monoclonal antibodies.  









 = 31.7% CD14
+




 = 4.6% PI
+
 = 19.2% 
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DCs from this purified culture were shown to be capable of responding to 
biomaterials, though to a lesser extent, as compared to the heterogeneous cell culture.  
DCs treated with PLGA or agarose were stained for the expression of surface markers, 
including CD83, CD86, and DC-SIGN.  It is important to note that the purified culture 
resulted in less variability in surface marker expression in differentially treated DCs as 
compared to the heterogeneous cell culture method.  DCs cultured by both methods 
responded to LPS at similar levels (Figure A2-4).  
 
 
Figure A2-4: Comparison of DC response to biomaterials using DCs from purified DC culture and 
conventional culture method.  gMFIs of the surface markers were determined by flow cytometry 




A.3. Other approaches for developing high-throughput methodology for DC 
phenotype screening 
In the process of developing the HTP method, a number of other approaches were 
attempted before the filter plate approached was validated.  These methods included 1) 
magnetic bead approach, 2) agarose entrapment approach, and 3) transwell approach.  
These approaches were initially conceived to magnetically or physically “trap” DCs 
during washing steps due to the loosely adherent nature of DCs.  Regular cell-based 
ELISA was unusable for the HTP method because the washing steps were expected to 
wash away the majority of the cells.  This appendix section describes the various 
approaches.   
 
A.3.1. Magnetic bead approach 
 
 




Figure A3-1:  Schematic of the magnetic beads approach.  DCs were linked to magnetic beads via 
incubation with first, an anti-CD1c-biotin antibody and second, CD1c molecule expressed on DCs.  
After the application of a magnet, the excess cells and fluorescently-labeled antibody can be removed, 
and then the fluorescent intensity in each well can be measured.  Size of magnetic bead ~ 4.5 µm, and 
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Intended experimental procedure for analysis DC phenotype in 96-well plate using 
magnetic bead approach 
 
 
Figure A3-2: Schematic of intended experimental procedure on 96-well plate for magnetic bead 
approach.  A) DCs are plated in 96-well plate coated with different biomaterials at a known 
concentration on day 5.  The inset shows a single well in the microplate.  B) On day 6 culture, 
magnetic beads coated with CD1c-biotin are incubated with the cells.  A magnet is applied so that the 
unbound cells are washed away.  The bead-bound cells are then labeled with anti-CD86-PE and 
Hoechst 33342 and washed with the application of a magnet.  Finally the fluorescent intensity of the 
microplate is measured by a fluorescent plate reader. CD86 is a costimulatory molecule that 
upregulates with DC maturation and is a good indicator of DC response to biomaterials.  Hoechst 
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Before performing the actual microplate experiments, the “conjugation 
efficiency” needed to be determined.  Conjugation efficiency was defined as (# DCs 
bound to magnetic beads) / (total DCs).  Reasonably high conjugation efficiency was 
required to retain enough DCs in the wells for fluorescent detection.  Figure A3-3 
illustrates the experimental procedure for determining conjugation efficiency.  
 
Figure A3-3: Determination of conjugation efficiency of DCs to magnetic beads.  A manufacturer-
recommended amount of magnetic beads were labeled with anti-CD1c-biotin antibody in an 
Eppendorf tube.  Subsequently a known number of DCs were added to the tube for conjugation.  
Three washes were performed and the washes were collected for the determination of the unbound 
cells by Coulter counter. The difference of initial cell number and the unbound cell number was the 
cells that were bound to the beads. 
 
 
Surprisingly, the conjugation efficiency was consistently very close to zero (i.e. 
less than 5%).   CD1c-biotin antibody binding to the beads was analyzed by staining the 
CD1c-biotin antibody-coated beads with FITC-labeled antibodies against biotin or Fab 
fragment of the antibody.  As shown in Figure A3-4, beads labeled with anti-CD1c-biotin 
antibodies were fluorescent after staining with either of the antibodies, and the 
fluorescence intensity decreased with increasing anti-CD1c-biotin density, potentially 
due to steric hindrance. 
Subsequently, various adjustments were made to improve conjugation efficiency 
(Table A3-1).  Unfortunately, none of these adjustments, including an indirect labeling 
method, improved conjugation efficiency.   
Therefore, the anti-CD1c-biotin antibody was able to independently bind to the 
magnetic beads or DCs well.  However, when the anti-CD1c-biotin antibodies were 
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bound to the beads first prior to the addition of DCs, the conjugation of DCs to the beads 
was very inefficient.  This is potentially due to steric hindrance or sub-optimal orientation 
of the anti-CD1c-biotin antibodies presented on the magnetic beads for DCs to efficiently 
bind to.  
 
Figure A3-4: Evaluation of anti-CD1c-biotin coating.  Magnetic beads coated with various 
concentrations of anti-CD1c-biotin antibodies were labeled with anti-biotin-FITC (blue bars) or anti-
Fab-FITC (purple bars). Beads labeled with anti-CD1c-biotin antibodies were fluorescent after 
staining with either of the antibodies, and the fluorescence intensity decreased at higher anti-CD1c-
biotin density, potentially due to steric hindrance.  
 
 
Table A3-1:  Changes that were made to attempt to improve conjugation efficiency. 
Adjustments  Improvement? 
Increase CD1c-biotin concentration such that it will bind to 
the magnetic beads more efficiently 
NO 
Make sure the beads were properly bound by anti-CD1c-
biotin 
NO 
Increase incubation time of DCs with the beads NO 
Change the Eppendorf tube to a flat-bottom microcentrifuge 
tube to ensure complete mixing during incubation 
NO 
Indirect method: first label cells with anti-CD1c-biot, and 









Figure A3-5:  An illustration showing that the antibody can independently binds to the beads and the 


















A.3.2. Agarose entrapment approach 
Low melting temperature (LMT) agarose was used to trap the cells in the wells 
during cell washing.  LMT agarose was used so that the cells would not be in contact 
with high temperature agarose solution.  A low concentration of agarose was used so that 
it was easier to rinse antibodies out of the agarose gel.  Figure A3-5 illustrates how 
agarose entrapment was used for the HTP assay. 
 
Intended experimental procedure for analysis DC phenotype in 96-well plate using 
agarose entrapment approach 
 
Figure A3-6: Schematic of intended experimental procedure on 96-well plate for agarose entrapment 
approach.  A) DCs are plated in 96-well plate coated with different biomaterials at a known 
concentration on day 5.  The inset shows a single well in the microplate.  B) On day 6 culture, a low 
melting temperature agarose solution is cast on to the cells and gels.  The entrapped cells are then 
labeled with anti-CD86-PE and Hoechst 33342 and washed.  Finally the fluorescent intensity of the 
microplate is measured by a fluorescent plate reader. 
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To assess this method prior to the actual microplate experiments, the cells were 
pre-mixed with agarose (0.25%, 0.5%, or 0.75%) and then cast onto the microplate to 
keep volume consistent.  The entrapped cells were then stained with anti-CD86-PE and 
Hoechst 33342.  
This method requires extreme care during operation due to the delicate agarose 
gel.  No vacuum aspiration was allowed because all three concentrations of agarose films 
were easily aspirated away along with the supernatants.  Instead, the removal of 
supernatant had to be done very carefully with an Eppendorf pipette one well at a time, 
which resulted in a labor intensive and potentially highly erroneous procedure.  At 
0.25%, some agarose films were still accidentally removed by careful pipetting.  In 
addition, it required >7 washes and >2 h to effectively remove the excess antibody from a 
96-well plate (Figure A3-6), rendering this a low-throughput method due to its time-
consuming nature.  
 
Figure A3-7: More than 7 washes were required to effectively wash away the abundant dye in the 
agarose film in the microplate wells.  DCs were stained in the Eppendorf tubes with anti-CD86-PE 
and Hoechst 33342 for 1 hour.  An agarose solution was added to the tubes to reach concentration of 
0.25%. 0.5% or 0.75% agarose, and then plated into a 96-well plate.  Buffer was then added on top 
of the agarose film to wash the abundant.   The time indicated in the legend was the soaking time in 
the specified wash.  Unstained cells are pre-stained cells entrapped in agarose were used as control.  
Pre-stained cells were stained in the eppendorf tube and washed 2x and subsequently mixed with 
agarose and cast into the wells.  Data shown were Mean ± SD generated by triplicate.  The result 
indicated that it required >7 washes to remove the abundant dye, which also implies that if the cells 
entrapped in the agarose were to be stained with dye solution added on top of the agarose film, it 
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stained + wash 7x (20hr)
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A.3.3. Transwell approach 
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Figure A3-8: Schematic of intended experimental procedure on 96-well plate for the transwell 
approach.  A) DCs are plated in 96-well receiver plate coated with different biomaterials at a 
known concentration on day 5.  The inset shows a single well in the microplate.  B) On day 6 
culture, a membrane insert is placed into the well to remove the supernatant.  The cells are then 
labeled with anti-CD86-PE and washed.  Finally the fluorescent intensity of the microplate is 
measured by a fluorescent plate reader 
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To evaluate this method before performing the actual microplate experiments, the 
cells were serially diluted on a black 96-well receiver plate and stained with anti-CD86-
PE and CD1c-AlexaFluor 488.  A membrane insert was used to trap the cells in the well 
during washing.   
The membranes only come in two materials: polyester (PET) or polycarbonate 
(PC).  PC membranes were very weak and therefore broke very easily during aspiration.  
Membranes of pore size of 0.4 µm, 1µm, and 3µm were tested but none of them resulted 
in a linear fluorescent intensity vs. cell number curve (Figure A3-8). Cells were lost 
through the cracks and therefore the method was prone to errors.  On the other hand, 
PET membranes were much stronger but only came in very small pore size (0.4 and 1 
µm) or large pore size (8µm).  The small pore size membranes did not allow supernatant 
aspiration while large pore size caused DCs to be aspirated along with the supernatants.  
 
 
Figure A3-9: Transwell approach failed to generate linear relationship between fluorescent intensity 
of CD86 or CD1c surface marker and cell number. The PC membrane of the 96-well plate insert was 

































































































A.4. Transcription factor profiling using reporter gene in transfected DCs 
 
Initially, a reporter gene approach was undertaken to understand transcription 
factor activation profiles of DCs treated with different biomaterials.  In this approach, 
human primary monocyte-derived DCs were transfected with reporter plasmid whose 
transcription was inducible by the activation of TFs.  Transfected DCs were expected to 
express the reporter to different levels depending on the treatment used (Figure A4-1).  
 
Figure A4-1: Schematic of DC TF activation profiling experiments by using TF-inducible reporter 
plasmid activity. 
 
Human primary DCs are one of the most difficult cell types to transfect because 
they are suspension, non-proliferative, and extremely sensitive immune cell type.  Two 
methods were primarily used for introducing external DNA into DCs, including 
electroporation and lentiviral transduction.  The latter is cost-inhibitive, so DCs were 
transfected by electroporation using Nucleofector device (Lonza).  Several additional 
steps were found to be important in optimizing transfection efficiency and cell viability 
post electroporation: 
1. DNA plasmids used to transfect the cells needed to undergo additional PEG 
precipitation (in addition to endotoxin-free DNA prep) to remove any trace 
amount of endotoxin. 
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2. FBS or antibiotics must not be included in the recovery medium after DC 
electroporation. 
3. OptiMEM was superior to RPMI in enhancing DC viability as the recovery 
medium after electroporation. 
 
DC transfection protocol was optimized with GFP expressing DNA plasmids 
controlled by CMV promoter to a) maximize transfection efficiency, b) maximize cell 
viability, and c) minimize DC pre-activation during the electroporation process.  Using 
the optimized protocol, DC transfection efficiency was 55% from the 78% viable cells by 
24 h (Figure A4-2).  DC viability decreased to approximately 50% by 40 h, most likely 
due to the electric shock and the presence of DNA plasmids inside the cells.  Cell 
viability and transfection efficiency have been shown by others to be much higher with 
siRNA or mRNA.  Therefore, any analysis on transfected DCs (DNA plasmid 
transfection) should be performed within approximately 24 – 30 h.  In addition, 
transfected DCs were not pre-activated based on DC surface maturation marker CD83 
and CD86 staining 24 h post electroporation (Figure A4-3). 
 
 
Figure A4-2: Representative transfection data from three independent trials with different donors 
that yielded similar results.  2106 DCs were transfected with 2 µg GFP DNA plasmid.  Cells were 
stained with propidium iodide (PI) and then analyzed by flow cytometry.  78% of DCs were PI 
negative (viable), while 55% of the viable cells were GFP positive (transfection efficiency).  PE 








Figure A4-3: Representative transfection data from three independent trials with different donors 
that yielded similar results.  2106 DCs were transfected with 2 µg GFP DNA plasmid.  24 h post 
electroporation, DCs were analyzed for surface marker expression, including CD83 and CD86, both 
are regulated when DCs are activated.  
 
After DC transfection protocol was optimized, DCs were transfected with positive 
control plasmid with constitutive expression for the reporter SEAP (secreted alkaline 
phosphatase) controlled by SV40 promoter.  The objective of this experiment was to 
determine how soon (time point) the SEAP reporter protein could be detected and if any 
dilution was necessary to accurately quantify the SEAP within 24 h.  However, very low 
levels of SEAP reporter activity (close to blank) were detected (data not shown).  The 
expression of SEAP by this positive control reporter is controlled by the promoter SV40, 
which is known to be much weaker than CMV (as the case in the GFP plasmid), and is 
often particularly weak in primary cells [310]. When DCs were transfected with CMV 
controlled Metluc (secretive luciferase reporter) plasmid, very high and time-dependent 
chemiluminescence signal was detected (Figure A4-4) in the medium.  Therefore, 





with no DNA 
Electroporation 





Figure A4-4: DCs strongly expressed luciferase reporter controlled by a CMV promoter at a time-
dependent manner.  DCs were transfected with Metluc plasmid (Clontech) and the cell culture 
medium was collected at the indicated time points for assaying luciferase activity as compared to 
empty vector transfected control.   DCs strongly expressed the Metluc reporter under CMV control 
in a time-dependent fashion.  
 
NFkB-inducible SEAP reporter plasmid (Clontech) was used to transfect DCs.  
DCs were then treated with LPS to induce NFkB activation.  However, similar to the 
control plasmid, very low levels of reporter activity was detected – the 
chemiluminescence from transfected DCs with LPS treatment was only 10 fold higher 
than non-transfected cells (Figure A4-5), which is unacceptably low for using this 
plasmid for future experiments.  The lack of reporter activity is most likely due to low 
promoter activity of the plasmid in the DCs.  The enhancer element sequences as well as 
the accompanying minimal promoter may be altered to optimize promoter activity in 
DCs.  Several vendors sell inducible plasmids with different designs.  Unfortunately, 




Figure A4-5: DCs transfected with NF-κB inducible plasmid and treated with LPS for 24 or 48 h in 
the presence or absence of 2% FBS. Transfected DCs were recovered in OptiMEM for 2 h post 
electroporation.  At this point, either LPS alone was added or LPS + FBS were added for a final FBS 
concentration of 2%.  NT was the non-transfected DC control, while +SEAP was the positive control 
with placental alkaline phosphatase.  The chemiluminescence values are labeled above the bars.  The 
LPS treated DCs only resulted in 10 fold change compared to the non-transfected control, which is 
unacceptable for future experiments.  
 
Chemical or lipid reagents, including TransIT-200 (Mirus), FugeneHD (Roche), 
and GeneJuice (EMD), were also tested and all with close to 0% transfection efficiency 
with human primary DCs.  
Invitrogen Neon electroporation device was also used for transfection but resulted 
in over 70% cell death and <20% transfection efficiency out of all 20 conditions tested.  
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A.5. Dendritic Cell Response to Nanotopography 
(Collaborated with Dr. Clemens van Blitterswijk at University of Twente in the 
Netherlands)  
 
 The TopoChip, developed by Drs. Jan de Boer and Clemens van Blitterswijk at the 
University of Twente in the Netherlands, was fabricated by hot embossing and was composed 
of 2178 unique TopoUnits in duplicate (total 4356 TopoUnits).   The TopoChip provided a 
high-throughput system to assess DC phenotype to an important biomaterial property, 
nanotopography.  Through the proof-of-concept experiments at University of Twente, a 
human DC-like cell line, KG-1 cells, was used to assess the effect of nanotopography on DC 
phenotype.   
 KG-1 cells were used due to the time limitation during the visit at the University of 
Twente to complete necessary experiments.  Prior to using KG-1 cells with the TopoChip, the 
cells were characterized at Georgia Tech for their response to standard biomaterials, 
including PLGA and agarose, as well as PDLLA, which was the base material of TopoChip, 
in vitro.  A longer culture time (48 h) was required for these cells to respond to biomaterials, 
as oppose to the shorter culture time (24 h) required for primary human DCs to respond 
(Figure A5-1).  
 During the three-week visit at the University of Twente, KG-1 cells were cultured 
on the TopoChip for 6 h without media exchange.  Long-term cultures were not 
performed as the perfusion pump was not operable at a time.  Cells were immediately 
fixed and stained with anti-CD86-PE monoclonal antibodies (Ancell).  Each wash step 
was carefully performed so as not to rinse away cells.  Stained cells were then mounted 
on a customized TopoChip loader into a BD Pathway imager for data acquisition.  The 
image of each TopoUnit was then cropped from the original large image using a 
customized MATLAB script.  These images were subsequently analyzed using 
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CellProfiler cell image analysis software (Broad Institute).   KG-1 cells differentially 
adhered to the different TopoUnits (Figure A5-2); however, the results were not 
reproducible during my time at University of Twente.  Due to the lack of experience with 
culturing loose-adherent cells on the TopoChips, more experiments need to be performed 
to optimize the cell culture protocol of KG-1 cells or human primary DCs onto these 
devices. 
 Transfection of KG-1 cells with a reporter plasmid was also attempted using 
GeneJuice or FugeneHD.  However, transfection efficiency was very low (<5%) and 
therefore this approach was not used.  Other transfection reagents might be more 




Figure A5-1: KG-1 cells required longer culture time to respond to biomaterials.  KG-1 cells were 
cultured with the indicated treated for 24 h (A) or 48 h (B) and then the cells were collected for 
surface marker quantification by flow cytometry.  Results were shown for N ≥ 4 (mean ± SEM) for 
24 h (A) or n = 2 (mean ± range) for 48 h.  It is important to note that the magnitude of surface 






Figure A5-2: KG-1 cells differentially adhered to the TopoUnits.  The color intensities indicate the 
number of cells remained in each of the TopoUnits (represented by each square).   However, the 







A.5. Deriving DC phenotype-biomaterial property relationships using terpolymer 
library 
 
As shown in CHAPTER 6, the terpolymer library was used as the prediction set to 
verify the robustness of the PLSR model constructed based on the pMA library training 
set.  To make full use of the material property and DC phenotypic data DCs already 
generated using the terpolymer library, multivariate analysis was again performed for this 
set of polymers.  It is important to note that the original terpolymer library also included 
three additional nitrogen-containing terpolymers (#10 – 12 in table A6-1) that were 
excluded from the prediction set in CHAPTER 6.  These terpolymers were excluded 
because the pMAs that the PLSR model was based upon did not contain any nitrogen and 
therefore was not “trained” to predict DC response towards terpolymers that contain 
nitrogen.  
 
Table A6-1: List of original polymers in the terpolymer library.  Note that #1 – 9 and 13 were used as 
the prediction set in CHAPTER 6.  Nitrogen-containing terpolymers #10 – 12 were excluded in the 
prediction set because the pMA library used for model construction did not contain any nitrogen.  
#13 and #14 are common biomaterials included in the study.  
terpolymer # Abbreviation Composition 
1 2A       A55T20G25 – 55%A-co-20%T-co-25%GMA 
2 2B       A40T35G25 – 40%A-co-35%T-co-25%GMA 
3 2D       A10T65G25 – 10%A-co-65%T-co-25%GMA 
4 5B       H40T35G25 – 40%H-co-35%T-co-25%GMA 
5 5C       H25T50G25 – 25%H-co-50%T-co-25%GMA 
6 5D       H10T65G25 – 10%H-co-65%T-co-25%GMA 
7 6A       A55H20G25 – 55%A-co-20%H-co-25%GMA 
8 6B       A40H35G25 – 40%A-co-35%H-co-25%GMA 
9 6C       A25H50G25 – 25%A-co-50%H-co-25%GMA 
10 7B H40N35G25 – 40%H-co-35%N-co-25%GMA 
11 7C H25N50G25 – 25%H-co-50%N-co-25%GMA 
12 7D H10N65G25 – 10%H-co-65%N-co-25%GMA 
13 HEMA 100% H 




These terpolymers were initially synthesized with the goal of varying only one 
material property at one time (Table A6-2).  However, although the certain bulk or 
surface properties may be maintained through careful design of polymer composition, the 
underlying chemistry of the polymers and potentially other material properties are 
inevitably altered as well.  Therefore, multivariate analysis of induced DC response to 
these terpolymers is necessary to simultaneously analyze the effects of a combination of 
material properties on DCs.  
 
Table A6-2: The wet modulus, Tg, and contact angle of terpolymers.  These terpolymers were 
synthesized with the goal of varying one property at a time and were divided into four groups as 
color-coded in the table.  Within each group, two of the material properties were kept similar as 







2A A55T20G25 32 -37 96 
2B A40T35G25 37 -37 92 
2D A10T65G25 39 -41 85 
5B H40T35G25 354 -5 75 
5C H25T50G25 157 -3 69 
5D H10T65G25 52 -28 72 
6A A55H20G25 1275 15 94 
6B A40H35G25 3380 37 82 
6C A25H50G25 2697 68 75 
7B H40N35G25 2280 138 61 
7C H25N50G25 1850 119 65 







The induced DC phenotype upon treatment with the terpolymers was measured in 
terms of MF, defined by CD86/DC-SIGN ratio, using the HTP method described in 
CHAPTER 4 (Figure A6-1). In addition, the production ofcytokines and chemokines by 
treated DCs was quantified using multiplex bead assay.  Similarly to the pMA-induced 
DC response, the terpolymers also induced a trend of increasing DC maturation as shown 
by the expression of MF in the ordering of terpolymers in the x-axis (Figure A6-1).  
When keeping the ordering of polymers the same, similar trends could be observed for 
the release of pro-inflammatory cytokines, IL-1β (Figure A6-2A) and TNF-α (A6-2B), 
and chemokine, IL-8 (Figure A6-2C), by treated DCs.  The production of anti-
inflammatory cytokine, IL-16, also followed roughly the same trend, but with pHEMA 
also inducing high production of IL-16 by treated DCs (Figure A6-2D).   IL-1ra (anti-
inflammatory) and MCP-1 (chemokine) were also assayed but did not follow the same 
trend (Figure A6-3).   However, it is interesting to note that pHEMA induced low levels 
of all the cytokines or chemokines examined.  The pMAs did not induce significant 
cytotoxicity in treated DCs.  Interestingly, pHEMA induced lower cell death as compared 
to all the other pMAs (Figure A6-4).  
 
 
Figure A6-1: DC responded differential to the terpolymers and the common biomaterials, pHEMA 
and PLLA. Maturation factor (CD86/DC-SIGN) is shown with mean ± SEM (n = 6 donors). *: p<0.05 








Figure A6-2: Terpolymers induced differential cytokine and chemokine production.  IL-1β (A) and 
TNF-α (B) are pro-inflammatory cytokines.  IL-8 (C) is a chemokine.  IL-16 (D) is a pleiotropic 
cytokine. Data are shown with mean ± SEM (n = 6 donors). The numbers in parentheses correspond 
to Table A6-1*: p<0.05 higher than iDC; #: p<0.05 lower than mDC; brackets: p<0.05 between 






Figure A6-3: Terpolymers induced differential IL1-ra and MCP-1 production.  IL-1ra (A) and MCP-
1 (B) did follow the same trend of increasing DC maturation along the same ordering of polymers 
listed in the x-axis cytokine as compared to Figure A6-2. Data are shown with mean ± SEM (n = 6 




Figure A6-4: Terpolymers did not induce significant cytotoxicity as compared to iDC.  It is obvious 
that pHEMA induced the least cytotoxicity as measured by the release of cytosolic enzyme, G6PD.  
The fluorescent signals from the samples were compared to a standard curve generated by lysed iDC 
to determine the percent dead cells.  Results contained large donor-to-donor variations.  Data are 
shown with mean ± SEM (n = 6 donors). Brackets: p<0.05 between treatments. 
 
 
PCA was performed to analyze the effects of the different material properties on 
DC phenotype upon biomaterial treatment using the variables shown in Table A6-3.  A 
summary of material characterization is shown in Table A6-4.  Appendix 8 show the 
representative XPS high resolution C1s scans, and Appendix 10 show the representative 
surface roughness images. A six-component PCA model was determined by cross-
validation to be the most optimal for representing this dataset with R
2
 = 0.88 and Q
2
 = 
0.80, meaning that this model can capture 88% with excellent predictability.  The five 
components could individually capture 32.6%, 22.2%, 12.8%, 10.3%, 5.6% and 4.3% of 
data information, respectively.  No major outliers were identified by the Hotelling’s T
2
 
statistic.  Very importantly, this model was generated with the exclusion of PLLA. A 
model with PLLA included resulted in similar R
2
 of 0.87 but a significantly poorer Q
2
 of 
only 0.47 (results not shown).  The discrepancy in model performance subjected to the 
inclusion of PLLA was potentially due to the dissimilarity of PLLA as compared to the 
rest of the members in the polymer library.  We hypothesize in order to predict the effects 
of a more diverse group of polymers on DC phenotype, multiple members are needed for 
each type of chemistry so that statistically meaningful models can be derived.  
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Similar to the pMA study, the score plot of the terpolymers also showed a wide 
spread nature of the projection of the observations, indicating that the terpolymers 
induced a wide range of DC responses (Figure A6-5A).  However, in contrast to the PCA 
model for pMAs, PC1 alone is not sufficient for segregating highly activating materials 
from nearly bio-inert polymers.  Instead, both PC1 and PC2 together can roughly separate 
the polymers based on their ability to mature DCs, with more activating materials 
concentrated in the top right quadrant (Figure A6-5A).  For example, pHEMA was 
strongly loaded on negative PC1, while 7C, which was sufficiently activating on DCs, 
also had negative loading on PC1 but a strong positive loading on PC2.  Activating 
materials like 7B and 7D were projected positively to both PC1 and PC2 (Figure A6-5A).  
The conclusions from the loading plots were very similar to those drawn from the 
pMA study, and the overall results were very similar regardless of the combinations of 
PCs.   First, all the phenotypic variables measured strongly clustered and mostly located 
in the top right quadrant (associated with activating polymers in the score plot) opposite 
from IL-16 (Figure A6-5B).  Second, the projections of the theoretical values of 
elemental composition and C-C, C-O, and O-C=O bond composition were very similar to 
the projections of the experimental values (Figure A6-5B). % carbon and % nitrogen 
were associated with DC maturation because they were projected positively on PC1, 
while % oxygen was associated with less mature DCs due to their negative projections on 
PC1.  Since XPS cannot distinguish between C-N and C-O bonds or between N-C=O and 
N-C=O bonds, the experimental values of these bonds were projected as a combination of 
the oxygen- and the N-containing bonds.  Since the amount of oxygen-containing bonds 
was much higher as compared to the nitrogen-containing bonds in the terpolymers, the 
combined effects of the two were similar to the projections of oxygen-containing bonds 
alone.  However, the composition of these bonds could be theoretically calculated 
separately.  When the theoretical bond information was projected, it was apparent that the 
oxygen-containing versions of these bonds were negatively associated with DC 
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maturation by being situated towards the left of the PC1, while the nitrogen-containing 
versions of these bonds were positively associated with DC maturation by locating in the 
same quadrant as the mature phenotypic variables (Figure A6-5B).  
 
 
Figure A6-5: Score and loading plots showing the projection of the treatments and variables on the 
PC space for the terpolymer library.  PC1 captures 32.6% and PC2 captures 22.2% of the data, 
which together represent >50% of the original data information.  A) Score plot shows the projection 
of the pMA treatments, each with six data points obtained from six independent experiments with 
different donors.  B) Loading plots shows the projection of the variables on the PC space.  See text 
for detailed interpretation of the plots. The following color code is used for the loading plot: Blue: 
phenotypic variables; black: chemical composition; red: contact angle; orange: roughness; dark 
green: Tg; neon green: monomer composition; pink: surface area.  The interpretation of the 
combination of PC1 with other PCs resulted in similar conclusion; therefore these plots are omitted 
for simplicity.  
 
In addition, wet modulus (WetM) was associated with DC maturation due to its 
proximity with the maturation phenotypic variables (Figure A6-5B).  If plotted 
individually against the different phenotypic variables, wet modulus could be strongly 
associated with TNF-α and MCP-1 with R
2
 of 0.70 and 0.83, respectively.  In contrast, 
surface roughness (Sa), as well as other roughness-related variables such as Sk, Spk, Svk, 
Vvv, etc., were located away from the maturation variables except for Str.  Obviously, a 
strong redundancy was present due to the strong clustering of these variables.  Tg and 
contact angle did not contribute to PC1, but they were projected positively and negatively 
on PC2, respectively (Figure A6-5B).  Although this might suggest that Tg and contact 
angle were moderately associated with more or less DC maturation based on PC2, 
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respectively, these two variables had little effects on DC phenotype because their 
projections onto other PCs were mostly close to zero (data not shown).  The projections 
of monomer composition of T, H, A, G, and N onto the loading plot corresponded to the 
positions of terpolymers in the score plot.  For example, 2D, 5C, 5D were polymers that 
contained high percentage of T, and their positions in the score plot matched the location 
of T in the loading plot (Figure A6-5B).  
Therefore, the PCA results herein were consistent with the conclusions from 
CHAPTER 6, where chemical composition was consistently the most informative data 
for DC phenotype.  Specifically, elemental oxygen and oxygen-containing chemical 
bonds have been consistently shown in CHAPTER 5, 6, and this Appendix for their 
association with iDC phenotype, whereas elemental carbon and C-C bonds have been 
shown to associate with DC maturation.  C=O contamination has also been consistently 
shown to co-vary with DC maturation.  In this Appendix, elemental nitrogen and 
nitrogen-containing bonds were additionally shown to associate with a mDC phenotype, 
consistent with results shown in CHAPTER 5.  Variables such as contact angle, Tg, and 
roughness might suggest moderate correlations with DC response depending on the 
systems used, but their effects have not been consistent and therefore are not expected to 
possess strong predictive power for DC response. Although wet modulus was shown to 
associate with DC maturation in this Appendix (Figure A6-5B), more studies should be 
conducted to confirm this finding. 
Because chemical information of the polymers have been consistently 
demonstrated to be the most useful for modeling DC response to biomaterials, ToF-SIMS 
(Appendix 11) was also performed on this terpolymer library to derive more complex 
mass fragment information.  The analysis of this is underway to determine whether PLSR 
model can be successfully constructed with stronger predictive power compared to the 
model shown in CHAPTER 6. 
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MF Maturation factor (CD86/DC-SIGN) Mean 1 
IL-1β Interleukin-1β Mean 1 
IL-1ra Interleukin-1 receptor antagonist Mean 1 
IL-8 Interleukin-8  Mean 1 
IL-16 Interleukin-16 Mean 1 
IL-18 Interleukin-18 Mean 1 
MCP-1 Monocyte chemotactic protein-1 Mean 1 
TNF-α Tumor necrosis factor-α Mean 1 
Si2p (E) Experimental Si2p Mean 1 
C% (E) Experimental C1s Mean 1 
O% (E) Experimental O1s Mean 1 
N% (E) Experimental N1s Mean 1 
C% (T) Theoretical C1s Mean 1 
O% (T) Theoretical O1s Mean 1 
N% (T) Theoretical N1s Mean 1 
C-C (E) Experimental C-C  Mean 1 
C-O or C-N 
(E) 
Experimental C-O or C-N Mean 1 
O-C=O or  
N-C=O (E) 
Experimental O-C=O or N-C=O Mean 1 
Beta C (E) Experimental Beta C  Mean 1 
C=O (E) Experimental C=O  Mean 1 
C-C (T) Theoretical C-C Mean 1 
C-O (T) Theoretical C-O Mean 1 
C-N (T) Theoretical C-N Mean 1 
O-C=O (T) Theoretical O-C=O  Mean 1 
N-C=O (T) Theoretical N-C=O Mean 1 
Sa Arithmetic mean height Mean 1 
Sq Root mean square Mean 1 
Ssk Skewness Mean 1 
Sku Kurtosis Mean 1 
Sp Maximum peak height Mean 1 
Sv Maximum pit depth Mean 1 
Sz Maximum height (Sp+Sv) Mean 1 
Sk Level difference for a core part Mean 1 
Spk Reduced peak height Mean 1 
Svk Reduced valley height Mean 1 
SMr1 
Load area ratio to separate between a reduced peak part 
and a core part 
Mean 1 
SMr2 
Load area ratio to separate between a reduced valley part 
and a core part 
Mean 1 
Sxp Load area ratio from 97.5 to 50% Mean 1 
Vvv The void volume at valley region (load area ratio 80%) Mean 1 
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Table A6-3 continued: 
Vvc 
The void volume at a core part (load area ratio from 10 
to 80%) 
Mean 1 
Vmp The actual volume at a peak region (load area ratio 10%) Mean 1 
Vmc 
The actual volume at a core part (load area ratio from 10 
to 80%) 
Mean 1 
Sal Auto-correlation length Mean 1 
Str Texture aspect ratio Mean 1 
SurfArea Surface Area Mean 1 
Tg Glass transition temperature Mean 1 
Theta Air-water contact angle Mean 1 
WetM Wet modulus Mean 1 
T % T monomer as measured by NMR Mean 1 
A % A monomer as measured by NMR Mean 1 
H % H monomer as measured by NMR Mean 1 
N % N monomer as measured by NMR Mean 1 
G % G monomer as measured by NMR Mean 1 
Total   53 
Red text indicates new variables compared to the list of variables used for the construction of PCA and 
PLSR models for the pMA library. 
 
 
Table A6-4: Material characterization of the polymers used in the PCA model. 
 
2A 2B 2D 5B 5C 5D 6A 6B 6C 7B 7C 7D HEMA 
H 0 0 0 35 24 13 20 36 51 36 22 14 100 
A 62 42 18 0 0 0 52 37 26 0 0 0 0 
T 14 27 53 37 50 59 0 0 0 0 0 0 0 
N 0 0 0 0 0 0 0 0 0 40 49 57 0 
G 23 31 29 28 26 28 27 27 23 24 29 29 0 
C%(E) 0.81 0.78 0.74 0.76 0.72 0.85 0.78 0.75 0.78 0.68 0.68 0.75 0.67 
O%(E) 0.18 0.21 0.25 0.21 0.26 0.14 0.21 0.23 0.22 0.23 0.24 0.18 0.30 
N%(E) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.02 0.03 0.03 0.00 
Si%(E) 0.01 0.01 0.02 0.02 0.02 0.01 0.00 0.01 0.00 0.06 0.06 0.04 0.03 
C%(T) 0.79 0.76 0.72 0.68 0.69 0.69 0.78 0.73 0.76 0.71 0.71 0.72 0.67 
O%(T) 0.21 0.24 0.28 0.32 0.31 0.31 0.22 0.27 0.24 0.25 0.23 0.21 0.33 
N%(T) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.06 0.07 0.00 
C-C (E) 0.59 0.48 0.37 0.53 0.35 0.68 0.54 0.59 0.51 0.57 0.49 0.65 0.39 
C-O or 
C-N(E) 




0.08 0.09 0.09 0.08 0.09 0.05 0.11 0.09 0.11 0.08 0.10 0.05 0.15 
Beta 
C(E) 
0.08 0.09 0.09 0.08 0.10 0.06 0.11 0.10 0.11 0.09 0.12 0.06 0.16 
C=O (E) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.02 0.03 0.04 0.00 
C-C(T) 0.67 0.57 0.41 0.37 0.34 0.33 0.69 0.64 0.61 0.54 0.55 0.57 0.50 
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Table A6-4 continued: 
C-O(T) 0.23 0.33 0.48 0.51 0.54 0.57 0.20 0.23 0.26 0.23 0.21 0.18 0.33 
C-N(T) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.08 0.09 0.00 
O-
C=O(T) 
0.10 0.10 0.10 0.12 0.11 0.11 0.11 0.12 0.13 0.10 0.08 0.07 0.17 
O-
N=O(T) 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.08 0.09 0.00 
Sq 0.52 0.40 0.28 0.24 0.22 0.55 0.41 0.27 0.25 0.21 1.43 0.21 3.09 
































8.85 4.96 6.21 3.65 7.77 6.33 3.37 4.87 3.63 8.56 2.95 13.02 















Sa 0.30 0.25 0.20 0.18 0.17 0.41 0.26 0.21 0.19 0.16 1.04 0.16 2.21 
Sk 0.73 0.66 0.60 0.53 0.52 1.19 0.66 0.64 0.57 0.50 1.80 0.50 4.43 
Spk 0.95 0.54 0.36 0.27 0.27 0.65 0.34 0.25 0.22 0.21 2.42 0.21 5.47 














































Sxp 0.63 0.60 0.51 0.45 0.44 1.07 0.56 0.53 0.48 0.41 2.71 0.42 5.87 
Vvv 0.06 0.05 0.03 0.03 0.02 0.06 0.07 0.04 0.03 0.03 0.18 0.03 0.40 
Vvc 0.37 0.36 0.29 0.25 0.25 0.64 0.32 0.30 0.27 0.24 1.72 0.24 3.55 
Vmp 0.05 0.03 0.02 0.01 0.01 0.03 0.02 0.01 0.01 0.01 0.08 0.01 0.21 




















Str 0.53 0.46 0.49 0.69 0.36 0.40 0.70 0.68 0.66 0.62 0.54 0.56 0.50 
Surface 
area 
4.49 4.46 4.44 4.55 4.38 4.61 4.66 4.65 4.61 4.48 6.69 4.49 11.04 
WetM 32.0 37.0 39.0 354 157 52.0 1275 3380 2697 2280 1850 1150 * 
Tg -37 -37 -41 -5 -3 -28 15 37 68 138 119 119 87.6 
Theta 96.0 92.0 85.0 75.0 69.0 72.0 94.0 82.0 75.0 61.0 65.0 64.0 69.5 





A.7. Representative high resolution C1s XPS data for polymethacrylate library 
These data were fitted by Dr. Rana Sodhi at University of Toronto.  
C1s = C-C 
C1sA = C-O 
C1sB = O-C=O 
C1sC = C-COO (beta carbon) 
C1sD = C=O 
 
polyEGMA (EGMA) poly(hydroprypyl)MA (HP) 
  







































A.8. Representative high resolution C1s XPS data for terpolymer library 
 
These data were fitted by myself at Georgia Institute of Technology.  
C1s = C-C 
C1sA = C-O 
C1sB = O-C=O 
C1sC = C-COO (beta carbon) 





























A.9. Representative surface roughness images for polymethacrylate library 
(measured by LEXT 3D confocal microscope) 
 
 
polyEGMA (EGMA) poly(hydroprypyl)MA (HP) 
  
poly(isobornyl)MA (isobornyl) poly(methyl-EGMA) (Me-EGMA) 
  

































A.10. Representative surface roughness images for terpolymer library 

























A.11. Representative ToF-SIMS scans for terpolymer library 
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